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Abstract 
We have become very familiar with the genome being represented as a one-
dimensional sequence of the four nucleobases – cytosine, guanine, adenine and 
thymine. However, in reality this chain folds and is densely packed into the nucleus 
of eukaryotic cells in a three-dimensional (3D) setting, meaning that pairs of 
otherwise remote areas of the genome can come into close proximity in 3D space. It 
is thought that the expression of target genes is influenced by remotely acting 
regulatory elements, such as enhancers, which are often located several kilobases 
away from the genes they target. 
In our studies we hypothesised that communication between widely spaced genomic 
elements is facilitated by the spatial organisation of chromosomes that bring genes 
and their regulatory elements in close spatial proximity. We explored this hypothesis 
in three distinct contexts: (1) reduced/incomplete penetrance, where disease 
genotypes do not always induce the expected phenotype; (2) gene fusion events, 
known to be frequent in cancer; (3) schizophrenia, a complex brain disorder. Whilst 
previous studies acknowledged the role of polygenic activity in these genetic 
diseases and phenomena, they did not integrate this idea into existing 
detection/prediction techniques. Our analysis addressed this oversight by 
transforming traditionally one-dimensional studies into a contextually relevant, 3D 
setting. 
We utilised data describing the 3D structure of the human genome, alongside prior 
knowledge of various diseases and genetic phenomena, to predict novel genomic 
regions of association. Our approaches incorporated network, statistical and 
computational methods to identify where these regions of interest lie. Identified 
regions were investigated further to ascertain biological properties, such as an 
enriched presence of mutations, functionally relevant genes, regulatory elements, or 
all of the above. Whilst existing approaches tend to fixate on only these static 
properties, our studies also focused on the communication of otherwise remote 
regions by creating 3D interaction networks that describe the spatial proximities of 
genomic fragments. The most important units of such networks were identified via 
x 
 
centrality measures and statistical testing, followed by subsequent biological 
interrogation of so-called candidate regions. This method ultimately confirmed 
whether regions were genuinely disease-associated via polygenic activity, or not. 
A total of 35 novel schizophrenia candidate regions were identified using our 
approach, 22 of which contained polymorphisms with prior schizophrenia 
association; most variants found were shown to influence gene expression 
specifically in brain tissues. We were also successful in showing that cancer-causing 
gene fusion events are catalysed by paired fusion gene-containing fragments (of 
lengths 1 megabase and 100 kilobases) sharing small 3D neighbourhoods, 
particularly for genes residing on different chromosomes. Our transformation of 
existing approaches into 3D studies has therefore elucidated features and properties 
of genetic disease and cancer that were otherwise unknown or overlooked.   
xi 
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Chapter I 
Introduction 
 
1. Introduction 
Our current understanding of genetics originates from as early as the mid-nineteenth 
century, with Gregor Mendel’s experiments on smooth/wrinkled pea plants (Mendel, 
1865). His work was the first to describe inheritance as a culmination of discrete 
hereditary units (now known as genes) rather than a blend of parental traits. At the 
time, Mendel focused on the biological output, or observed traits (phenotype), in 
order to make implications about the nature of the genetic input (genotype). 
Nowadays, thanks to the various stages of DNA discovery (reviewed in Dahm, 2008; 
Watson & Crick, 1953), we know the physical structure of our genome. We are also 
beginning to understand that changes in the genome, called polymorphisms (that 
occur in >1% of the population) or mutations (that occur in <1% of the population), 
may or may not alter our phenotype. Quite often, a single mutation does not change 
any physical trait, although a specific collection of mutations could work together to 
induce phenotypic change. There are many well-understood cases of single gene 
mutations causing disease (monogenic disorders), such as sickle cell disease (Ashley-
Koch et al., 2000), cystic fibrosis (Ratjen & Döring, 2003), polycystic kidney disease 
(Adeva et al., 2006) and Tay-Sachs disease (Neudorfer et al., 2005). However, most 
diseases are complex, involving a number of different mutations at multiple genes. It 
is the interactions and relationships between genes in this context that is understood 
to a lesser extent – particularly when a group of related genes are at seemingly 
remote distances from one another. This has been previously reported as the 
omnigenic model (Boyle et al., 2017). 
Single nucleotide polymorphisms (SNPs) are individual DNA base pair changes 
common in the human genome. Most SNPs occurring in humans do not induce any 
negative effects, but it is important to catalogue those that do, whether they are a 
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major participant in a monogenic disorder or a minor participant in a polygenic 
disorder. The cataloguing procedure is achieved via genome-wide association studies 
(GWAS): SNPs are measured and analysed from across the genomes of patients and 
healthy individuals in order to reveal genetic risk factors for disease (Bush & Moore, 
2012). For common, monogenic disorders, this process is straightforward (given a 
large enough sample size). However, for rarer or more complex diseases involving 
multiple SNPs at multiple genes, the process is less clear, since a number of SNPs 
could have a large combined effect despite having individually small effect sizes (this 
idea is explored further in section 6.1.2). 
This uncertainty motivated advances in genome sequencing (reviewed in Goodwin et 
al., 2016) and the interrogation of 3D genomic structure by measuring proximities of 
DNA fragment pairs (described at length in chapter 2). The ENCODE (Encyclopaedia 
of DNA Elements) Project has also been responsible for cataloguing various 
regulatory DNA elements which regulate gene expression; these elements lie in 
regions that were previously thought to have no functional relevance (so-called junk 
DNA; The ENCODE Project Consortium, 2012). 
Improving the accuracy, cost and cell line availability for these new laboratory 
techniques is now the main focus, especially if we wish to use resulting data to 
investigate cell-specific diseases. With increasingly comprehensive laboratory data 
available, we are better able to identify novel long-range relationships between 
genomic regions by employing various network techniques (described in chapter 3) 
and other bioinformatics tools. Furthermore, the amalgamation of cutting edge 
methods for quantifying 3D genomic distances alongside the techniques of network 
science promises to provide a gateway into identifying previously unknown 
regulators of genetic disease. 
In particular, we focus on the effects of remotely acting SNPs in three areas: (1) 
schizophrenia, a complex disorder of the brain; (2) reduced penetrance, a 
phenomenon where one’s genetic code does not always predict the expected trait; 
(3) cancer-associated gene fusion events, where two previously separate (and often 
7 
 
remote) genes merge as a result of the rearrangement of large chromosomal 
segments. 
The proceeding sections outline our formulated hypotheses, which is followed by a 
historical review of existing approaches that partially address the problems we 
discuss. We then go on to review previous biological applications of network analysis, 
with the view to incorporate similar techniques in our work. 
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1.1. Thesis Aims and Objectives 
The aim of this study is to combine cutting edge data quantifying the 3D structure of 
the human genome and network science approaches to identify and investigate 
previously unknown remotely acting regulatory regions underlying genetic disease 
and cancer. The following text outlines the hypotheses for each of our studies, which 
are described in more intricate detail in later chapters. All computational analysis in 
this thesis was implemented in version R2016a of MATLAB and/or version 3.6 of 
Python.  
For the reduced penetrance phenomenon, we hypothesised that the folding 
principles of the human genome are at least partially responsible for the level of 
penetrance exhibited in a population. We aimed to test this hypothesis by showing 
that (1) remote pairs of genes known to participate in the incomplete penetrance of 
a disease are within shared 3D neighbourhoods; (2) all or most known genes share 
communications with common genomic fragments; (3) each unique gene pair 
communicates with their own distinct genomic fragments. 
For cancer-causing gene fusion events, we hypothesised that the 3D structure of the 
human genome contributes to the choice of fusion partners. This was investigated 
using two main approaches: (1) we proposed that any region harbouring a fusion 
gene would show a closeness to other fragments within the cell nucleus, and (2) we 
hypothesised that one half of a known fusion gene pair would consistently favour a 
particular gene as a fusion candidate. 
Finally, for our analysis of schizophrenia, we hypothesised that both common and 
individually rare variants exert their influence on gene expression, either (1) directly 
via long-range looping interactions between fragments that harbour regulatory 
elements and target genes, or (2) are propagated via the network of communications 
governed by the 3D architecture of the human genome. We also further investigated 
any interesting regions found to determine various factors such as the ontology of 
contained genes, the relative expression of such genes in brain tissues and the 
presence/absence of mutations. This was in order to build evidence for regions 
having a genuine and previously unfound association with schizophrenia. 
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1.2. Penetrance 
Penetrance is a genetic phenomenon whereby an individual can harbour a particular 
disease mutation without actually exhibiting any of the disease traits. The terms 
penetrance and expressivity are distinct, but are often mistaken as being identical. In 
actual fact, penetrance for an individual patient is the binary identifier of phenotype 
presence, given a particular genotype, whereas expressivity describes the (non-
binary) extent to which an existing phenotype is expressed. Hence, despite the 
distinctions, there is overlap in the two phenomena; it is possible for one to view 
penetrance as a pole on the expressivity scale (Zlotogora, 2003). It is also important 
to note that penetrance can be measured on a scale, although this scale would be 
the ratio of patients from a population that exhibit the binary true phenotype to 
those that do not. 
1.2.1. Approaches that Predict Penetrance 
Since penetrance is typically a lifetime measure (i.e. the detection of phenotype 
presence at any stage during one’s lifetime), the ideal way to predict penetrance 
would be to obtain sequenced genomes from birth and track each patient’s disease 
status until death. This would allow us to group patients with a similar genotype 
together and identify a subset that developed the disease in question at some point 
before death, thus giving us the true penetrance. Unfortunately, this method has 
some logistical problems, such as: (1) it would take a whole lifetime to generate 
meaningful results, and (2) despite recent improvements, the cost of sequencing a 
single human genome is still too large to be performed on a mass scale (initially 
costing approximately $100 million per genome in 2001, to several thousands of 
dollars today; Wetterstrand, 2017). 
Therefore, researchers have devised more practical methods to estimate the 
penetrance of genetic diseases. To circumnavigate time and cost, it has become 
common practice to seek out individuals with a disease phenotype and work 
backwards to ascertain their genotype. Typically, immediate relatives would also be 
investigated and a level of penetrance would be predicted from a collection of 
resulting family samples, in what is commonly known as the family-based method 
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(Ford et al., 1998; Wang et al., 2006; Gong et al., 2010). The family-based method, 
however, is prone to overestimating penetrance based on the biased way in which 
data is collected (Minikel et al., 2014). The sampling is not representative of the 
population, since (1) subjects were preferentially chosen based on exhibiting the 
phenotype of a rare disease, (2) families were preferentially chosen if more than one 
relative exhibited the phenotype and (3) relatives not displaying the phenotype may 
not have been genotyped. 
The criticisms described above are difficult to avoid, since it is not common practice 
to test seemingly healthy individuals for rare disease; resources will usually only be 
used for those that show relevant symptoms. Despite this mentality, attempts have 
been made to eliminate the preferential sampling bias, such as the kin-cohort 
method (Wacholder et al., 1998), which obtained the 70-year penetrance of 
mutations in the BRCA1 and BRCA2 genes responsible for breast/ovarian cancer 
(reported as 63%), by genotyping randomly selected individuals and first-degree 
relatives. This, however, is only feasible for common mutations, since it is possible 
that random sampling will not pick up any individuals affected by a rare variant, even 
for large sample sizes. 
Due to the various limitations of family-based techniques, recent research has 
shifted to population-based methods, which is principled on the assumption that a 
genetic variant with perfect penetrance is no more present in the population than its 
corresponding phenotype. However, population-based methods for complex 
diseases rely on the availability of large databases that capture genetic variation. The 
Exome Aggregation Consortium browser (ExAC) partially solves this problem; it has 
summary data of 60,706 unrelated sequences obtained from an array of published 
disease studies (Lek et al., 2016). Allele frequencies for uncommon disease-causing 
variants can easily be queried using ExAC, which therefore gives the user a clear idea 
of the expected phenotype frequency and enables them to compare this to an 
observed phenotype frequency, thus measuring penetrance. 
The key advantage with this method is the lack of sampling bias seen for family-
based methods, although one should be wary of how variants in population-based 
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databases have been classified as disease-associated. Databases such as the Human 
Gene Mutation Database (HGMD) have information for approximately 203,000 
unique gene lesions obtained from around 2,600 journals (Stenson et al., 2017), 
although if each of the reported disease-associated lesions resulted in the expected 
phenotype, the average individual in ExAC would have a plethora of genetic diseases 
(Lek et al., 2016). It is therefore difficult to distinguish between reports of genuine 
disease-causing mutations that have incomplete penetrance to those that are simply 
falsely interpreted as being associated. We suggest that a possible way to alleviate 
this problem is to use 3D interaction data to determine whether variants participate 
in polygenic activity. This would act as a vetting process for individual variants that 
would either strengthen or weaken the claim that they are disease-associated and 
have low penetrance. For example, variant 1S  has a reported association with 
bipolar disorder, but is almost completely non-penetrant according to ExAC data. It is 
possible that 1S  interacts with a remote variant, 2S , which in turn causes an 
increased penetrance of bipolar disorder. Ordinarily, 1S  may have been reported as 
being falsely associated, whereas 2S  would claim full credit for the association with 
bipolar disorder. In reality, 1S  is not discounted, since it participates in long-range 
polygenic activity that increases the effect of 2S . 
1.3. Gene Fusion Events 
A fusion gene forms from the merging or two previously separate (and often remote) 
genes as a result of rearrangements of large chromosomal segments. The first 
discovery of a gene fusion was initially mistaken in 1960 for a large deletion, 
resulting in patients with chronic myeloid leukaemia (CML) having an unusually small 
chromosome (Nowell, 2007). Since this initial observation, it was shown that a 
translocation had occurred between breakpoints at the ABL1 gene on chromosome 9 
and the BCR gene on chromosome 22. The resulting BCR-ABL1 fusion was the first 
discovery of its kind; the host of the fusion gene itself would later be termed the 
Philadelphia chromosome, named after the location of its origin (Mitelman et al., 
2007). 
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1.3.1. Databases of Fusion Genes 
Subsequent years of research have led to a developed understanding of 
chromosomal rearrangement. Because of the significant ties fusion genes have with 
carcinogenesis (Edwards, 2010), numerous attempts have been made to 
comprehensively list all known and potential cases through varied approaches (Novo 
et al., 2007; Kim et al., 2007; Kim et al., 2006, 2009; Frenkel-Morgenstern, 2012; 
Forbes et al., 2014; Wang et al., 2015, Lee et al., 2017). The number of putative gene 
fusion events has increased dramatically from several hundred (358; Mitelman et al., 
2007) to thousands (10,534; Forbes et al., 2014). 
Initial efforts focused on the identification of translocation breakpoints as a first step 
towards finding fusion genes. The database of Translocations in Human Cancer 
(TICdb; Novo et al., 2007) catalogues the genomic locations of 1,225 breakpoints in 
tumours; 949 were shown at nucleotide level and the remaining 276 were described 
at intron/exon resolution. In later work, an increasing number of breakpoints were 
found (8,943 deletion breakpoints) and their association with epigenetic features 
and 3D proximity was investigated (Abyzov et al., 2015). 
The Catalogue of Somatic Mutations in Cancer (COSMIC; Bamford et al., 2004; Forbes 
et al., 2016) was also being curated at a similar time to TICdb. Originally, this 
database identified four cancer genes, but has since utilised 12,542 cancer genomes 
to identify over 10,000 fusion mutations as well as millions of coding and non-coding 
mutations (Forbes et al., 2014). Both databases validate their entries by searching 
existing literature via PubMed and online data portals. 
Further research incorporated computational techniques in order to predict fusion 
regions as well as identify them. Developments of sequencing technologies gave way 
to detections of more fusions, particularly through transcriptome analysis (Wang et 
al., 2015). The second version of ChimerDB was created using human transcriptome 
(RNA-seq) data, with fusion candidates pruned through literature mining (Kim et al., 
2009). This consequently acted as a reliable reference dataset for computational 
tools that sought to predict fusion regions, such as the Fusion Simulator (FUSIM; 
Bruno et al., 2013). The database of Chimeric Transcripts and RNA-seq data (ChiTaRS; 
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Frenkel-Morgenstern et al., 2012) is an extension of ChimerDB; it includes 
approximately 2,000 cancer breakpoints from humans, mice and fruit flies. It also 
describes expression relative to specific tissues, as well as ranking regions based on 
the strength of evidence for breakpoint presence among repeated experiments. 
Recently, ChimerDB has undertaken a further revision (ChimerDB 3.0; Lee et al., 
2017). It is a development of version two that includes further data via a three-
pronged attack: firstly through a knowledgebase from public resources and 
experimental evidence (such as COSMIC, ChimerDB 2.0, TICdb, OMIM and 
Mitelman’s database); secondly via keyword mining of PubMed abstracts; and finally 
from next-generation sequencing data as well as further data on the molecular 
characteristics of human cancer, such as The Cancer Genome Atlas (TCGA; The 
Cancer Genome Atlas Research Network, 2008). ChimerDB 3.0 is therefore perhaps 
the most complete and reliable database as a result of its incorporation of historical 
and new identification techniques. 
1.3.2. Approaches that Predict Fusion Events 
Fusion events are characterised by a large variation in linear genome structure, 
usually via deletions or insertions of relatively long DNA sequences (Wang et al., 
2012). Gene fusions are of particular interest because of their strong link to a 
number of cancers (Watson et al., 2013; Yoshihara et al., 2015). The size of the 
deletion/insertion is what makes fusion events distinct from other mutations; 
computational techniques that aim to identify and predict fusion events are 
therefore designed to detect this signature by comparing various sample sequences 
to a reference sequence. 
In recent years, the efficiency of various sequencing methods, collectively known as 
next generation sequencing (NGS) technologies, has vastly improved. It is no surprise 
that the development of NGS has given way to advances in detection and prediction 
of gene fusion events, since computational tools heavily rely on the availability of 
sequence data. Almost all detection algorithms utilise data from one of three NGS 
methods: whole genome sequencing (WGS), whole transcriptome sequencing 
(commonly referred to as RNA-seq) and targeted sequencing. 
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As its name implies, WGS is a thorough method that sequences the entire collection 
of approximately 3 billion base pairs of coding and non-coding DNA. Bioinformatics 
tools that utilise data from WGS have identified an array of novel cancer-causing 
fusion events, including: various fusions of genes PML, RARA and LOXL1 affecting 
acute myeloid leukaemia (AML; Welch et al., 2011); fusion gene VTI1A-TCF7L2 
causing colorectal cancer (Bass et al., 2011); fusion gene PVT1-CHD7 causing lung 
cancer (using lung cell lines; Pleasance et al., 2010). The benefit of using WGS over 
other NGS methods is its comprehensiveness, although this can come at a huge 
computational cost. The start-to-end process of detecting and validating a fusion 
gene can take months (for example, WGS identification of gene fusions causing AML 
took 7 weeks; Welch et al., 2011). Also, the inclusion of non-coding regions implies 
that an additional step of observing the expression of potential fusion sites is 
required before classifying them as genuine fusion events. 
Mostly because of the computational cost of WGS methods, RNA-seq tools have 
emerged as the preferred choice to identify gene fusions. The transcriptome is a 
collection of protein-coding genes derived from the original recipe of the genome 
and therefore consists of a small subset of the initial ~3 billion base pairs 
(approximately 2%; Sboner et al., 2010). This poses a significant speed advantage 
over WGS at the cost of reduced complexity. Nevertheless, it is evident that RNA-seq 
is the preferred choice of NGS data, since the majority of recent studies use it for 
detection and prediction. Examples include: a total of 51 novel fusions found to 
affect breast cancer (Zhao et al., 2009; Maher et al., 2009a; Ha et al., 2011; Edgren et 
al., 2011; Robinson et al., 2011); 39 fusion genes affecting prostate cancer (Maher et 
al., 2009a; Maher et al., 2009b; Palanisamy et al., 2010; Nacu et al., 2011; Pflueger et 
al., 2011); fusion gene AGTRAP-BRAF causing gastric cancer (Palanisamy et al., 2010). 
Despite the popularity of RNA-seq techniques, one must be wary of the limitations 
that a reduction of complexity causes, such as its inability to detect fusion sites in 
non-coding regions. Furthermore, genes have typically variable expression profiles 
across different tissues, hence making the detection of a genuine fusion transcript 
slightly more complicated than the comprehensive WGS method. 
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Targeted sequencing is a lesser-used NGS method that is perhaps seen as the 
middle-ground between WGS and RNA-seq, in that it maintains the complexity of 
WGS methods, whilst performing at a speed comparable to RNA-seq. The relative 
speed of this method comes as a result of only a portion of the genome being 
sequenced. This has been successfully applied in some cases, such as identifying 11 
novel fusion genes causing leukaemia (Grossman et al., 2011) and also detecting the 
fusion gene C6orf204-PDGFRB affecting T lymphoblastic lymphoma (Chmielecki et al., 
2010). However, it is difficult to apply targeted sequencing to the general detection 
and prediction of fusion events, because of its reliance on prior knowledge. 
It seems that of the two most commonly used NGS techniques, WGS and RNA-seq, 
the trade-off when considering which to use tends to be speed versus complexity. 
Hence, given the continued increase of computing power coupled with the 
optimisation of bioinformatics techniques, it is perhaps feasible to detect and predict 
fusion events by finding overlaps between both methods. This has already been 
successfully attempted with a study validating fusion events responsible for prostate 
cancer (McPherson et al., 2011), although the study cited a large computational time 
as a limitation, and one could argue that requiring a common agreement between 
both techniques could lead to genuine gene fusions being missed. 
1.4. Schizophrenia 
Schizophrenia is a chronic, severe and disabling brain disorder, with common 
symptoms including hallucinations, delusions and changes in behaviour. Many brain 
disorders, including schizophrenia, are typically diagnosed based on the observations 
of a subject’s behaviour and functions rather than on genetic factors (McCarthy et al., 
2014). This is especially surprising given that schizophrenia is widely established as a 
heritable disease (Cardno & Gottesman, 2000; Keller et al., 2012). The historical aim 
has been to be able to diagnose and treat schizophrenia based on knowledge of 
genetic markers, rather than rely on observed phenotype. Despite huge advances in 
sequencing techniques, there is still an absence of individual genes known to have a 
large influence on schizophrenia (Kumar et al., 2014). 
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1.4.1. Approaches that Predict Schizophrenia-Associated Variants 
Genome-wide association studies (GWAS) have, however, succeeded in identifying a 
community of common variants that have a small effect on the disorder (Ripke et al., 
2011, 2013). These variants are among millions of single nucleotide polymorphisms 
(SNPs) that are assigned schizophrenia association p-values. Furthermore, common 
SNPs, such as the ones found by GWAS, are responsible for an estimated 23% of 
total schizophrenia risk (Lee et al., 2012), with this percentage projected to increase 
after an increase of sample sizes. 
Whilst these studies are effective at introducing small-effect SNPs and implying their 
combined influence on schizophrenia, the interactions between SNPs and underlying 
mechanisms were seldom explored. Hence, emphasis seems to have shifted to 
understanding and identifying polygenic activity in schizophrenia development. A 
case-control study found thousands of common alleles of small effect size 
contributing to a considerable schizophrenia risk, as well as other brain-related 
disorders such as bipolar disorder (Purcell et al., 2009). Results like this have 
motivated the polygenic risk score (PRS; Euesden et al., 2014), which predicts 
phenotype likelihood based on an accumulation of SNPs with varying individual 
effect. PRSs were achieved by performing logistic regression analysis (described in 
detail in section 3.2.1) using SNPs sampled at various association thresholds, hence 
casting a wider net by including individually small-effect SNPs. Various studies 
proposed that SNPs with high PRSs were not randomly distributed among genes, 
rather they resided in or near genes whose functions were related. This hypothesis 
has been supported via pathway-based and gene set analyses for neurological 
disorders such as Parkinson’s disease (Holmans et al., 2012), bipolar disorder 
(Holmans et al., 2009) and schizophrenia (He et al., 2017). Pathway- and set-based 
analyses are methods that categorise SNPs and expressed genes into distinct 
biological processes or functions, therefore creating various groups containing 
affected genes of perceived similarity. For complex disease, these methods are 
important, since the emphasis lies on identifying interdependent variants that do not 
have stand-alone disease associations. The Multi-marker Analysis of GenoMic 
Annotation (MAGMA) tool (de Leeuw et al., 2015) is perhaps one of the strongest 
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examples of analysing aggregated GWAS data to predict genomic elements 
associated with disease, and has been found to perform well in identifying additional 
influencers of Crohn’s disease. 
A fundamental flaw that is common with these methods, however, is the initial 
process of pairing SNPs with the correct target genes. Typically, SNPs were paired 
with the nearest gene on a one-dimensional (1D) chromosome, despite 
approximately 86% of SNPs targeting genes outside of their nearest 1D neighbour 
(Mumbach et al., 2017). This gives way to a high risk of incorrect targets, which could 
be alleviated by incorporating data that captures 3D proximities of the whole human 
genome in order to correctly identify target genes. 
We are now entering a new era of investigation of complex disorders such as 
schizophrenia. The recent emergence of putative schizophrenia markers and the 
knowledge that schizophrenia is a disorder of the developing brain (Hannon et al., 
2016) has given way to techniques that quantify genomic fragment proximities in 
young brain tissues (Won et al., 2016). This allows for small-effect SNPs identified by 
GWAS and groups with high polygenic risk scores to be investigated in a tissue-
specific context and as a community of interactions, rather than individually, since 
schizophrenia is far from monogenic in nature. 
1.5. Biological Networks 
We have arrived at a point in research where our knowledge of biological 
components is good, but our understanding of how they communicate in systems is 
still lacking. Traditionally, we have interpreted systems in a linear and chronological 
sense, like a chain reaction or domino effect. Nowadays, we understand that 
complex biological systems communicate in all directions and often in parallel 
(Buchanan, 2010). In the following text, we describe prevalent examples of networks 
in biology that aim to elucidate and quantify these communications within biological 
processes. 
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1.5.1. Cellular Networks 
Gene regulatory networks are a perfect example of what were once thought to flow 
in a single direction. Our initial understanding was that genes coded for proteins, and 
proteins carried out a particular function. We have since discovered that genes are 
regulated by proteins called transcription factors (TFs), which bind to promoters that 
control the transcription of other genes. Clearly, the information flow described here 
is from protein to gene, therefore the previously-thought chronological process is 
shown to also communicate in more than one direction. The biological components 
in gene regulatory networks are classified as either sequence information or proteins, 
where sequences can include genes, promoters, enhancers, silencers or RNA – all of 
which influence gene expression. The connections in these networks are 
representative of the passing of information, ultimately leading to the expression of 
a gene. In such networks, one must also account for activity within the cell. That is, 
cells behave differently depending on their cell cycle stage, therefore these networks 
are time-dependent; information flows that exist at one moment may not 
necessarily exist at an earlier/later stage. 
Since proteins rarely work in isolation (Robinson et al., 2007), it is important to 
understand how they can interact to form larger structures and affect the speed or 
nature of a biological process. One can therefore investigate proteins independently 
from genes or promoters, in what are called protein-protein interaction networks 
(PPIs; Phizicky & Fields, 1995). The connection of proteins is determined by whether 
they physically or logically interact. Physical interaction constitutes a spatial 
neighbourhood between single proteins that may result in their merging into a larger 
structure, whereas logical interactions account for protein complexes. That is, 
connections exist between proteins that are a part of larger interacting structures, 
despite them not being individually bound together (Gavin et al., 2002). 
Metabolic networks describe reactions caused by specific proteins called enzymes 
(Jeong et al., 2000). The components of a metabolic network are chemical 
compounds present in the cell, and typically one-way connections describe a 
reaction that leads to a new compound. In many cases, the chemical reactions 
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produce more than one output – connections can be assigned weights 
corresponding to the physical quantity of each output, thus distinguishing between 
the efficacies of various chemical reactions. 
1.5.2. Disease Networks 
The relationship between hazardous genotypes and phenotypes (collectively known 
as the diseasome) is often described using human disease networks (HDN; Goh et al., 
2007), where members of the diseasome connect if a gene has some functional 
association with the disease phenotype. Since many disorders are complex in nature, 
it follows that a single disease can be connected to many genes and conversely, a 
single gene may play a role in more than one disorder. 
To this end, the disease gene network (DGN) is an adaptation of the HDN that 
connects genes that are associated with the same disorder (Goh et al., 2007). The 
DGN is flexible in the sense that the interpretation of ‘disorder’ can vary – one could 
connect genes associated with schizophrenia, for example, but one could also simply 
connect genes that are associated with any brain disorder. The benefit of these 
networks is that they can reveal clusters of genes that could consequently be 
investigated in other settings, such as the aforementioned PPIs, regulatory networks 
or even 3D interaction networks. 
1.5.3. Neuronal Networks 
Using neuronal networks to map both the functional and structural features of the 
brain has become more commonplace in recent literature, especially because of 
advances in technologies such as magnetic resonance imaging (MRI; Bullmore & 
Sporns, 2009). Ideally, a network would consist of individual neurons being 
connected by synapses, although this soon renders the network too complex for 
current technology if considering the whole human brain. Therefore, larger-scale 
networks partition the brain into regions, and connections form as a result of general 
synaptic activity, which sacrifices specificity for the benefit of computational 
efficiency. 
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The common denominator with all of the existing biological networks described 
above is the unique ability of networks to be able to represent communications, 
rather than observing biological units in isolation. This is exactly why we have chosen 
to utilise networks for our own analysis – we are interested in the long-range 
communications between sections of the human genome, as opposed to simply 
observing the features of DNA fragments independently. 
1.6. Thesis Overview 
This thesis employs mathematical, statistical and computational procedures to 
identify and catalogue novel genomic regions which have an association with 
particular diseases and genetic phenomena. Our search criteria for identifying sets of 
SNPs is primarily focused on the 3D architecture of the human genome; the premise 
is that one-dimensionally remote regions of the genome can be spatially close in a 
3D setting, which can consequently affect mutation behaviour and therefore overall 
function. 
Chapter 2 gives an in-depth description of our most fundamental resource, Hi-C data, 
and articulates the history of methods that led to this means of quantifying the 
proximities of all genomic regions. A timeline of these procedures is given; the 
efficacy of such experiments has a correlation with developments in computing and 
consequently sequencing power. As such, we find that the pool of up-to-date Hi-C 
procedures offer the most reliable means of analysing the folding patterns of the 
human genome. Emphasis is given to interaction frequencies and reported 
normalisation techniques implemented to avoid potential bias in any experimental 
procedures, so that clear and accurate conclusions are made. 
In Chapter 3, we introduce the mathematical techniques that are applied to our Hi-C 
data that aid in the identification of important genomic regions. Firstly, we define 
what a network is and provide a number of examples of the different types of 
network models that have been used to describe biological data to date. We then go 
on to describe various network measures, focussing on those that are useful for 
identifying the most important/influential genomic regions. We then consider the 
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implementation of two different network studies: a top-down (global) and bottom-
up (targeted) approach, where regions that are detected by both approaches are 
considered particularly significant, thus highlighting the power of such a two-
pronged attack. The second section of this chapter describes the statistical analysis 
undertaken. Hypothesis testing and predictive modelling are the two predominant 
methods that we use – both of which have p-values at their core. As well as 
describing each statistical method, we also emphasise the importance of the p-
values found, show how they can be used to interpret results and consider how to 
overcome multiple testing problems common in this area. Finally, we outline the 
implementation of these methods with respect to our aims and hypotheses – the 
results of which are discussed in subsequent chapters. 
In Chapter 4 we observe the first disease-causing genetic phenomenon of our 
investigations – reduced (or low/incomplete) penetrance. A detailed definition is 
given first, followed by a description of how we are able to quantify levels of 
penetrance within populations. We give an outline of our aims and hypotheses for 
the proceeding analysis, and continue on to explain our motivations for choosing 
such hypotheses. A comprehensive database of genes known to influence clinical 
penetrance is introduced, which forms the basis for targeted analysis. For each 
hypothesis, we describe our intended approach in an algorithmic manner. We end 
this chapter by summarising our results and discussing their implications, with the 
end goal of addressing whether we have improved the knowledge of penetrance by 
performing our 3D analysis. 
The second disease-causing genetic phenomenon that we investigate – gene fusion 
events – is the focus of Chapter 5. We first describe a gene fusion by showing the 
three possible processes in which one can occur: a translocation, deletion or 
inversion. Descriptions of hypotheses as well as our motivations are once again 
outlined, followed by the introduction of a database, ChimerDB, which catalogues 
known fusion events. We then present our methods via tailored algorithms and 
finish with a summary and discussion of results obtained from the execution of these 
algorithms. Our discussion includes a critique of our implemented methods as well 
as a conversation about the implications of such results. Most importantly, we 
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discuss whether our findings show an association between the 3D structure of the 
human genome and the incidence of gene fusion events. 
Chapter 6 reports our investigation of the well-known brain disorder schizophrenia. 
We first give an overview of the disease, including some key statistics regarding 
incidence and cause. We follow this with an introduction of single nucleotide 
polymorphisms (SNPs) and explain their role and importance in schizophrenia 
development. Alongside the stating of our hypotheses, we also introduce and 
describe the various tools which aid us in our global and targeted approaches, such 
as DAVID, Braineac and FANTOM. Whilst Hi-C data is now available for brain tissues, 
at the time of study we only had access to Hi-C for blood cell lines. Hence, we justify 
the use of blood Hi-C in this chapter by showing that there is an association between 
the data we used and brain-specific data. Various data sources, including 
schizophrenia-associated genes and SNPs found from genome-wide association 
studies (GWAS), are described. These datasets form the basis for our analysis, 
allowing us first to focus only on regions of the genome relevant to the disease in 
question. We then outline the design of our algorithms and finish by describing our 
findings. Here we apply network techniques to study Hi-C and schizophrenia data. 
Beginning with the global approach outlined earlier, we attempt to find novel 
regions with schizophrenia association. We then use a range of targeted approaches 
to provide supporting evidence which implicate these regions in schizophrenia 
development. That is, an accumulation of positive results for a given region indicates 
strength of association with the disease. We conclude this chapter by highlighting 
the novel candidate regions most likely to be associated with schizophrenia, and 
suggest possible amendments to our analysis given the emergence of cell-specific Hi-
C data. 
Chapter 7 knits all of our analysis in preceding chapters together; our results and the 
efficacy of our methods is summarised, which leads to a discussion regarding routes 
for future work. 
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Chapter II 
Hi-C Data Description 
 
2. Hi-C Data Description 
This thesis centres on the use of Hi-C data and its application in both network and 
statistical approaches. In what follows we shall present a chronological history of 
molecular techniques that serve to quantify the three-dimensional architecture of 
the human genome. We follow this by reviewing existing types of Hi-C protocol in 
order to ascertain strengths/weaknesses of each procedure. Finally, we investigate 
methods that aim to remove pre-existing bias through matrix normalisation 
techniques.  
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2.1. A History of Chromosome Conformation Capture 
Techniques 
The molecular techniques in this chapter all probe the spatial organisation of 
chromatin, which is a complex of DNA, RNA and proteins found in the nucleus of 
eukaryotic cells. Human DNA of a single cell totals an approximate length of two 
metres (reviewed by de Wit & de Laat, 2012), and is therefore densely packed into 
structures called chromatin. We can imagine DNA as a piece of string being wrapped 
around biological spools, which in this case are the alkaline proteins called histones. 
Considering the appropriate resolution, this can resemble a “beads on a string” 
structure. Finally, at a lower resolution and with the addition of so-called scaffold 
proteins, we see DNA packed into a familiar “two-pronged” shape that we recognise 
as a chromosome. 
Understanding the folding mechanisms of chromatin and hence the overall structure 
of chromosomes is the main purpose for developing chromosome conformation 
capture techniques. The resolution of these molecular approaches far outweighs 
what is possible with microscopic techniques (50-100 nanometres (nm); reviewed by 
Barutcu et al., 2015), which is why we see a rapid development of protocols 
described in this section. 
2.1.1. Chromosome Conformation Capture (3C) 
The chromosome conformation capture (3C) technique is known as a one-to-one 
method, since the protocol measures the interaction frequency of two specified 
regions of the genome. The pair of fragments can be either inter- or intra-
chromosomal and the interaction frequency between them correlates to their spatial 
closeness in 3D space, achieved by capturing a population average proximity of the 
locus pair (Dekker, 2006). 
The process for all chromosome conformation capture techniques is initially similar 
in nature: DNA is crosslinked at the location of interest, the chromatin is then 
digested with a particular restriction enzyme, ligation then occurs to “tie up” the 
loose ends in dilute conditions and DNA is then purified. The final stage for 3C is to 
25 
 
detect ligated products using polymerase chain reaction (PCR), which is a method 
that “photocopies” small DNA fragments in order to reveal the interaction frequency 
of pairs from sequence information. 
The choice of restriction enzyme is important when designing a 3C experiment. A 
large-base cutter will digest a fragment of DNA less frequently, resulting in a lower 
resolution because of the larger distance between cuts. A small-base cutter gives 
improved resolution at the expense of increased complexity (figure 2.1). The essence 
of choosing the appropriate restriction enzyme lies in the hypothesis that one may 
wish to test. That is, if the interactions are expected to be over several kilobases (kb), 
a 6-base cutter would suffice (digesting DNA approximately once every 4 kb) 
whereas if the experimenter was interested in a fine mapping of a particular element 
over a few hundred base pairs (bp), a 4-base cutter would be more suitable 
(digestion occurs approximately once every 256 bp; reviewed in Barutcu et al., 2016). 
 
Figure 2.1 Visual representation of 2- and 3-base cutters. A 2-base cutter (GC, blue) digests DNA 
more frequently than a 3-base cutter (GCC, green), resulting in smaller DNA fragments between cuts 
and therefore a higher and more complex resolution. The larger the restriction enzyme, the lower the 
3C resolution. 
With enough 3C experiments, an all-to-all library of interaction frequencies is 
possible, but this would prove to be inefficient in this case. For this reason, it is 
accepted that 3C serves as a technique to use when some prior information is 
already known about the region/s in question, since the most efficient way to utilise 
this protocol would be to specify one region (or very few regions) of interest to 
investigate. 
It is also advised to be mindful when considering the limitations of the 3C procedure. 
For example, the quantified spatial proximity between a given pair of regions from 
3C does not specify which type of long-range contact is made. Therefore, the contact 
of chromosomes could be any or all of the following types: paternal-maternal, 
paternal-paternal or maternal-maternal. Furthermore, 3C may be able to give an 
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indicator of proximity, but it lacks the ability to infer the functional relevance of such 
regions. Finally, 3C is reliable with contacts within a range of approximately 1 
megabase (Mb), but a larger distance affects the accuracy of detection. One should 
therefore be cautious before interpreting results from a 3C experiment – the use of 
additional techniques to validate hypotheses are recommended. 
2.1.2. 4C Methods 
The key to a successful 3C experiment is having prior knowledge about the regions of 
interest before commencing the one-to-one method. The next natural step for 3C 
technologies is therefore to suppose that the interacting regions are not explicitly 
known. For example, perhaps we have a gene that is known to contribute to a 
particular disease, but we are aware that the expression of this gene is regulated by 
a region elsewhere on the genome. The notion of one-to-all approaches is therefore 
necessary to interrogate the entire genome for interactions with a specified region. 
A number of one-to-all approaches were independently developed, all termed as 4C 
methods: 3C on chromatin immunoprecipitation (ChIP) (Simonis et al., 2006), circular 
3C (Zhao et al., 2006), open-ended 3C (Wurtele & Chartrand, 2006) and olfactory 
receptor 3C (Lomvardas et al., 2006). The initial steps of crosslinking, digestion, 
ligation and purification are shared, albeit with particular differences between each 
protocol. For example, the most popular method, 3C on ChIP (which we will now 
exclusively term as 4C), performs two digestion and ligation events in order to trim 
initially large molecules into DNA fragments suitable for PCR (van de Werken et al., 
2012). The defining difference between 4C and 3C techniques is the application of 
“bait” to the region of interest, which in turn results in a pool of interacting regions 
both in cis (inter-chromosomal) or in trans (intra-chromosomal) (reviewed in Sati & 
Cavalli et al., 2017). 
Whilst 4C is a powerful tool to probe genome-wide interactions for a given region, 
one should pay close attention to the results of a 4C experiment. One-dimensional 
neighbours of the baited region should always be represented in 4C libraries with 
high interaction frequencies relative to typically long-range regions. If this is not the 
case, the 4C experiment could be the victim of poor crosslinking, which leads to a 
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high false positive rate from frequent random ligation events (reviewed in Barutcu et 
al., 2015). 
2.1.3. Chromosome Conformation Capture Carbon Copy (5C) 
Prior knowledge of particular fragments of DNA are required for the one-to-one 3C 
technique, as is the case for the chromosome conformation capture carbon copy (5C) 
method (Dostie et al., 2006). The difference, however, is the size of the predefined 
region/s of interest. The 3C method requires a pair of single fragments to be queried, 
whereas the 5C method can probe a group of neighbouring regions, thus converting 
a one-to-one approach into a many-to-many approach. 
Initially, the 3C steps of cross-linking, digestion and ligation are performed, followed 
by the introduction of 5C primers. Hundreds of primers are used as a means of 
simultaneously recombining DNA back into double-helix form at ligation junctions 
from the original 3C library. Once ligated, fragments are amplified using PCR, and 
genomic location is detected with the aid of deep sequencing (Ferraiuolo et al., 
2012). 
This technique seems favourable in comparison to 3C experiments not just because 
of the number of fragments being interrogated, but rather the biological implication 
this has. Transcription often occurs as a result of the interactions of a network of 
neighbours. The neighbourhood of a gene commonly includes interacting enhancers, 
silencers or promoters which are likely to be separated by a region of length ranging 
from a few base pairs up to 1 Mb in distance. Therefore, a many-to-many approach 
encapsulates all of these important genetic elements. 
Due to its similarities to the 3C method, the drawbacks of the 5C design are also 
shared. In particular, the detection range is limited to approximately 1 Mb, hence, 
the exposure of remote interactions is restricted. Moreover, the 5C technique is not 
genome-wide, despite its ability to handle a sample of fragments. This implies that 
one cannot simply go into a 5C experiment blindfolded – some prior knowledge is 
required in order to receive effective results. 
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2.1.4. Hi-C 
We finally arrive at Hi-C – a method that comprehensively maps intra- and inter-
chromosomal interactions of the entire human genome simultaneously (Lieberman-
Aiden et al., 2009; Rao et al., 2014). The general method follows the 3C protocol, 
except changes are made at the point of ligation. Digested ends are filled with biotin 
prior to ligation and unbiased interactions are detected post-ligation with the aid of 
streptavidin – a protein with a high non-covalent affinity to biotin (Green, 1975). 
This all-to-all approach allows for a global view of chromosomal folding, which 
benefits studies that may not have prior knowledge about the region/s of interest for 
the particular genetic feature or disease in question. Of all 3C-based methods 
described, Hi-C is a tool which is perhaps the most suited to find novel regions 
associated with a given disease or feature because of its genome-wide detection 
window. Furthermore, there exists a range of resolutions available for this type of 
data, thanks to the use of several restriction enzymes. 
Interaction frequencies from Hi-C techniques are obtained from millions of cells, and 
are therefore resultants of a so-called snapshot or population average of the 
genome. Thus, the data itself cannot be used to make informed decisions about 3D 
proximity within specific cells/tissues or even the persistence of certain long-range 
interactions over a full cell cycle. One must also be aware of the heterogeneous 
nature of fragment digestion throughout the genome. As discussed earlier, 
restriction enzymes target a specified sequence; therefore guarantees cannot be 
made about their whereabouts. The possibility of high resolution fragment digestion 
at fixed intervals is appealing but not currently viable, and so until this becomes 
plausible, we must understand the limitations of variable fragment lengths and 
choose binned region sizes appropriately. 
The Hi-C method, amongst all preceding methods, is described graphically in figure 
2.2. 
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Figure 2.2 Graphical interpretation of chromosome conformation capture methods: (A) 3C method 
(one-to-one; Dekker, 2006), (B) 4C method (one-to-all; Simonis et al., 2006), (C) 5C method (many-
to-many; Dostie et al., 2006), (D) Hi-C (all-to-all; Lieberman-Aiden et al., 2009). Green nodes 
represent regions of the genome, and edges connect them if interaction frequencies are obtained 
between said regions from the method in question. 
2.2. Hi-C Methods 
2.2.1. Dilution Hi-C 
The first all-to-all 3C-based approach is now commonly referred to as dilution Hi-C 
(Lieberman-Aiden et al., 2009) due to the ligation step of the method being 
performed under highly diluted conditions. The rationale for this is to reduce the 
frequency of illegitimate ligation pairs from molecules that are not initially 
crosslinked. An overview of the dilution Hi-C experiment design is given below. 
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After crosslinking of DNA, genomic fragments are digested using 6-cutter restriction 
enzymes HindIII or NcoI, which cleave DNA at palindromic nucleotide sequences 
A^AGCT_T and C^CATG_G respectively (read from 5’ end to 3’ end; symbols “^” and 
“_” represent exact separation sites). These fragments are ligated in dilute 
conditions if they were crosslinked (hence spatially close), and their genomic 
positions are identified through alignment with the reference human genome, 
revealing the 1 Mb or 100 kb fragments (bins) in which the pair of ligation products 
lie. This constitutes a single interaction frequency between these bins. The process is 
repeated for all ligated pairs and the numbers of interactions are counted. Each of 
these binned regions is represented by a pair of co-ordinates (chromosome, bin 
number), where the bin number corresponds to a genomic range in which a 
particular fragment lies according to the hg18 reference genome (released in March 
2006 and accessed using the Human Genome Browser; Kent et al., 2002). As an 
example, consider a ligated pair of fragments: fragment 1F  lies on chromosome 7 
between positions 9,645,937 and 9,647,029 (inclusive) and fragment 2F  lies on 
chromosome 10 between positions 3,019,234 and 3,024,938. Assuming that the for 
the 1 Mb binning process, fragments within positions 1-1,000,000 are labelled bin 1, 
fragments within positions 1,000,001-2,000,000 are labelled bin 2 (and so on), it 
follows that 1F  has genomic co-ordinates (7, 10) and 2F  has co-ordinates (10, 4). 
Similarly, for the 100 kb binning process, 1F  and 2F  have genomic co-ordinates (7, 
97) and (10, 31), respectively. 
The binning process is executed for DNA regions of size 1 Mb and 100 kb for inter- 
and intra-chromosomal interactions, and the resulting cumulative counts, or 
interaction frequencies (IFs), are collected. Each IF is an indicator of the spatial 
proximity between two given fragments of the genome. That is, a high IF 
corresponds to a pair of fragments being relatively close together in three-
dimensional space, and so the IF can be seen as inversely proportional to distance. 
The ij th entry of contact matrix  ,'M  gives the IF between the i th and j th 
binned regions of chromosomes   and  , respectively. Assuming data is available 
for identical bin sizes of all   and   combinations, we can concatenate each 
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chromosome-chromosome contact matrix into a genome-wide contact matrix, M , 
describing IFs of any pair of regions: 
   
   

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



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Entries of M  are denoted ijm , with each binned region, regardless of chromosome, 
now having a unique index. Suppose  2321 ,,, bbbB   is the set of values that 
represents the number of bins in a given chromosome (e.g.  1,1'M  is of size 1b -by-
1b ,  2,1'M  is of size 1b -by- 2b , etc.). Indices i  and j  of M  can be easily 
recalculated from the original  ,'M  as follows: 
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where 'i  and 'j  are the original indices of  ,'M , and 00 b . 
For example, bins of matrix  1,1'M  would be identical in M , although this changes 
after chromosome 1: bin 154 of  2,2'M  ordinarily has an index of 154. However, 
for the concatenated matrix M , its unique index would be 154 greater than the 
highest index found in  1,1'M . That is, 1541  bi . Indices for subsequent 
chromosomes in matrix M  follow the same rule. 
Both chromosome and genome-wide matrices (sometimes referred to as libraries) 
exist for both karyotypically normal (GM06990 – female blood) and aberrant (K562 – 
female blood with chronic myeloid leukaemia (CML)) cell lines, obtained from a total 
of approximately 10 million individual cells (available at 
http://www.ncbi.nlm.nih.gov/geo/, accession number: GSE18199). 
2.2.2. In Situ Hi-C 
The in situ Hi-C protocol (Rao et al., 2014) follows a similar methodology to the 
dilution Hi-C procedure, but with some key advantages. Four-cutter restriction 
enzymes, MboI and DpnII, are used to digest the genome into small fragments, 
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which consequently allows for a higher resolution of Hi-C library. We have intra-
chromosomal bins ranging from 1 kb to 1 Mb for the in situ method, which achieves 
a resolution 100 times better than the smallest dilution Hi-C bin size. There is also 
inter-chromosomal data available at 100 kb resolution. Also, and perhaps most 
importantly, this new Hi-C method is not performed in dilute solution (in vitro), but 
rather in a true biological context (in situ). This results in a much-reduced false 
positive rate of ligation products, since the frequency of random ligation in situ is far 
lower than in vitro because of chromatin crosslinking being frozen in its natural 
environment (hence there is less unnatural intrusion in the protocol).  
Although the in situ Hi-C experiments devised by Rao et al. span 8 unique human cell 
lines (available at http://www.ncbi.nlm.nih.gov/geo/, accession number: GSE63525), 
we chose to focus on the most comprehensive of these libraries (GM12878 – female 
blood cell line; between 2-5 million individual cells used) for three reasons. Firstly, 
this particular Hi-C library has the highest and most varied resolution of the 8 cell 
lines (ranging from 1 Mb to 1 kb bins). Secondly, the GM12878 cell line is most 
similar to the previous GM06990 cell line used in the dilution Hi-C experiments. This 
enables us to make more confident comparisons between results from both sets of 
libraries. Finally, the in situ Hi-C procedure has an improved signal to noise ratio in 
comparison to dilution Hi-C because of the relative lack of spurious ligations, as 
described above (reviewed in Sati & Cavalli, 2017). 
It is also worth noting that the in situ Hi-C libraries align with the hg19 reference 
genome (released in February 2009 and accessed using the Human Genome Browser: 
http://genome.ucsc.edu/cgi-bin/hgGateway).  Thus, when comparing results 
obtained from both dilution and in situ Hi-C procedures, we can use the Lift Genome 
Annotation program available at http://genome.ucsc.edu/cgi-bin/hgLiftOver on gene 
datasets in order to attain accurate genomic positions between both hg18 and hg19 
reference genomes. 
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2.2.3. Capture Hi-C 
The cost of Hi-C experiments is dependent on the number of paired ends analysed. 
Therefore, the larger the genome, the less likely it is to be able to map genome-wide 
interactions at a high resolution efficiently. The Capture Hi-C (CHi-C) assay (Mifsud et 
al., 2015) is designed in order to circumvent this issue. This approach combines the 
typical Hi-C approach with hybridisation techniques as a means of capturing 
predefined regions of the genome. One could see this technique as a hybrid of Hi-C 
and other 3C-based approaches, since this is a hypothesis-driven Hi-C design. 
The long-range interactions of approximately 22,000 gene promoters are captured 
for two cell lines (GM12878 and CD34, both blood cell types; 30 million total cells 
analysed). For our analysis, we decided to exclusively use reads from the GM12878 
cell line (available at http://www.ebi.ac.uk/arrayexpress/experiments/, accession 
number: E-MTAB-2323), since this sample is common in both CHi-C and in situ Hi-C 
protocols. Baits are used to target promoter regions in the genome and 
subsequently probe interacting fragments, which typically span a few thousand base 
pairs. With this in mind, it is clear that CHi-C provides an extremely high resolution of 
interacting sequences in comparison to the 100 kb and 1 Mb bins seen in dilution Hi-
C procedures. However, due to the specific nature of CHi-C, we do not have 
complete genome-wide libraries at binned intervals, but rather a comprehensive list 
of bait regions and their interacting partners. Thus, CHi-C is likely to be used as a 
secondary tool for analysis after initial findings from all-to-all Hi-C investigations. 
Furthermore, both CHi-C and in situ Hi-C align with the hg19 reference genome, 
which allows for seamless analysis; the need to convert genomic positions is 
removed. 
2.3. Normalisation of Hi-C Data 
The Hi-C procedures described above are not experimentally flawless; there are two 
common biases in particular that exist with most Hi-C experiments. Firstly, it is 
possible that after crosslinking and digestion, the loose ends of a pair of genomic 
fragments may not ligate with one another. Ligation may occur with preference to a 
site which is outside of the intended pair (Yaffe & Tanay, 2011). This results in the 
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presence of false positive reads: a higher than expected IF is observed, leading to the 
potential identification of regions being in a 3D neighbourhood when in actual fact, 
they may be remote. Secondly, the pool of digested fragments is not uniform in 
length, since restriction enzymes target a nucleotide sequence rather than a specific 
position. Hence, crosslinked pairs can have variable lengths which consequently 
affects ligation efficacy (Yaffe & Tanay, 2011). For example, the loose end of a long 
fragment may be too far away to ligate to the intended shorter fragment end, 
resulting in the absence of an interaction where there should be one. Without 
repeating the Hi-C experiment with a catalogue of different restriction enzymes, this 
bias is likely to be predominant in specific genomic regions, since the same 
nucleotide sequence is being queried for cleavage each time. 
There are two ways in which these biases can be treated. Firstly, changes could be 
made to the experimental procedure, such as the choice of restriction enzymes. 
Secondly, a dry-lab solution would be to post-process the resulting data via matrix 
normalisation. Since we are not the creators of Hi-C data and hence cannot change 
experimental procedure, we introduce published techniques which serve to balance 
the contact matrices obtained from Hi-C experiments as a means of lessening the 
effects of experimental bias. These are outlined and described in the proceeding text. 
2.3.1. Raw Data 
Chromosomal fragments are cut at irregular intervals by restriction enzymes, 
resulting in the crosslinked fragments having variable lengths. With this method 
being executed for all regions of the genome, we are left with a pool of ligation pairs 
of different sizes, which are then sorted into an appropriate bin for our contact 
matrix, M . For example, a crosslinked pair of genomic fragments – locus i  from 
chromosome 6, positions 2,387,049-2,388,067 and locus j , also from chromosome 6, 
positions 37,587,185-37,587,980 would have an interaction recorded in 100 kb 
contact matrix M corresponding to row 24 and column 376, corresponding to 
genomic regions 2,300,000-2,400,000 and 37,500,000-37,600,000, respectively. All 
other ligated pairs are indexed using the same procedure until we have a complete 
raw library of interactions between all loci. In cases where the digested fragment is 
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present in two consecutive bins, the interaction frequency is divided evenly between 
both intervals. In rare cases where a fragment may span 3 consecutive bins, the 
central bin will be empty, with the surrounding bins sharing the recorded contact. 
Duplicate contacts, reads that correspond to unligated fragments, or pairs that do 
not uniquely align to the genome are excluded from the completed library. 
2.3.2. Vanilla Coverage Normalisation 
Vanilla coverage (VC) normalisation is used for contact matrices produced by both 
the dilution Hi-C procedure (Lieberman-Aiden et al., 2009) and the in situ Hi-C 
procedure (Rao et al., 2014); it is considered a single iteration version of the 
Sinkhorn-Knopp matrix balancing algorithm (Sinkhorn & Knopp, 1967). Each entry of 
a raw intra-chromosomal contact matrix is given a normalised value corresponding 
to the sum of the row and column it lies upon. The normalised value corresponding 
to the i th row of square matrix M  is given by 
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where n  is the total number of columns (or rows) in M . The denominator in this 
expression equates to the degree of region i , typically denoted ik . Similarly, we 
have the normalised value corresponding to the j th column of matrix M  given by 
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Therefore, each entry of the normalised matrix *M  is denoted as 
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The advantages of this normalisation technique are its simplicity, since it is 
computationally inexpensive (even for large  nn  matrices), and also its ability to 
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handle sparse data, which can cause problems for more complex normalisation 
algorithms. 
Square Root Vanilla Coverage (SQRTVC) 
The VC normalisation technique is prone to an over-adjustment of raw interactions; 
the scalar multipliers ir  and jc  have a large influence on entries of 
*M . In order to 
reduce the effects of these multipliers, each normalisation vector is square-rooted 
such that 
.5.05.0*
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This variant of the VC procedure is known as the square root vanilla coverage 
(SQRTVC) normalisation – it produces normalised counts that share a similarity to 
much more complex and expensive balancing algorithms (Rao et al., 2014). 
Genome-wide Vanilla Coverage (GWVC) 
Ordinarily, the VC procedure performs normalisations per matrix. That is, each raw 
interaction matrix consists of all interactions between a pair of identical 
chromosomes. The genome-wide vanilla coverage (GWVC) method calculates 
vectors r  and c  after concatenating raw matrices of all 529 (23-by-23) chromosome 
pairs, whether inter- or intra-chromosomal. 
This has the advantage of incorporating information for all interactions, so that 
normalisation can be a truer representation of the global folding behaviour of the 
genome rather than focusing on local activity. 
Inter-chromosomal Vanilla Coverage (INTERVC) 
The issue with incorporating both inter- and intra-chromosomal interactions into a 
matrix balancing procedure is that intra-chromosomal counts tend to dominate, 
since their raw interaction frequencies are on average much higher than their inter-
chromosomal counterparts. 
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Hence, the inter-chromosomal vanilla coverage (INTERVC) normalisation procedure 
is created by concatenating all chromosome pairs (as seen for GWVC), but then 
setting all intra-chromosomal interaction frequencies to zero before calculating 
vectors r  and c . Inter-chromosomal interactions are therefore no longer washed 
out by intra-chromosomal counts – this gives a global balancing procedure without 
the bias of one-dimensional proximities. 
2.3.3. Knight and Ruiz Matrix Balancing 
The Knight & Ruiz (KR) normalisation procedure (Knight & Ruiz, 2013) is used 
predominantly with in situ Hi-C data (Rao et al., 2014). Provided that a raw matrix is 
square and has no negative entries, the KR method will normalise such that *M  is 
doubly-stochastic (all rows/columns have an equal sum). 
This was originally achieved by repeating the VC normalisation procedure on a matrix 
until convergence (Sinkhorn & Knopp, 1967), but has since been adapted by Knight & 
Ruiz with improved efficiency. Assuming D  is the operator that converts a vector 
into a diagonal matrix and e  is a vector of ones, the KR method on a square, 
symmetric and non-negative Hi-C matrix,   nnjimM  , is designed to take an 
initial guess for a balancing vector, ox  (usually a vector of ones), and execute 
iterations (similar to Newton’s method) until M  is doubly-stochastic: 
  .11 eMxDx kk

   
After convergence, the final balancing vector, x , is used to create the doubly-
stochastic normalised matrix, *M : 
   .* xMDxDM   
Sparse matrices can be problematic with this method, although this can be 
circumnavigated by removing rows/columns with the highest sparsity. 
Genome-wide Knight and Ruiz Normalisation (GWKR) 
This procedure behaves identically to GWVC (seen in section 2.3.2), with the 
exception that the normalisation technique used is KR rather than VC. 
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Inter-chromosomal Knight and Ruiz Normalisation (INTERKR) 
This procedure behaves identically to INTERVC (seen in section 2.3.2), with the 
exception that the normalisation technique used is KR rather than VC. 
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Chapter III 
General Methods and Implementation 
 
3. General Methods and Implementation 
The analysis carried out in this thesis centres around two main approaches based on 
network theory and statistical testing. This chapter serves as a guide for 
understanding these approaches by giving a description of each measure or test, 
sometimes with example applications. We also briefly discuss the implementation of 
these approaches for our analysis, with supplementary explanations being given in 
the methods sections of subsequent chapters.  
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3.1. Network Theory 
3.1.1. Types of Network 
A network (or graph), G , is a pair of disjoint sets  EV , , where V  is a non-empty 
finite set of elements called nodes (or vertices) and E  is a finite set of distinct pairs 
of elements  ji vv ,  of V  called edges (Wilson, 1970; Newman, 2010). The decision 
to connect a pair of nodes with an edge depends upon the context of a network. 
Typically, nodes represent a set of objects (such as people, genes or websites) and 
edges connect them if there exists some meaningful relationship between a pair of 
such objects (such as functional similarity for a set of genes). 
Often, we can display these as simple networks. A simple network has the property 
of having no loops or multiple edges. That is, a single node cannot have an edge 
connecting to itself (a loop) or a pair of nodes cannot share any more than one edge 
between them (multiple edges). Networks containing multiple edges are called 
multigraphs and those that contain both multiple edges and loops are called 
pseudographs (figure 3.1). 
 
Figure 3.1 Types of network: (A) a simple graph, (B) a multigraph containing multiple edges and (C) a 
pseudograph containing multiple edges and loops. 
Whilst it is possible to display fairly small networks as a diagram of points joined by 
lines, as networks become larger or more complex, this means of display becomes 
unsuitable and does not offer a mathematically viable way of performing analysis. 
Hence, the adjacency matrix representation of a network offers a mathematical 
alternative by allowing us to employ a wealth of tools and techniques from linear 
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algebra. A simple network G  with n  nodes  nvvvV ,,, 21   has an adjacency 
matrix, A , of size nn  whose ij th entry is either zeroes or ones depending on 
whether there exists an edge from set  mEEEE ,,, 21   that connects the vertex 
pair  ji vv , . Nodes connected by an edge are adjacent, whereas edges are incident if 
they share the same node. Entries of A  are given by 




.,0
,~,1
otherwise
vvif
A
ji
ij  
Note that ji vv ~  denotes a connection between two nodes. 
Directed/Undirected Networks 
A network may also have undirected edges. This means that a relationship between a 
pair of nodes is mutual and has no specified direction (figure 3.2A). For example, 
vehicle access between a pair of locations via road systems is undirected, although 
this property could be lost if the connecting roads were part of a one-way traffic 
system. In this context, our simple network changes to a simple digraph, where 
edges are directed. As a result of directed edges, our adjacency matrix, A , loses the 
property of being symmetric (where jiij AA  ), since a connection from node iv  to 
node jv  is not necessarily reciprocated (from jv  to iv ; figure 3.2B). 
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Figure 3.2 Visual representations and corresponding adjacency matrices of (A) an undirected network 
and (B) a directed network. 
Binary/Weighted Networks 
We initially defined an adjacency matrix as having entries of either zero or one – 
either an edge exists between a pair of nodes, or it does not. This is the binary case. 
Networks can, however, describe connections between nodes in a non-binary 
manner. It is possible to attach discrete or continuous values to each edge to give 
them weighting; connections may exist between particular node pairs, but some 
connections may have more importance or weight than others (figure 3.3). 
 
Figure 3.3 A weighted network with corresponding adjacency matrix. 
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A multigraph can be transformed into a discretely weighted, simple network by 
counting the numbers of shared edges between node pairs and assigning the 
frequency to a single edge, for example. If we consider the network of locations 
connected by road systems, a simple network with continuous weights can be 
created by calculating the physical distances and labelling each edge with this value. 
As a result, discrete or continuous weighted networks are conducive to attaining 
more detail by making distinctions between connected node pairs. 
K-partite Networks 
Nodes in a simple network can be partitioned into smaller groups according to which 
other nodes they share an edge with. Consider node set V  being partitioned into 
two distinct subsets,  nuuU ,,1   and  mwwW ,,1  , where WU  Ø. That is, 
ji wu ~  is possible, but ji uu ~  and ji ww ~  are not. These conditions satisfy what 
we call the bipartite property (figure 3.4A), which is the k-partite property at 2k . 
Note that this rule can be extended for any choice of k  corresponding to the 
number of distinct subsets (a tripartite example is shown in figure 3.4B). 
 
Figure 3.4 Examples of k-partite networks: (A) a bipartite network, showing two distinct node groups 
(red and yellow) connecting between one another but not within their own groups, and (B) a tripartite 
network, showing three distinct node groups (red, yellow and blue) with the same connective properties. 
3.1.2. Network Measures 
Recent literature has shown a sharp increase of the practical use of network theory 
thanks to its ability to model a diverse range of systems; nodes can be representative 
of a wide variety of discrete objects and defining the relationship that an edge 
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symbolises is equally as flexible (Havlin et al., 2012). Various network measures act 
as tools to identify the most interesting and influential nodes in a network (Liu et al., 
2016). In the proceeding section, we describe four of the most popular network 
measures that are used to make these identifications. We also determine why each 
measure has its own importance and explain how aggregating such measures can 
help to recognise influential nodes. 
Degree Distribution 
Any node in an undirected and unweighted network, has a degree, which is 
measured by counting the number of edges incident to iv . In this case, the degree, 
ik , can be found by summing the i
th row of the adjacency matrix: 
.
1



n
j
iji Ak  
We can consider the complete collection of node degrees as a degree distribution by 
plotting the probabilities of choosing a node with degree k : 
  .
n
n
kP k  
Note that n  is the total number of nodes in the network and kn  is the number of 
nodes with degree k . Our definition of degree is modified if we consider digraphs; 
an edge directed from iv  to jv  implies that node iv  has an out-degree, and an edge 
directed from jv  to iv  implies that node iv  has an in-degree. Separate in- and out-
degree distributions are computed in this case. 
Path Length 
A finite sequence of edges connecting node iv  to node jv  through a chain of distinct 
nodes is called a path. Although it is possible for many paths to exist that connect iv  
to jv , the path containing the fewest edges is known as the shortest path for 
unweighted networks. This is denoted by a distance measure, ijd , which 
corresponds to the number of edges in the shortest path. For weighted networks, 
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the calculation of ijd  is modified such that the sum of the edge weights is prioritised, 
rather than simply the number of edges. For example, if edges are weighted 
according to physical distance, such as in road network described earlier, two roads 
of length 6 and 7 miles would be shorter than a single 15-mile road. Hence, the 
shortest path for weighted networks does not necessarily have the fewest edges. It is 
also important to understand the context of weighted networks before rushing into 
calculations such as path lengths. A network that is weighted according to the 
strength of connections between pairs of nodes would behave in the opposite 
manner to networks where edges described distance. That is, the most important 
connections would have the highest weights. Therefore, we would calculate path 
lengths by summing the reciprocals of each weighted edge connecting iv  to jv , so 
that the shortest path still represents the journey of minimum cost or maximum 
efficiency. 
It is possible that no paths exist connecting particular node pairs. This can occur as a 
result of an unconnected network, where nodes are completely isolated from the 
rest of the network (figure 3.5A). Alternatively, this can be a consequence obtained 
from digraphs, where iv  connects to jv  in only one direction (figure 3.5B). In both 
cases,  ijd . 
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Figure 3.5 Visual representations and corresponding shortest path matrices for (A) a disconnected 
network and (B) a directed network. 
We can also take a more global approach by considering the average distance of a 
node with respect to the connections made to all other nodes. This is achieved by 
calculating the mean of all shortest paths corresponding to iv : 
 
.
1
1



ji
ijd
nn
  
At this stage, this measure is still problematic for isolated nodes (i.e. node pairs can 
still satisfy ijd ). There are a number of ways to circumnavigate this issue: we 
could (1) omit these shortest paths to avoid divergence; (2) study only the largest 
component of the network (i.e. a sub-network where no nodes are isolated); (3) 
remove the directionality from the network. However, all of the above remedies 
would fundamentally change the properties of the network and/or would leave us 
with an incomplete representation of our population of nodes. Therefore, a more 
elegant solution known as the global efficiency, GE, is used (Latora & Marchiori, 
2001): 
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 
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
ji ijdnn
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This is still a measure that correlates with the average distance, but instead scales to 
boundaries of zero and one, where a higher efficiency (tending to one) corresponds 
to a shorter average distance and vice versa. 
Whilst path length alone is not directly indicative of the general importance of a 
node, the calculation serves as an intermediary to a larger process that ultimately 
identifies global properties, such as the aforementioned global efficiency (which 
gives us an idea of a network’s communicative ability) as well as some centrality 
calculations, described later in this section. 
Clustering Coefficient 
The clustering coefficient is a measure of how connected a node’s neighbours are 
with each other in a network. A complete network has the property of all nodes 
connecting to one another – we are looking for near-completeness within sections of 
complex networks as a way to identify clusters. Clustering is, of course, relative. 
Although a large, complete network has the property we are looking for, there is no 
distinction between any nodes/sub-networks here because the network has no areas 
of sparseness. Hence, the local clustering coefficient, C , was introduced to measure 
the relative clustering of each node (Watts & Strogatz, 1998). It defines the 
clustering strength of a node by the ratio of triangles (complete networks with 3n  
nodes, 3C ) that neighbour iv  to connected triples (incomplete, connected networks 
with 3n  nodes; commonly called 2-paths, 2P ) with centre iv : 
 
 
 
.
2
3
iP
iC
iC   
Note that 2P  can be calculated using information of a node’s degree, such that 
 
 
,
2
1
2

 ii
kk
iP  
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and knowing that the adjacency matrix raised to the r th power counts the number of 
routes between two nodes via exactly r  edges (known as r -walks), one can find the 
number of triangles, 3C : 
  .
2
1 3
3 iiAiC   
The total number of 3-walks from iv  to iv  is halved to account for walks travelling 
across the same triangle in opposite directions. 
Hence, the local clustering coefficient of node iv  can be expressed as 
 
 
.
1
3


ii
ii
kk
A
iC  
This satisfies 10  C , where a high value of C  corresponds to a node exhibiting 
clustering properties, and vice versa. 
The global clustering coefficient, C , is a measure attributed to a network as a whole, 
rather than each node. It acts as a way of giving context to local clustering 
coefficients by describing how small-world a network is, which is a measure of how 
connected a network is relative to its number of nodes, n . To be considered small-
world, the average shortest path of a network typically satisfies (or falls below) 
 nlog  (Watts & Strogatz, 1998). The global clustering coefficient is computed by 
taking an average of local coefficients: 
 .
1
1



n
i
iC
n
C  
This measure is important for comparing local clustering coefficients between 
different networks. For example, two nodes from separate networks (i.e. 1Gui   
and 2Gwi  ) may have an identical local clustering coefficient, but node iu  carries a 
higher importance if    21 GCGC  . A combination of local and global measures is 
therefore important in order to attain a reasonable understanding of a node’s 
clustering status. 
49 
 
Connected Components 
If any pair of nodes from a sub-network are connected by at least one path and do 
not connect to any node from elsewhere in the global network, the sub-network is 
known as a connected component. Although not an actual measure, observing the 
connected components of a large network enables the reduction of analysis 
complexity by focusing on smaller communities of well-connected nodes. Connected 
components are often used as a preliminary step before calculating network 
measures, so that isolated (and therefore trivial) nodes are rightfully omitted when 
considering which are most important, thus increasing computational efficiency. 
Centrality 
For complex networks, a common method to identify influential nodes is through 
centrality measurements. Generally speaking, this is a measure of the importance of 
nodes relative to the wider network (Estrada, 2012); a classic example of high 
centrality would be a node participating in a large number of shortest paths between 
node pairs. However, centrality is a diverse term which can be applied in a multitude 
of ways. We outline a handful of the most popular centrality measures in the 
proceeding text. 
Degree centrality is a simple score, which counts the number of edges incident to a 
node (in other words its degree, k ). Digraphs have both in- and out-degree 
measurements, as detailed previously. Whilst the degree can be an efficient means 
of measuring a node’s importance, it is apparent that there is a flaw regarding its 
ignorance to the wider network. That is, degree centrality only takes into account 
nearest neighbours and ignores broader mechanisms, such as connective traits that 
extend beyond the first point of contact. 
Eigenvector centrality is a measure that scores nodes based on their connections to 
other highly central nodes. For example, node iv  with degree 6k  can have a 
higher eigenvector centrality than node jv  with degree 6k  because iv  connects 
to other nodes which have a high centrality score, whereas jv  does not. This can be 
likened to the concept that someone can be considered influential based on another 
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important person perceiving them as such (Kiss & Bichler, 2008). The eigenvector 
centrality, ic , is defined as 
,
1
1
j
n
j
ijii xAxc 



 
where x  is the principal eigenvector corresponding to the maximum eigenvalue  . 
This method is recursive in nature, as all nodes initially start with a score of one and 
iterations are performed until centrality scores converge. 
PageRank centrality follows a similar process, although the output is a score based 
on the probability of arriving at a particular node during a random walk and 
therefore uses a modified Markov matrix (the Google matrix, G ) instead of the 
adjacency matrix (Brin & Page, 1998). This special Markov matrix is created via three 
main steps. The first is to modify the adjacency matrix such that 





.,0
,~,1
otherwise
vvif
kH
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iij  
Now, the matrix H  is almost row-stochastic, containing transition probabilities at 
each entry. The only place where H  is not row-stochastic would be in cases of dead-
ends (typically found for nodes with zero out-degree in a directed network; the row 
sum would be zero). Therefore, the second step replaces entries of the zero-sum 
rows of H , with a constant, n1 , thus creating a new matrix S . Every node now 
contains a transition probability to at least one other node, thus removing the 
possibility of encountering dead-ends. This also extends trivially for undirected 
networks (a dead-end node has zero in- and out-degree and would therefore be 
remedied in the same way). The third step accounts for a damping factor,  , which 
is the probability that the walk will teleport to a random node in the network. This is 
a predefined input which is typically set to 85.0  for analysis of website networks 
(Page et al., 1999). The damping factor was introduced in order to guarantee the 
existence of an equilibrium solution for the Markov process; directed networks 
typically have weak connectivity and there is hence a motivation to avoid the 
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possibility of not reaching certain areas of the network. The Google matrix 
accounting for the damping factor is therefore given by 
,
1
SJ
n
G n 



  
where nJ  is the nn  matrix of ones and serves as an important term in ensuring all 
nodes of the network are accessible. The PageRank centrality of node iv  is hence 
obtained by observing the i th entry of 1rx : 
,1 Gxx rr   
which is the power method for computing the eigenvectors of G . Given that the 
maximum eigenvalue for a stochastic matrix is 1 , x  is the corresponding left 
eigenvector – the approximation of which improves with increasing r . 
So far, each centrality measure has been strongly associated with the degree of a 
node. Betweenness centrality, however, has less emphasis on this property and more 
emphasis on how well it connects other nodes. Consider a social network, containing 
work colleagues and sports teammates of subject A. Assuming that these two circles 
do not communicate, subject A would act as a node with high betweenness 
centrality – without this person, the groups would be isolated, hence this node 
carries high influence. Consider also that healthy brain networks, describing both 
structure and function, rely heavily on this type of interconnectedness. It was found 
that these networks become less connected in post-stroke patients, thus 
emphasising the communicative importance of remaining nodes, measured using 
betweenness centrality (Li et al., 2014).  
Mathematically, the betweenness centrality score, ib , correlates with the number of 
times it is a participant in the shortest path between two other nodes (Freeman, 
1977): 
 
,

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where hj  is the number of shortest paths between nodes hv  and jv , and  ihj  is 
the number of those paths which pass through node iv . 
3.1.3. Comparison of Network Measures 
Particularly with the choice of centrality measures, we have looked to previous 
publications (described below) that compare measures in terms of performance and 
sensitivity to change, to inform us of the best way to identify important nodes. 
We settled on four centrality measures: betweenness, degree, eigenvector and 
PageRank, based on various findings. Comparing three centrality measures in social 
task-based networks, it was found that betweenness centrality was the most 
accurate indicator of the perceived leader (Freeman et al., 1979). This result was 
supported by further research into larger social networks: both betweenness and 
degree-based centrality measures displayed a high sensitivity to random variation in 
network structure, hence capturing small changes well (Bolland, 1988). Betweenness 
centrality, however, seemed to perform less effectively when networks were 
incomplete or sampled. Eigenvector-based methods handled this problem better, 
displaying a better correlation between full and sampled networks than other 
measures (Costenbader & Valente, 2003). 
The four selected measures represent a good diversity in terms of their method of 
identifying important nodes. For example, betweenness correlates the least with 
other measures because high ranking nodes do not necessarily have high degree. 
One could argue that the eigenvector and PageRank methods are so well correlated, 
that only one is required. However, the damping factor of PageRank provides an 
opportunity for variation between these measures. Whilst the application of the 
damping factor is typically explained with a web surfer’s chance of resetting to a 
random webpage, this property is perhaps conceivable for some biological networks 
and therefore important to include for our analysis. 
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3.2. Statistical Approaches 
The approaches described in this chapter follow a chronology in our analysis. 
Generally speaking, network measures are employed first and interesting nodes are 
then interrogated further using statistical tests and methods. This section gives an 
overview of such methods. Particular emphasis is given to statistical p-values from 
our results; it is therefore important to understand how they are calculated so that 
the correct interpretations can be made. 
3.2.1. Logistic Regression 
Logistic regression is a modification of linear regression. Both types of model share 
common properties, such as predictors being continuous and/or categorical, but the 
key difference is that the response for logistic regression is transformed into a binary 
decision, i.e. success or failure (reviewed in Bush & Moore, 2012), whereas the 
response variable for linear regression is continuous. Logistic regression therefore 
enables us to distinctly categorise cases based on a whole range of characteristics, 
which is especially useful in biology with factors affecting the presence/absence of 
disease, for example. 
The general logistic regression model is given by 
,
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where the response, known as the logit function, describes the log-odds of success 
(i.e. for random binary variable X ,   1XP  and    10XP ), Tix  is a 
vector of measurements corresponding to predictors and   is a vector of 
coefficients (Dobson & Barnett, 2008). Note that in this form, logistic regression is 
versatile to any number of predictors. 
Not only does logistic regression make it possible to categorise cases based on the 
predictive traits, the probability of obtaining success,  , can also be calculated by 
rearranging the logit function: 
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This is a powerful tool for diagnosis; given a patient’s characteristics, one can predict 
the likelihood of developing a specified disease. These models are, however, at the 
mercy of sample size – the predictive power of logistic regression is proportional to 
the initial number of entries used to form the model. 
3.2.2. Tests for Associations 
The chi-square test investigates the level of dependence/independence between 
categorical variables. Contingency tables are used to count frequencies of events 
(observations), which are tested against expected frequencies. 
Fisher’s exact test is a modification of the chi-square test, which is applicable for 2-
by-2 contingency tables and also small observation counts. Consider two categorical 
variables, A  and B . The corresponding contingency table for observations of these 
variables is shown in table 3.1. 
Table 3.1 Contingency table showing success/failure of categorical variables A and B. 
 Variable A success Variable A failure Total 
Variable B success a  b  ba   
Variable B failure c  d  dc   
Total ca   db   n  
 
The probability of obtaining the observed set of frequencies under the assumption 
that the proportions between A  and B  are equal is given by a p-value. This is an 
indicator for the level of association between A  and B . For a one-tailed test, a small 
p-value corresponds to a high success count for both A  and B  (frequency a ) 
compared to other observed frequencies – this in turn causes a difference in 
proportions. The calculation for p  is given by 
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If p  is less than a level of statistical confidence (typically 05.0p ), we reject the 
null hypothesis in favour of variables A  and B  having an association. 
3.2.3. Tests for Differences in Means 
The two-sample t-test is a parametric test that investigates the difference of means 
between two independent, normally distributed variables. Considering two samples, 
1X  and 2X  of size 1n  and 2n , respectively with equal variances, we arrive at the test 
statistic, t , using the following steps: 
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and 2s  is the sample variance. An increase in the test statistic is proportional to a 
decrease in p-value, since the probability density function for the Student’s t-
distribution, given by: 
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follows a similar shape to the normal distribution centred at zero (figure 3.6). 
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Figure 3.6 Probability density functions of Student’s t-distribution at various degrees of freedom, v . 
A small p-value ( 05.0p  for 95% confidence) points to a rejection of the null 
hypothesis in favour of there being a significant difference in means between 1X  
and 2X . In cases where multiple comparisons are made, one must make a 
Bonferroni correction. That is, if there are m  comparisons made, the p-value 
threshold would change to 
m
p
05.0
 . 
3.3. Implementation 
The overarching aim of this thesis is to find novel long-range genomic interactions 
that influence disease or genetic phenomena. The various network measures and 
statistical approaches described above were our tools to help find such regions. This 
implementation section therefore serves to explain the preceding measures in the 
context of 3D genomic interactions and also highlights its relevance to our 
hypotheses. We also evaluate the computational hurdles that arose from our 
analysis and explain how we overcame them. 
3.3.1. Hi-C Networks 
The networks used in this thesis were all constructed from various Hi-C datasets. In 
all cases, nodes represented the collection of binned genomic regions and edges 
connected them if there existed at least one interaction between a pair of regions. 
Henceforth, we refer to such networks either as Hi-C networks or 3D interaction 
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networks. Without any further treatment, these networks were weighted. That is, 
the higher the weighted edge connecting two nodes, the smaller the 3D distance 
between the corresponding regions. In some cases, we used a threshold to convert a 
Hi-C network from weighted to unweighted; connections therefore constituted a pair 
of regions being sufficiently nearby within the nucleus, without distinguishing how 
close. 
3.3.2. Network Features 
It is hypothesised that in any of our created networks, well-connected nodes were 
representative of regions of the genome with most influence over other remote 
regions. Hence, our network measures were chosen specifically to identify such 
nodes. We utilised two computational toolboxes to calculate various network 
measures: the Brain Connectivity Toolbox (BCT) written in MATLAB (Rubinov & 
Sporns, 2010) and the Python-based NetworKit (Staudt et al., 2016). Both toolboxes 
contained the means to calculate all measures mentioned above, so we decided to 
run network analysis using each toolbox where possible and compare results to 
ensure they consistently agreed.  
We further justify the choice of centrality measures by considering how they each 
align with our underlying hypothesis. The degree centrality, for example, directly 
measures the connectedness of a node. Hence for an inter-chromosomal Hi-C 
network, we could identify a node with high degree centrality (i.e. many inter-
chromosomal connections) as a region that spends the majority of its time on the 
periphery of a folded chromosome. We could then use this information to explain 
how a previously found long-range interaction influences a disease, rather than 
simply knowing that it does. Furthermore, highly central nodes found using 
eigenvector/PageRank centrality measures could also indicate that particular loops 
preferentially locate at the surface of a compacted chromosome. Finally, nodes of 
high betweenness centrality would correspond to regions that connect otherwise 
disconnected components of the network. Polygenic diseases may not express the 
expected phenotype as a result of the absence of a node with high betweenness 
centrality, for example. 
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3.3.3. Computational Complexity 
The measures we present provide varying degrees of computational complexity, 
which could be problematic given that we are working with large networks (tens of 
thousands of nodes and millions of edges). The calculation of degree centrality lies 
on the faster end of this scale, with computational complexity  knm   , where 
m , n  and k  are the number of edges, the number of nodes and the average 
degree of the network, respectively (Liu et al., 2016). The opposite end of this scale is 
where we find measures such as betweenness, since the nature of the method is not 
well designed for scalability. For large networks, it is clear that the computational 
cost of calculating betweenness centrality (given by  3n ; Liu et al., 2016) can 
quickly become problematic. 
There are a number of ways that we have approached these problem cases for our 
analysis. We first suggested that we could pre-process our Hi-C networks by 
converting the corresponding adjacency matrices from weighted to binary (i.e. 
zeroes and ones), based on a chosen threshold. This would preserve the size of a 
network, whilst significantly reducing the file size of the adjacency matrix. It also 
speeds up calculations such as path lengths, since path length algorithms are much 
faster on unweighted networks. Our alternative suggestion was to randomly sample 
path length calculations (for betweenness centrality in particular) in order to obtain 
a de facto average path length. The former seems much more desirable than the 
latter, since we were able to investigate using all available data. We have also seen 
that some centrality measures do not perform accurately under sampling conditions 
(described in section 3.1.3), which is more reason to choose the thresholding 
method to improve computational efficiency. We were careful not to completely 
discount sampling methods, however, since a handful of measures still perform well 
under these conditions.  
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Chapter IV 
Reduced Penetrance 
 
4. Reduced Penetrance 
It is known that an individual can harbour a particular disease mutation without 
actually exhibiting any of the disease traits. Such an individual may be termed a 
carrier, although biologically speaking, this is known as reduced (or incomplete) 
penetrance. To describe this phenomenon in basic quantifiable terms, let G  be the 
frequency of individuals from a population with a hazardous genetic variant (disease 
genotype) and let P  be the frequency of those individuals that express the ill effect 
of the variant (phenotype) at some point during their lifetime. It follows that reduced 
penetrance occurs when PG  . We measure the penetrance of disease by 
calculating 
G
P
, where values can lie in the range  1,0  (a value of 1 indicates 
complete penetrance). To summarise, disparity between G  and P  is an indicator for 
a level of penetrance, therefore genotype is not directly predictive of phenotype 
(Cooper et al., 2013). 
Reduced penetrance poses somewhat of a conundrum when considering heritable 
disease; implying that DNA language codes for a subsequent trait is not completely 
true. A confounding example would be a parent and child carrying the same 
mutation, but only the child exhibiting the subsequent trait. We are effectively 
saying that reduced penetrance has synonymous properties with the type 2 error, or 
false negative. That is, a genetic variant exists that influences disease formation, but 
we do not witness the manifestation of this disease and we therefore fail to reject 
our null hypothesis that the variant is not associated with the disease. This 
interpretation is also distinctly binary; we assume that variants either do or do not 
influence a disease, without considering the possibility that disease may develop 
only when a group of variants exist within an individual. Consider a hypothetical 
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disorder that develops as a result of three variants at separate loci. The absence of 
one of these variants would mean an absence of the disorder. Therefore, does this 
mean that the other two variants have zero effect? It is likely that variants are 
interdependent and investigating interactions between variants is extremely 
important to understand the true mechanisms of penetrance. 
Perhaps there may also be concern about identifying whether a genotype has a 
significantly low penetrance or if it simply has no effect on the suggested disease. 
This notion is quashed by observing the genotypes and phenotypes of carriers’ 
ascendants/descendants in what is called cascade genetic screening (Berge et al., 
2008), thus providing hereditary evidence for this phenomenon. The idea of variable 
expression efficacy of genotype also supports this, whereby studying a collection of 
variants and their interactions is likely to be a key component in identifying causes of 
penetrance. 
In complex disease, the presence of a single gene variant is not sufficient for a 
resulting phenotype, despite it coding for a function which clearly affects the disease. 
Quite often, we find that variants in cis or in trans are responsible for altering the 
function of the primary gene, whether that is by amplifying, silencing or even 
completely changing the gene’s final function. Such cases are termed modifier genes. 
The mechanism of primary and modifier gene interactions affecting expression is 
known as epistasis; we argue that this phenomenon is a key component in explaining 
variable levels of penetrance for disease. 
Interdependent genes in complex disease can also manifest themselves slightly 
differently. In contrast to the domino-effect nature of primary and modifier genes 
(which implies a chronology of cause and effect), gene pairs exists that influence 
digenic inheritance. This is where variants at two unlinked genes cooperate to 
consequently produce a phenotype. There is no order of one gene affecting another, 
and the absence of either variant results in a zero-penetrance of the other, hence an 
absence of expected phenotype. 
In this chapter, we hypothesised that: (1) the level of penetrance can be partially 
determined by the occurrence of distal variants, such as modifier genes, coming into 
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close contact with known primary disease genes via the folding of the genome in 3D 
space; (2) genes associated with reduced penetrance share common third-party 
interacting fragments; (3) primary-modifier and digenic reduced penetrance gene 
pairs are regulated by such third-party fragments, if not more. The latter in particular 
alludes to our earlier suggestion of interdependency between variants associated 
with low penetrance. We utilised Hi-C data describing 3D proximity of genomic 
fragments (Lieberman-Aiden et al., 2009; Rao et al., 2014) to investigate all three of 
our hypotheses.  
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4.1. Background 
4.1.1. Factors Affecting Penetrance 
Historically, reduced penetrance was thought to be a phenomenon associated only 
with autosomal dominant disorders, such as glaucoma (Morissette et al., 1998), 
retinitis pigmentosa (Saini et al., 2012) and long QT syndrome (Mathias et al., 2013). 
However, developments in molecular techniques have revealed the presence of 
disease-causing mutations in healthy phenotypes for autosomal recessive disorders, 
such as hemochromatosis (Beutler, 2003) and deafness (Fairley et al., 2008). This 
revelation has opened the floodgates for identifying factors affecting penetrance, 
since a much larger pool of genotype profiles now have reported associations. The 
various factors affecting penetrance are discussed below. 
Mutation Type 
Mutation type is one such factor. Whilst there are few studies which investigate 
specific mutation types and their effect on penetrance, we do have exposure to a 
multitude of studies which report on mutations affecting particular diseases such as 
missense mutations, nonsense mutations, insertions and deletions (described in 
figure 4.1). 
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Figure 4.1 Pairs of ordinary and mutated sequences that illustrate types of mutation: (A) a missense 
mutation, caused by a single base change and resulting in an amino acid change; (B) a nonsense 
mutation, caused by a single base change and resulting in a premature signal to stop building a protein; 
(C) an insertion of one (or more) bases, which causes a frame shift, resulting in a change of the 
subsequent amino acid sequence; (D) a deletion of one (or more) bases, which causes a frame shift, 
resulting in a change of the subsequent amino acid sequence. Changes in DNA or amino acid sequence 
are highlighted in grey. 
A well-known example of a highly penetrant mutation is the in-frame deletion in the 
CFTR gene (removal of CTT; rs113993960), causing cystic fibrosis (found in 
approximately 70% of cystic fibrosis patients; Kerem et al., 1989), whereas there 
exists a missense mutation in the same gene (change from G to A; rs78655421) 
which at best has a very mild clinical consequence (penetrance in the range .03-.06%; 
Thauvin-Robinet et al., 2009). 
The type of mutation need not be different in order to observe differences in 
penetrance. Consider missense mutations in the BRCA1 gene, causing a change of 
amino acid from arginine to glutamine. The 70-year penetrance of breast/ovarian 
cancer from this type of mutation is 24% (Spurdle et al., 2012) compared to the 
average penetrance for breast and ovarian cancer via BRCA1 mutations being 71.4% 
and 58.9%, respectively (van der Kolk et al., 2010). This suggests that perhaps the 
effect of the mutation (resulting amino acid sequence), as opposed to the type of 
mutation (insertion, deletion, missense, nonsense, etc.) is a driving factor in 
penetrance. 
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Digenic Inheritance 
The occurrence of digenic inheritance is dependent upon the interaction of two 
variant genes and a subsequent expression of phenotype (Shawky, 2014). Attempts 
have been made to catalogue cases of digenic inheritance and reduced penetrance 
(table A4.2; Cooper et al., 2013), although one must be wary of distinguishing 
between true digenic inheritance and a coinheritance of two genes that exacerbates 
a phenotype. Despite this, there are well-studied examples of digenic inheritance 
causing variable penetrance, such as the interactions of mutations in the FGFR1 and 
NELF genes causing idiopathic hypogonadotropic hypogonadism (Pitteloud et al., 
2007) and even three mutations in any two of four BBS genes (BBS1, BBS2, BBS4 and 
BBS6) causing Bardet-Biedle syndrome (Schäffer, 2013). 
Modifier Genes 
It is possible for a phenotype to exist given the presence of mutation/s in a single 
gene. However, a second modifier gene may interact with the original primary gene 
which consequently affects the severity of the phenotype and ultimately, penetrance 
(Cooper et al., 2013). This has similarities with digenic inheritance, whereby an 
interaction of a pair of genes is necessary, although the key difference is that this 
mechanism has a chronology as well as dependence. 
Cystic fibrosis is a typical example – predicting the phenotype using only information 
from a mutated CFTR gene is unreliable. There is reported to be a minimum of seven 
associated modifier genes, such as TGFB1 (Drumm et al., 2005), that each adjusts 
phenotype expression and therefore penetrance (Badano & Katsanis, 2002). 
Epigenetic Factors 
The penetrance of a phenotype may also be controlled by modifications outside of 
changes in genetic code. Epigenetic factors, such as histone modifications and DNA 
methylation are able to activate or repress gene expression by altering the 
environment in which DNA resides (Dong & Weng, 2013; Kass et al., 1997). 
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Monozygotic twin studies are able to best explain differences in phenotype despite 
observed similarities in genotype (Wong et al., 2005). A higher methylation of BRCA1 
was observed in one patient affected by childhood leukaemia (12%) compared to her 
unaffected sister (3%), for example (Galetzka et al., 2012). Furthermore, methylation 
of SLC6A4 correlated with a presence of bipolar disorder in another twin study 
(Sugawara et al., 2011). This was replicated in a case versus control setting by finding 
higher methylation in post-mortem brains of patients suffering from bipolar disorder. 
Sex 
Differences in penetrance for autosomal disorders between male and female 
patients can be observed in one of two ways. A disorder can be described as either 
sex limited or sex influenced (Shawky, 2014). A sex limited disorder can only occur in 
males or females; one gender has a 0% penetrance and the other displays at least 
some penetrance. Precocious puberty as a result of LCGR mutations is an example of 
this. Females are unaffected by the hazardous mutation, whereas males exhibit the 
phenotype (Coleman & Tsongalis, 2010). By contrast, a sex influenced disorder 
affects both males and females, but to varying degrees. As an example, duplications 
and deletions on chromosome 16, positions 14,800,000-16,800,000 are associated 
with a set of brain-related disorders including autism, epilepsy, attention deficit 
hyperactivity disorder and schizophrenia. However, there is a reported bias of 
penetrance towards men (Ramalingam et al., 2011; Tropeano et al., 2013), although 
a proportion females still experience the phenotype. 
4.2. Materials 
4.2.1. Dataset of Primary and Modifier Genes 
In our studies, we utilised a dataset of 37 primary and modifier gene pairs, where 
variants in the modifier genes have been found to modulate the penetrance of a 
variety of inherited diseases (table A4.1; Cooper et al., 2013). These mutations have 
been found to be a cause for a range of diseases, such as breast cancer (Antoniou et 
al., 2007), cystic fibrosis (Drumm et al., 2005) and Parkinson’s disease (Gan-Or et al., 
2011). There are 32 inter- and five intra-chromosomal gene pairs in this dataset. 
66 
 
4.2.2. Dataset of Genes Responsible for Digenic Inheritance 
We have a comprehensive dataset of 133 unique gene pairs (split into 121 inter- and 
12 intra-chromosomal pairs) that are known to contribute to disease via digenic 
mutations (table A4.2; Cooper et al., 2013). Gene pairs in table A4.2 are 
unambiguous cases; the digenic mutations are strictly from genes that have a 
functional association with the corresponding disease, thus reducing the chance of 
pairs being found by coincidence. Examples of diseases affected by digenic activity 
include chronic lung disease (Bullard & Nogee, 2007), colorectal cancer (Uhrhammer 
& Bignon, 2008; Li-Chang et al., 2013) and polycystic kidney disease (Pei et al., 2001; 
Dedoussis et al., 2008). There is also some overlap between this dataset and our list 
of primary/modifier genes with regards to the underlying disease, such as breast 
cancer (Pern et al., 2012) and Parkinson’s disease (Dächsel et al., 2006). 
4.3. Methods 
4.3.1. Proximity of Gene Pairs 
Our first step was to determine whether gene pairs associated with reduced 
penetrance had high interaction frequencies (IFs) in Hi-C data relative to randomly 
selected control regions. If this was indeed the case, we could confirm our 
hypothesis that reduced penetrance gene pairs are chosen non-randomly and the 3D 
architecture of the human genome is associated with this. 
We defined a pair of genomic fragments on chromosome  , bin i  and chromosome 
  , bin j  to be relatively close in 3D space if their IF was higher than most 
interactions between chromosome  , bin i  and other fragments. This led us to 
construct a method to rank the IFs of fragment pairs in descending order (figure 4.2) 
and compare them to a rank threshold, in order to categorise an interaction as being 
either high (thus being close in 3D space) or not high (implying remoteness). 
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R1. 
[Construct counter vector.] Let f  be the index of the genome-wide, 
kk   contact matrix, M , that corresponds to chromosome  , bin i . 
It follows that ],,,[ 21 kffff mmmM  , where lfm  is the 
interaction frequency between region f  and any other region, l . 
We construct our counter vector, ],,,[ 21 nvvvv  , where 1v  is a 
counter for the number of interactions (or entries of fM ) with 
frequency 1, 2v  with frequency 2, and so on. The last entry, nv , 
corresponds to the maximum interaction frequency recorded for 
fragment f . 
R2. 
[Find IF of pair.] Find gfm , where g  is the index of M  
corresponding to chromosome  , bin j . 
R3. 
[Find IF rank.] If gfmc  , then the interaction frequency rank, r , is 
found by counting the number of non-zero entries of v  between cv  
and nv . If 0c , then 1 nr . 
Figure 4.2 Algorithm R: pseudocode ranking fragment pairs according to their interaction frequency 
relative to other interacting fragments. A higher rank implies the tested pair of regions are relative 
neighbours in 3D space. 
We set a number of rank thresholds in order to find an appropriate stringency; a 
small rank threshold could miss out potential neighbouring pairs, whereas a large 
threshold would cause a high false positive rate. That is, remote fragment pairs could 
be recorded as being 3D neighbours. After all interactions corresponding to gene 
pairs in our datasets were considered, we tabulated the frequencies of pairs that 
were 3D neighbours and those that were not. We also recorded the same 
information for controls (figure 4.3). The control algorithm was repeated 1,000 times 
and frequency entries were averaged, thus giving values on the continuous scale. 
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C1. 
[Retain primary fragment and secondary fragment chromosome.] 
Given a test fragment pair ),( i  and ),( j , the corresponding 
control pair is given by *)*,( i  and *)*,( j , where  * , ii *  
and  * . 
C2. 
[Select random secondary fragment bin.] Randomly generate a bin, 
*j , within the bin range appropriate for chromosome  . 
C3. 
[Is secondary fragment associated with reduced penetrance?] If the 
control region *)*,( j  does not exist in the test dataset, algorithm 
terminates; *)*,( j  is our control region. If the region does exist in 
the dataset, repeat C2. 
Figure 4.3 Algorithm C: pseudocode generating control fragment pairs to test against reduced 
penetrance gene pairs. 
The motivation for retaining the primary fragment in our controls was to ensure we 
focused on the choice of partner. Randomising the primary fragment in this instance 
would not have been logical, as we would then not be looking at a choice in partner, 
rather a completely disassociated pair. 
After tabulation of frequencies, we performed chi-square proportion tests to 
measure the statistical difference in the proportions of neighbouring regions 
between reduced penetrance pairs and controls. Small p-values ( 05.0p ) would 
lead us to reject our null hypothesis, in favour of concluding that the proportion of 
reduced penetrance partner choices within highly interacting fragments is greater 
than for controls. 
4.3.2. Identification of Penetrance Regulators 
We hypothesised that there are common fragments in the human genome that 
remotely interact with genes associated with reduced penetrance. Our rationale was 
that there could be distinct genomic regions which inhibit the expression of 
indiscriminate phenotypes, rather than disease-specific variants affecting penetrance. 
For each reduced penetrance gene forming an inter-chromosomal interaction, we 
found the corresponding top ten interacting fragments throughout genome-wide 
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dilution Hi-C data (using 1 Mb bins). The list of top ten interacting fragments 
excluded intra-chromosomal interactions in order to avoid the bias introduced by 
chromosome territories. From the resulting lists, we identified particular interacting 
fragments which were dominant throughout and compiled a table of these most 
commonly featuring fragments using prevalence values. These values were 
measured as a proportion; the number of times a region appeared in the top ten list 
of interacting fragments was divided by the total number of genes interrogated. It is 
worth noting that our prevalence calculation would adjust the total number of genes 
interrogated for cases where a commonly interacting region was on the same 
chromosome as some genes from the dataset. To clarify, 100% prevalence can be 
achieved by an interacting fragment on chromosome   if it is found in every list of 
top ten interactions except for those corresponding to genes which are on the same 
chromosome. We also compiled a similar table for all bins throughout the genome to 
act as a control and to see whether our prevalent fragments are in fact over- or 
under-represented in comparison. 
In order to statistically test the prevalence proportions between cases and controls, 
we also created a contingency table to count the frequencies of regions being either 
within or outside of a top ten list. We then used Fisher’s exact test to conclude 
whether a difference in proportions existed and ultimately decided whether we had 
found regions that indiscriminately influenced genes associated with incomplete 
penetrance. 
4.3.3. Identifying Third-Party Regulators of Specific Gene Pairs 
Our final motivation was to determine whether both genes within a reduced 
penetrance pair shared the same interacting fragment/s. We termed such cases as 
third-party fragments. Although this seems similar to our previous analysis, the key 
difference here was that we were looking for unique regulators between pairs, as 
opposed to finding single fragments that influenced the population of pairs (figure 
4.4). Hence, we formulated the following hypothesis: reduced penetrance gene pairs 
are regulated by at least one third-party interacting fragment. 
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Figure 4.4 Graphical interpretation of two distinct reduced penetrance analyses. Green nodes represent 
reduced penetrance genes (in pairs) and black nodes represent fragments which have a high interaction 
frequency with genes in Hi-C data. Edges form a connection if a fragment is found to be a close 
neighbour of a gene in 3D space. The network on the left depicts the identification of penetrance 
regulators (section 4.3.2) whereas the network on the right depicts analysis for third-party fragments 
(section 4.3.3). 
Using all reduced penetrance gene pairs that form an inter-chromosomal interaction, 
we found the top h  interacting fragments for each gene using in situ Hi-C data at 
100 kb resolution. We then examined each reduced penetrance pair and noted 
instances where a particular fragment was found in the top h  list of both the 
primary and modifier gene (or gene 1 and gene 2 for the dataset of digenic 
mutations). We termed these cases intersects; a reduced penetrance pair was then 
recorded as ‘containing at least one intersect’ or ‘containing no intersects’ and 
frequencies were entered into a contingency table of cases and controls. Controls 
were generated using algorithm C (figure 4.3), with the random generation being 
repeated 1,000 times and an average frequency being taken. 
Finally, we performed Fisher’s exact test to determine whether the ratio of 
intersects/no intersects from reduced penetrance gene pairs is statistically different 
to the ratio found for controls. If a significant difference was found, we could 
conclude that reduced penetrance pairs each have their own regulatory region/s 
which influence the presence of their respective expected phenotypes. It would then 
be possible to backtrack and identify regions that were labelled as intersects and 
investigate their function. 
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4.4. Results and Discussion 
4.4.1. Gene Pair Choices 
After postulating that there is a correlation between reduced penetrance gene pair 
choices and their 3D proximity in the cell nucleus, we found no evidence of such 
fragments being any more or less represented within the top interactions from 100 
kb in situ Hi-C data. The occurrences of IF ranks, r , being higher than our variable IF 
rank thresholds was not significantly different between cases and controls for both 
of our datasets (table 4.1). 
Table 4.1 Fisher’s exact test for proportions of reduced penetrance gene pairs being either local or 
remote (within the 3D cell nucleus) against controls. Local is defined by a pair’s IF rank being higher 
than a threshold (i.e. having an IF within the top 10 ranks, for example) and remote would therefore be 
cases where IF ranks are outside of a threshold. Dataset 1 contains inter-chromosomal primary and 
modifier gene pairs; dataset 2 contains inter-chromosomal digenic mutation pairs. 
Threshold 
Local pairs 
(dataset 1) 
P-value 
Local pairs 
(dataset 2) 
P-value 
10 4 0.330164 12 0.919297 
11 5 0.304127 19 0.651819 
12 6 0.337225 21 0.847624 
13 7 0.425228 26 0.915969 
14 9 0.411347 34 0.710361 
15 11 0.415691 43 0.407925 
16 11 0.835090 47 0.612769 
17 14 0.630172 52 0.563331 
18 14 0.860170 56 0.513406 
19 15 0.738332 59 0.493136 
20 16 0.621349 62 0.517863 
 
Despite our findings leading us to accept that the proportions of local and remote 
gene pairs for cases against controls are the same, there are some important points 
to consider. Firstly, as a result of this analysis, we could conclude that the choice of 
gene pairs associated with reduced penetrance comes down to much more than just 
the influence of 3D proximity. Hence, isolating this variable for inspection seems to 
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be an oversimplification. Secondly, and perhaps more importantly, we could suggest 
that although the gene pairs themselves are not neighbours, there could be other 
undiscovered genomic fragments that act as a regulatory bridge, thus activating or 
suppressing the expected phenotype. This idea led us to pursue the proceeding 
analyses of global and local penetrance modulators. 
4.4.2. Penetrance-Associated Regulators 
We identified the most prevalent 1 Mb fragments from our analysis of each gene 
associated with inter-chromosomal digenic activity. The more frequently a particular 
fragment was found to be in the top ten interactions with these genes, the higher 
the calculated prevalence. We hypothesise that high prevalence is an indicator for 
the region in question being influential in penetrance regulation for any phenotype. 
Table 4.2 shows genomic regions that had the highest prevalence values. These were 
also compared against the fragment’s prevalence in control regions in order to make 
an informed decision about whether the fragment is specifically interacting with 
penetrance-associated genes or if this behaviour is ubiquitous. 
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Table 4.2 Fragments which commonly occur in the top ten interactions with digenic mutation genes. 
Prevalence values underlined indicate overrepresentation compared to controls, and those that are bold 
indicate statistical significance of p<0.05. P-values are generated using Fisher’s exact test against 
controls. 
Fragment 
Gene 1 list 
prevalence % (and 
p-value) 
Gene 2 list 
prevalence % (and 
p-value) 
Control 
prevalence % 
chr10:41,000,001-
42,000,000 
98.41 (0.1510) 100 (0.0041) 94.72 
chr2:91,000,001-
92,000,000 
93.65 (0.4209) 94.57 (0.2436) 91.94 
chr17:22,000,001-
23,000,000 
35.38 45.45 56.50 
chr1:121,000,001-
122,000,000 
25.00 22.22 30.41 
chr3:198,000,001-
199,000,000 
20.97 (0.0272) 12.24 (0.4806) 11.68 
chr18:16,000,001-
17,000,000 
19.40 21.78 (0.4167) 20.50 
chr9:66,000,001-
67,000,000 
14.71 (0.1990) 10.00 10.79 
chr1:1-1,000,000 11.67 12.22 13.11 
chr4:48,000,001-
49,000,000 
10.77 (0.4836) 12.50 (0.2600) 10.03 
chr7:61,000,001-
62,000,000 
9.23 16.49 25.40 
chr16:33,000,001-
34,000,000 
9.09 7.07 9.82 
chr16:69,000,001-
70,000,000 
9.09 (0.0159) 7.07 (0.0332) 2.99 
chr1:141,000,001-
142,000,000 
6.67 3.33 10.09 
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At the top of our prevalence list, we encountered fragments chr10:41,000,001-
42,000,000 and chr2:91,000,001-92,000,000 exhibiting almost complete ubiquity 
amongst our digenic gene high interaction lists. However, we saw that for controls, 
i.e. regions not necessarily associated with any reduced penetrance characteristic, 
there was also an extremely high prevalence rate (94.72% and 91.94% respectively). 
A high prevalence in controls could imply a bias with our dilution Hi-C data; a single 
fragment cannot be physically close to all other genomic regions at any one time, 
although there could be other explanations. Since our Hi-C data is a snapshot of a 
population of cells, it is possible that these highly prevalent regions act as a hub of 
activity during different stages of a cell’s life. This therefore makes it possible that a 
single region can exhibit a high interaction frequency with many other genomic 
regions, albeit at different moments in time. 
Looking back at table 4.2, we encountered one megabase fragment on chromosome 
16, positions 69,000,001-70,000,000 which exhibited a significantly higher 
prevalence for both gene lists compared to controls (Fisher’s exact test; respective p-
values of 0.0159 and 0.0332). This region, containing a total of 20 genes (table 4.3), 
could therefore be seen as an indiscriminate regulator of penetrance due to its 
overrepresentation in digenic mutation gene pairs and its enrichment in genes. 
Table 4.3 List of genes contained within the region on chromosome 16, positions 69,000,001-
70,000,000. 
Genes 
TANGO6 HAS3 CHTF8 CIRH1A 
SNTB2 VPS4A PDF COG8 
NIP7 TMED6 TERF2 CYB5B 
MIR1538 NFAT5 NQO1 NOB1 
WWP2 MIR140 CLEC18A CLEC18C 
 
Two other regions with a significant presence in digenic interactions: chromosome 
10, positions 41,000,001-42,000,000 and chromosome 3, positions 198,000,001-
199,000,000, are gene-poor. 
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4.4.3. Third-Party Regulators of Reduced Penetrance Gene Pairs 
Even for the smallest choice of our threshold, h , we found intersect fragments from 
the case datasets. Our controls, however, tended to exhibit a statistically similar 
number of intersects at any given threshold choice (table 4.4). 
Table 4.4 Number of intersects between reduced penetrance pairs, given a threshold choice, h . P-
values are obtained by performing Fisher’s exact test against control pairs. Dataset 1 contains inter-
chromosomal primary and modifier gene pairs; dataset 2 contains inter-chromosomal digenic mutation 
pairs. 
Threshold 
Intersects (and p-value); 
dataset 1 
Intersects (and p-value); 
dataset 2 
1 12 (0.5) 37 (0.3889) 
2 14 (0.5) 48 (0.5522) 
3 15 (0.5988) 56 (0.3498) 
4 15 (0.5) 66 (0.5) 
5 17 (0.4007) 73 (0.5522) 
6 23 (0.3939) 85 (0.4446) 
7 25 (0.5) 93 (0.4402) 
8 30 (0.1283) 100 (0.4339) 
9 31 (0.0980) 109 (0.1648) 
10 32 (0.0566) 114 (0.0579) 
 
Despite obtaining smaller p-values as we relaxed our threshold further, we could not 
reach the point of statistically significant difference between cases and controls. 
Furthermore, increasing our threshold beyond 10h  would not see a continued 
decrease in p-values, since this is the stage where almost all gene pairs exhibit at 
least one intersect (32 out of 32 for primary and modifier pairs, 114 out of 121 for 
digenic mutation pairs). Therefore, any subsequent increase in intersect counts 
would only be seen in controls, resulting in a return to statistical similarity. 
From this analysis, we could not conclude to 95% confidence that partner genes 
shared common third-party interacting fragments, although there were things we 
could learn from the methodology and results. Firstly, our method focused on the 
number of intersects rather than their identity (genomic position). Perhaps the 
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number of third-party regions found between cases and controls should not have 
been the point of focus, but rather the identities of fragments – particularly those 
found in cases and not controls. Following from this observation, fragments 
satisfying a presence in cases and absence in controls could have a variable influence 
on the final function of the target genes. With the data available, we were not able 
to conduct experiments to investigate the level of influence of such fragments, but 
perhaps this is an area of future wet-lab research if potential regions were identified. 
It is possible that this analysis (and preceding analyses of reduced penetrance pairs) 
has fallen victim to small sample sizes; we worked with a total of 170 inter- and 
inter-chromosomal gene pairs between two datasets. Variable penetrance is in its 
infancy in terms of our understanding, therefore sourcing a reliable and 
comprehensive dataset of genes known to exhibit reduced penetrance traits is 
difficult. With the possibility of more discoveries in this field comes the opportunity 
to increase our database and consequently our sample size, which may yield 
improved results if our analysis is repeated in the future. 
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Chapter V 
Gene Fusion Events 
 
5. Gene Fusion Events 
The separation and relocation of a genomic fragment is known as chromosomal 
translocation. These can occur both inter- and intra-chromosomally and if genes are 
affected at the separation sites, this type of rearrangement can result in so-called 
fusion genes. It is known that cases of gene fusion events cause diverse types of 
genetic disease (Kim et al., 2009); a prominent example is the BCR-ABL1 gene fusion 
causing chronic myeloid leukaemia (CML; Hunter, 2007). Gene fusions account for 20% 
of human cancer morbidity (reviewed in Mitelman et al., 2007) and so an 
improvement in understanding the mechanisms involved would go a long way for 
prevention and treatment. 
Our general hypothesis in this chapter was that any two regions which harboured 
one half of a fusion gene pair would also be neighbours in 3D space. This is not to be 
confused with the proximity between all fusion genes; rather the initial locations of a 
pair of genes are known to commonly fuse together. We investigated this hypothesis 
using two approaches. Firstly, we proposed that any region harbouring a fusion gene 
would show an enrichment of interactions from our 3D interaction data (Hi-C; 
Lieberman-Aiden et al., 2009; Rao et al., 2014) and consequently a closeness to other 
fragments within the cell nucleus. Secondly, we hypothesised that the choice of gene 
fusion pairs is not random. That is, one half of a known fusion gene pair would 
consistently favour a particular gene as a fusion candidate. We understand that the 
3D proximity of gene pairs is not the only criterion for a fusion event – the nucleotide 
sequence of the potential fusion site must be acceptable for example – but we 
suggest that the 3D structure of the human genome contributes to the choice of 
partners.  
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5.1. Basic Definitions 
There are three types of chromosomal rearrangement that can lead to a fusion gene. 
For the inter-chromosomal case, a reciprocal translocation can occur, whereby two 
fragments on separate chromosomes can detach and simply swap places (figure 5.1). 
This is the type of rearrangement that occurs for the aforementioned BCR-ABL1 case, 
where the ABL1 gene on chromosome 9 fuses to the BCR gene on chromosome 22, 
forming the Philadelphia chromosome. 
 
Figure 5.1 Diagram describing an inter-chromosomal translocation. 
One intra-chromosomal example of rearrangement that leads to a gene fusion event 
is a deletion. This is where a fragment is removed from the chromosome and the 
remaining fragments join (figure 5.2). 
 
Figure 5.2 Diagram describing an intra-chromosomal deletion and subsequent fusion. 
The third example of rearrangement leading to a gene fusion is an intra-
chromosomal inversion (figure 5.3). Here, a fragment separates from the 
chromosome, rotates and reunites such that the fragment fuses to the opposite 
separation points. 
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Figure 5.3 Diagram describing an intra-chromosomal inversion. 
Gene fusion events are clearly a symptom of genomic reorganisation. Fragments 
containing genes that are known to be associated with fusion events are important 
to analyse by way of ascertaining their folding behaviours in healthy cell lines. In 
other words, it is necessary to determine whether these types of reorganisations 
occur within a small/precise 3D neighbourhood or rather a much larger space. The 
former seems likely; it is more plausible that a loose DNA fragment would rebind to 
something nearby rather than making a journey to a remote region. This idea is 
reinforced when considering that there are relatively common gene fusion events 
within the population – the folding principles of the human genome are non-random 
(Lieberman-Aiden et al., 2009), therefore fusion gene-containing fragments will 
often be found within the same 3D neighbourhood, which provides ideal conditions 
for chromosomal rearrangements to occur. 
5.2. Materials 
5.2.1. Dataset of Gene Fusion Pairs 
The ChimerDB 2.0 database (Kim et al., 2009), containing 11,747 fusion gene pairs, 
was used for our analysis. These were labelled head and tail genes in order to show 
the direction of the fusion event. Each fusion was sourced from various repositories: 
the Mitelman’s database (Mitelman et al., 2007), the Sanger Cancer Genome Project 
(Futreal et al., 2004), the Online Mendelian Inheritance in Man (OMIM) database 
(Amberger et al., 2008) and a range of PubMed searches. Entries were categorised 
into one of three classes: A, B or C, depending on the confidence of the pair 
representing a genuine fusion. From the total 11,747 fusion pairs available, 1,643 
were chosen. This represented the complete set of the most reliable, class A fusion 
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gene pairs, 76% of which were inter-chromosomal fusion events (1,247 total). The 
remaining 396 intra-chromosomal pairs were cases where the head and tail genes 
were separated by a minimum of 1 Mb and were therefore non-adjacent. 
5.3. Methods 
5.3.1. Generating Control Datasets 
In our gene fusion analysis, we employed a mixture of methods, which came under 
two main branches. The first branch involved the interrogation of head and tail 
genes independently; the second branch analysed head and tail genes as a 
dependent pair. Hence, our generation of control datasets needed to reflect each 
branch of analysis appropriately. 
Controls for Independent Genes 
For descriptive purposes, we define a binned genomic region in Hi-C data as a pair of 
co-ordinates (chromosome, bin number). Our controls corresponding to a list of 
independent head and/or tail genes would mimic the size of the list as well as the 
distribution of chromosomes. For example, the number of control fragments on 
chromosome 6 would match the number of genes found on chromosome 6 in our 
test list. A description of the algorithm for generating controls is shown in figure 5.4. 
I1. 
[Retain chromosome.] Given a gene fusion region  i,  and desired 
control region  **,i , set  * . 
I2. 
[Select random bin.] Randomly generate a bin, *i , within the bin 
range appropriate for chromosome  . 
I3. 
[Is region associated with gene fusions?] If the generated control 
region  **,i  does not exist as a head/tail gene in the ChimerDB 
database, our algorithm terminates;  **,i  is our control region. If 
the region does exist in ChimerDB, repeat step I2. 
Figure 5.4 Algorithm I: pseudocode generating control fragments to test against independent head/tail 
genes. 
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The motivation behind retaining the chromosome choice was to match cases and 
controls in terms of genomic location. This would avoid a chromosome bias that 
could be introduced by selecting any region. 
Controls for Dependent Gene Pairs 
The generation of controls for dependent fusion gene pairs followed the same 
principles as seen for independent genes, although this procedure was modified 
slightly to account for a pair of regions as opposed to one (figure 5.5). 
D1. 
[Retain entire head gene and chromosome of tail gene.] Given a 
gene fusion pair defined by head and tail regions  i,  and  j, , 
respectively and corresponding desired control regions  **,i  and 
 **, j , respectively, set  * , ii *  and  * . 
D2. 
[Select random tail gene bin.] Randomly generate a bin, *j , within 
the bin range appropriate for chromosome  . 
D3. 
[Is tail gene region associated with gene fusions?] If the generated 
control region  **, j  does not exist as a head/tail gene in the 
ChimerDB database, our algorithm terminates;  **, j  is our control 
region. If the region does exist in ChimerDB, repeat step D2. 
Figure 5.5 Algorithm D: pseudocode generating control fragment pairs to test against gene fusion pairs. 
Selecting a brand new pair of regions would not have represented a fair comparison 
between cases and controls. For our analysis of pairs, we wished to investigate the 
3D proximity of head and tail genes in comparison to the proximity of a head gene 
and an unrelated region. Hence, we retained the head gene for our controls and 
selected a random tail region on the original tail gene chromosome. 
5.3.2. Global Interaction Profiles of Fusion Genes 
Our first hypothesis was that regions harbouring either head or tail genes were 
enriched in interactions measured by various Hi-C methods. In other words, we 
proposed that a region containing a fusion gene was likely to be on average less 
isolated in 3D than a randomly selected control. If true, fusion gene regions could be 
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viewed as hubs, with various regulatory fragments being nearby in 3D space. We 
used both dilution Hi-C (Lieberman-Aiden et al., 2009) and in situ Hi-C data (Rao et al., 
2014) at resolutions of 1 Mb and 100 kb for this analysis. 
To test this hypothesis, we first obtained the mean interaction frequency (IF) for 
each fusion gene region. Since each index of a Hi-C matrix, M , corresponds to a 
given binned region, we were able to calculate both the intra- and inter-
chromosomal IF means (denoted by ix  for bin i ) by taking the sum of the 
corresponding row and dividing by the number of non-zero entries in that row. Given 
that ],,,[ 21 kffff mmmM  , where lfm  is the interaction frequency between 
region f  and any other region, l , let ]'',,'',''['' )(21 zkffff mmmM    be a subset 
of fM  containing only non-zero entries (hence, a total of z  zero entries are 
removed). Thus, ix  is given by 
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For each tested region, controls were generated 1,000 times and the mean, ix , was 
obtained by taking an average of the 1,000 control values. Thus, we had two sets of 
IF means: let F  be the vector of mean IF values for fusion genes and let C  be the 
vector of mean IF values for corresponding controls. The ordering of F  and C  is 
important, since entries are in matched pairs. 
In explicit terms, our null and alternative hypotheses were as follows: 
.0:
,0:
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
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We tested for differences in means using the two sample t-test; our alternative 
hypothesis was one-tailed. That is, we specified that the means for our fusion 
dataset would be greater than corresponding controls. 
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5.3.3. Proximity of Fusion Gene Pairs 
We also hypothesised that regions harbouring gene fusion pairs had high interaction 
frequencies in Hi-C data relative to control pairs. If true, this would consequently 
imply that the choice of gene fusion partner is non-random and the 3D architecture 
of the human genome plays a significant role in the choice. 
We used the counter vector method seen in our reduced penetrance analysis with 
gene fusion pairs (figure 5.6). Regions harbouring fusion genes were described by a 
pair of co-ordinates representing chromosome and bin. We were therefore able to 
determine the IF rank of both cases and controls, and we could consequently obtain 
frequencies of pairs that satisfied a chosen rank threshold, h . Corresponding 
controls were generated 1,000 times and the total frequencies were averaged, thus 
giving non-discrete counts in our tables. 
F1. 
[Construct counter vector.] Let f  be the index of the genome-wide, 
kk   contact matrix, M , that corresponds to chromosome  , bin i . 
It follows that ],,,[ 21 kffff mmmM  , where lfm  is the 
interaction frequency between region f  and any other region, l . 
We construct our counter vector, ],,,[ 21 nvvvv  , where 1v  is a 
counter for the number of interactions (or entries of fM ) with 
frequency 1, 2v  with frequency 2, and so on. The last entry, nv , 
corresponds to the maximum interaction frequency recorded for 
fragment f . 
F2. 
[Find IF of pair.] Find gfm , where g  is the index of M  
corresponding to chromosome  , bin j . 
F3. 
[Find IF rank.] If gfmc  , then the interaction frequency rank, r , is 
found by counting the number of non-zero entries of v  between cv  
and nv . If 0c , then 1 nr . 
Figure 5.6 Algorithm F: pseudocode ranking fragment pairs according to their interaction frequency 
relative to other interacting fragments. A higher rank implies the tested pair of regions are relative 
neighbours in 3D space. 
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After tabulation of frequencies, we performed one-tailed Fisher’s exact proportion 
tests to measure the statistical difference in the proportions of neighbouring regions 
between gene fusion pairs and controls. Our hypotheses were as follows: 
H0: The proportions of fusion events within the top h  interacting fragments are 
the same for both the dataset of fusion genes and controls. 
H1: The proportions of fusion events within the top h  interacting fragments are 
greater for our fusion genes dataset compared to controls. 
Resulting p-values that satisfied 05.0p  would lead us to reject our null hypothesis, 
in favour of concluding that the proportion of head and tail gene partners within 
highly interacting fragments is greater than for controls. 
5.4. Results and Discussion 
5.4.1. Interaction Enrichment of Fusion Genes 
Interrogation of regions harbouring fusion genes by using both dilution and in situ Hi-
C data at various resolutions revealed significant differences of interaction 
frequencies between cases and controls (table 5.1). 
Table 5.1 Two-sample t-testing of the interaction frequencies of regions harbouring fusion genes 
against controls. Small p-values indicate fusion regions having an enrichment of interactions from Hi-C 
data. 
  Head Gene Regions Tail Gene Regions 
Dilution Hi-C Intra 1 Mb 5.95 × 10-3 3.74 × 10-3 
 Intra 100 kb 6.47 × 10-12 1.15 × 10-10 
 Inter 1 Mb 5.95 × 10-63 9.49 × 10-67 
In situ Hi-C Intra 1 Mb 4.45 × 10-3 1.34 × 10-3 
 Intra 100 kb 0.090739 0.018708 
 Inter 100 kb 4.12 × 10-154 1.96 × 10-157 
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We see the most significant differences between fusion regions and controls for 
inter-chromosomal tests, particularly in comparison to intra-chromosomal t-tests. 
This difference in significance may occur as a result of two factors. Firstly, our intra-
chromosomal dataset is almost four times smaller than our inter-chromosomal 
dataset. Therefore, testing with a smaller n  has an effect on the relative statistical 
power. Secondly, intra-chromosomal results could be affected by chromosome 
territory bias. That is, interaction frequencies for intra-chromosomal pairs are much 
higher than their inter-chromosomal counterparts. This leads to a tiling property 
seen in heat maps of Hi-C data (figure 5.7). 
 
Figure 5.7 Interaction heat map displaying the intra-chromosomal tiling feature which exists as a result 
of chromosome territory bias. 
The reason this feature exists is because regions on the same chromosome are more 
likely to be 3D neighbours than those on different chromosomes. In essence, we are 
saying that the Hi-C methodology is prone to a one-dimensional proximity bias. 
Therefore, a lesser difference is observed between intra-chromosomal cases and 
controls because many more interaction frequencies are relatively high. 
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5.4.2. Fusion Gene Pair Choices 
Pairs of regions which harboured head and tail fusion genes were found more 
frequently within the highest IF ranks than corresponding controls. Table 5.2 shows 
results from a variety of threshold choices for Hi-C data at 1 Mb resolution. The more 
the IF rank threshold was relaxed, the higher the observed statistically significant 
difference in proportions between gene fusion regions and controls. For 1 Mb data, a 
threshold choice of 10h  represents approximately the top 8% of intra-
chromosomal interactions and the top 0.3% of inter-chromosomal interactions. We 
were able to conclude a significant difference in proportions at this choice for all 
three 1 Mb tests (inter-/intra-chromosomal dilution Hi-C and intra-chromosomal in 
situ Hi-C). This implies that the choice of gene fusion pairs is at least partially 
dependent on where these regions are in 3D space. 
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Table 5.2 Fisher’s exact test for proportions of gene fusion pairs being either local or remote (within 
the 3D cell nucleus) against controls. Local is defined by a pair’s IF rank being higher than a threshold 
(i.e. having an IF within the top 10 ranks, for example) and remote would therefore be cases where IF 
ranks are outside of a threshold. Results from this table were all calculated from 1 Mb Hi-C data. 
Threshold 
Local 
Pairs 
(intra 
dilution 
Hi-C) 
P-value 
Local 
pairs 
(intra in 
situ Hi-C) 
P-value 
Local 
pairs 
(inter 
dilution 
Hi-C) 
P-value 
1 0 1 8 1 0 1 
2 13 2.60 × 10-3 17 0.143123 0 1 
3 22 1.14 × 10-4 22 0.052604 1 1 
4 43 7.76 × 10-9 37 3.66 × 10-4 3 0.943798 
5 55 4.36 × 10-11 43 6.68 × 10-5 5 0.595015 
6 61 7.94 × 10-12 49 1.60 × 10-6 8 0.243799 
7 70 2.48 × 10-13 55 2.97 × 10-6 14 0.027174 
8 81 1.55 × 10-15 62 3.36 × 10-7 16 0.015058 
9 86 4.44 × 10-16 64 5.02 × 10-7 17 0.013782 
10 90 3.33 × 10-16 70 9.05 × 10-8 21 3.62 × 10-3 
 
We repeated this experiment for a higher resolution of in situ Hi-C data (100 kb; 
table 5.3). Once again, significant differences in proportions were found given the 
right threshold choices. For inter-chromosomal tests, we found significant 
proportion differences at a threshold choice of 8h  (at a 95% confidence level). 
This threshold represents approximately the top 0.03% of interactions, and is 
therefore still very stringent. Similarly, we found significance at a threshold choice of 
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29h  (corresponding to approximately the top 2.2% of interactions) for intra-
chromosomal tests. 
Table 5.3 Fisher’s exact test for proportions of gene fusion pairs being either local or remote (within 
the 3D cell nucleus) against controls. Results from this table were all calculated from 100 kb in situ Hi-
C data. 
Threshold 
Local pairs 
(inter) 
P-value Threshold 
Local pairs 
(intra) 
P-value 
5 13 0.223215 25 24 0.325254 
6 15 0.177400 26 26 0.214532 
7 17 0.367634 27 29 0.104971 
8 36 5.06 × 10-3 28 31 0.064102 
9 58 1.35 × 10-3 29 33 0.039045 
10 96 2.15 × 10-5 30 36 0.017635 
11 143 8.95 × 10-8 31 39 8.38 × 10-3 
12 200 4.41 × 10-10 32 40 8.83 × 10-3 
13 260 2.13 × 10-11 33 43 4.37 × 10-3 
14 322 2.00 × 10-14 34 45 3.59 × 10-3 
15 382 7.47 × 10-16 35 46 2.75 × 10-3 
 
Particular attention should be given to table 5.3, since the 100 kb resolution of this 
data is perfect for encompassing genes within one or two bins, whilst fragments 
remain small enough to make precise distinctions between immediate neighbours. 
For example, suppose a head gene was wholly contained within one 100 kb bin and 
its associated regulatory elements were located on a nearby, separate bin. With this 
resolution, it is possible to distinguish between the head gene itself being a 3D 
neighbour of a tail gene, or alternatively an associated promoter/enhancer being 
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closest. This is not as plausible with 1 Mb data, since the neighbourhood of a gene 
and associated regulatory elements are usually within a region of at most 1 Mb in 
length (Symmons & Spitz, 2013) and are therefore typically contained within the 
same bin. In uncommon cases where the distance between genes and regulatory 
elements is larger than 1 Mb, Hi-C data at 100 kb resolution remains the more 
precise means of distinguishing the closest fragments. 
The findings from our analysis all support the hypothesis that the 3D structure of the 
human genome is highly influential in fusion gene pair formations. At the very least, 
we know there is a correlation. The proximity of head and tail genes in healthy cell 
lines is proof that either (1) being in a 3D neighbourhood is a driving factor for gene 
fusion events, or (2) if 3D proximity is not the underlying cause, it certainly provides 
ideal conditions for fusion events to occur. 
Indeed, previous studies have found that DNA fragments that are loose as a result of 
double-stranded breaks have a limited mobility (reviewed in Wijchers & de Laat, 
2011). This lack of mobility was found by recreating a 3D spatial closeness of known 
head and tail fusion genes, and observing the fusion efficacy at given distances. For 
example, in prostate cancer cells, the head gene TMPRSS2 (on chromosome 21) was 
found to fuse to tail genes ERG (also on chromosome 21) and ETV1 (on chromosome 
7) when the 3D proximity between head and tail genes was sufficiently small (Lin et 
al., 2009; Mani et al., 2009). The fusion preferences of head and tail genes was also 
shown to be conserved between cells belonging to hosts of various ages. The head 
gene RET was found to fuse with tail regions containing NCOA4 and H4, causing 
thyroid cancer (Gandhi et al., 2006). These events occur despite such regions being 
one-dimensionally remote on chromosome 10: RET and NCOA4 are separated by 
almost eight million base pairs, for example. Furthermore, three gene families 
involved in recurrent translocations causing cancer, MYC, BCL and IGH, were found 
to preferentially fuse. Interestingly, genes from the three families described above 
were all commonly found at the interior of the nucleus, implying a small 3D genomic 
distance between one another (Roix et al., 2003). 
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An analysis of almost 9,000 non-pathogenic deletion breakpoints from over 1,000 
human samples showed a strong association between non-allelic breakpoint sites 
with a high sequence similarity and open chromatin marks, identified by eigenvector 
transformations of Hi-C matrices (Abyzov et al., 2015). Whilst these findings confirm 
that data describing the 3D structure of the human genome is influential, its focus is 
primarily on the chromatin state. Hence, our results align with this study, but further 
analysis is needed in order to ascertain whether our regions have an open or closed 
chromatin signature. 
Markers for fusion events can also transcend human cell lines. Additionally, both 
inter- and intra-chromosomal translocation frequencies were found to correlate with 
the 3D organisation of the mouse genome (Zhang et al., 2012). The study induced 
breakpoints across whole chromosomes and observed the frequency of translocation 
events at each breakpoint, whilst recording the initial distances between 
translocation pairs. Translocations in cis occurred between regions separated by at 
least 1 Mb, and there was also a correlation between inter-chromosomal Hi-C 
interaction frequencies at 5 Mb resolution and translocation frequencies at 
corresponding 3D locations. Whilst these results align with our own analysis for gene 
fusion events, it is important to note that the Hi-C data used was from a different 
species and, perhaps most interestingly, our results were obtained with up to a 50-
fold increase of Hi-C resolution. 
The next natural step for our gene fusion analysis is to incorporate various network 
measures, described in chapter 3 of this thesis, into analysis of networks based on 
published Hi-C data. In a previous study, it was suggested to use node centrality 
measures to identify drivers of gene fusion events (Wu et al., 2013). The key 
difference was that networks for this study were constructed by assigning head/tail 
genes as nodes, and edges connected a pair of nodes if they participated in a gene 
fusion event. Nodes with a high centrality, therefore acting as hubs in so-called 
fusion networks, were found to be the most prolific in tumour formation. 
Our proposal would be to identify fusion drivers for nominated disorders by 
constructing 3D interaction networks from cell-specific Hi-C data and using more 
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comprehensive datasets of fusion events. Whilst recent years have seen an increase 
in publications of cell-specific Hi-C data (such as for brain tissues; Won et al., 2016), 
at the time of study, we had a limited choice of reliable Hi-C libraries. Therefore, this 
was beyond the scope of the thesis and is a suggested direction for future work. One 
would expect to find that head/tail fusion genes exhibit an enrichment of 
connections in networks describing the 3D architecture of the human genome. 
Consequently, we would expect these fusion genes to be hubs in such networks, 
displaying high scores from various centrality measures. Furthermore, these hubs 
will be especially easy to identify when future studies increase the size and reliability 
of fusion event datasets.  
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Chapter VI 
Schizophrenia 
 
6. Schizophrenia 
Schizophrenia is a chronic, severe and disabling brain disorder that has a lifetime 
prevalence of 1% (reviewed in Rees et al., 2015), with common symptoms including 
hallucinations, delusions and changes in behaviour. The causes of schizophrenia are 
known to be a combination of environment, brain structure/chemistry and perhaps 
most importantly, genotype (Eaton et al., 2008). The role of the genotype is 
evidenced by the fact that the occurrence of schizophrenia is 10% for those that 
have a first-degree relative with the disorder, and 40-65% for a monozygotic twin 
(Cardno & Gottesman, 2000). Furthermore, heritability in liability to this disease is 
reported at 70-80% (Keller et al., 2012). 
Previous studies have identified genetic variants, such as single nucleotide 
polymorphisms (SNPs), that are known to play a role in the development of 
schizophrenia (Ripke et al., 2011). These variants have an association with the 
disorder measured by statistical p-values obtained from genome-wide association 
studies (GWAS). The cut-off for genome-wide significance of SNPs having a disease 
association is 8105 p . Whilst many SNPs do not meet this cut-off, it is 
commonly accepted that many genetic variants may each make a small contribution 
to a disorder through interactions with each other (Jia et al., 2010). Thus, individually, 
SNPs may not seem to have a significant effect on disease, but when treated as a 
group, one can investigate the combined effect this may have. This is especially 
important since the majority of SNPs are found in intergenic (non-coding) DNA 
regions, which account for approximately 98% of the human genome (Elgar & 
Vavouri, 2008). Although relatively little is known about these regions, recent 
research suggests that the non-coding regions in the human genome are enriched in 
functional elements (The ENCODE Project Consortium, 2012), therefore creating a 
94 
 
regulatory map of genetic variants found in these regions could shed light on the 
functional importance of SNPs in schizophrenia due to their role in influencing gene 
expression. 
In this study, we hypothesised that both common and individually rare variants 
found by GWAS exert their influence on target genes, either directly via long-range 
looping interactions between fragments that harbour SNPs and target 
genes/promoters, or are propagated via the network of interactions governed by the 
3D architecture of the human genome. Hi-C data was used to quantify 3D distances 
between chromosomal regions and various network measures were calculated in 
order to achieve our aim of producing a novel library of genomic regions most 
associated with schizophrenia. Subsequent techniques were also used as a means of 
interrogating such regions. We used DAVID software (Huang et al., 2009) to classify 
the genes found within our regions into functionally similar groups. Additionally, we 
utilised expression quantitative trait loci (eQTL) analysis (Shabalin, 2012) to identify 
gene expression within distinct regions of the organ which is primarily responsible 
for schizophrenia development – the brain.  
95 
 
6.1. Background 
6.1.1. Single Nucleotide Polymorphisms 
Single nucleotide polymorphisms (SNPs) are individual base pair changes in a 
genome and are the most frequent form of genetic variation in the human genome. 
Synonymous (or silent) SNPs are considered to have no effect on the proteins 
produced from a nucleotide sequence, whereas non-synonymous SNPs result in a 
change of the amino acid sequence via missense or nonsense polymorphisms. Whilst 
a missense SNP will alter the amino acid sequence, a nonsense SNP induces a 
premature stop codon, thus halting the function of proteins. The relative locations of 
SNPs are also indicators of functional change; they can occur in non-coding regions 
of the genome, such as promoters or enhancers, which in turn can affect gene 
expression. The locations and densities of such SNPs across different populations 
have been catalogued thanks to the International HapMap project (International 
HapMap Consortium, 2005). This project describes the common patterns of human 
genetic variation and is invaluable in finding genetic SNPs associated with disease via 
genome-wide association studies. 
6.1.2. Genome-Wide Association Studies 
Genome-wide association studies (GWAS) measure and analyse SNPs from across 
the human genome in an effort to identify genetic risk factors for diseases that are 
common in the population (Bush & Moore, 2012). For diseases that frequently occur 
within the population, the common disease/common variant (CD/CV) hypothesis 
was developed as a way of identifying disease associated SNPs (Reich & Lander, 
2001). The hypothesis states that a genetic variant in the population that is equally 
as prevalent as a disorder may share a direct cause-effect relationship. This does not 
ignore the idea that the SNPs found can have a variable effect on the disease in 
question. GWAS have identified common variants with a small influence on a disease, 
such as variants in the LMTK2 gene for prostate cancer (Eeles et al., 2008) and also 
common variants which have a large influence, such as SNPs found in the APOE4 
gene for Alzheimer’s disease (Corder et al., 1993). Typically, both SNP frequency and 
effect size, the latter measured by odds-ratios and statistical p-values, can lie 
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anywhere on a spectrum from small to large (effect size; odds-ratio) or rare to 
common (SNP frequency). The odds-ratio is a measure of the likelihood of disease in 
an exposed subject compared to non-exposed subjects (Clarke et al., 2011), where 
exposure can be interpreted as either having an allelic trait (i.e. allele a  or A ) or a 
genotypic trait (i.e. genotype AA , aa  or aA ). Corresponding p-values were initially 
calculated using a simple chi-square test of a 2-by-2 contingency table describing the 
incidence between cases and controls. 
Nowadays, logistic regression is used (described in section 3.2.1 and reviewed in 
Bush & Moore, 2012). This is a modification of linear regression, where predictors 
can be both continuous and categorical, whilst the response is transformed from 
continuous into binary form (i.e. phenotype presence/absence). For GWAS, the set 
of independent predictive variables,  nXXX ,,1  , always includes a genotype 
variable describing SNPs (for example, a normal genotype ‘…AATT…’ is set to 0iX  
and a SNP-affected genotype ‘…AAGT…’ is set to 1iX ), and can optionally 
incorporate variables such as age, sex, ethnicity, blood type, etc. to give the model 
additional complexity. 
Measures of effect size are commonplace in GWAS and form an integral part of the 
summary statistics in such studies. Such statistics, as well as SNP frequency, are 
important considerations when testing the CD/CV hypothesis. The CD/CV method 
can identify common SNPs associated with a disease, but it does not necessarily 
show a full picture, with potential rare variants being overlooked from this type of 
study. 
Thanks to HapMap genotype data, SNPs identified by GWAS can also identified as 
being in linkage equilibrium (LE) or linkage disequilibrium (LD). LD describes the co-
inheritance of SNPs within a population over time. Suppose we have two variants 
(alleles),  aA, , at locus 1 and two alleles,  bB, , at locus 2 on a section of 
chromosome (haplotype). The chance of inheritance for each allele can therefore be 
expressed as 
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Assuming independence, one would expect the following haplotype frequencies: 
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This set of frequencies describes perfect LE. That is, there is a distinct ratio of 
haplotype frequencies occurring through generations. It is worth noting that LE/LD is 
still applicable with more than two alleles. In cases where we do not see the 
expected haplotype frequencies, we have LD, which can be quantified using the 
measure D  (Lewontin & Kojima, 1960): 
).()()()( aBPAbPabPABPD   
Clearly, for a case of LE, as seen above, the value of D  is zero. A higher than 
expected frequency of our homozygotic pairs would satisfy 0D , whereas a higher 
frequency of heterozygotic pairs would satisfy 0D . 
The model after one generation can be expressed in a similar way: 
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and r  is the rate of recombination, which is a process where chromosomes can 
overlap and exchange genetic material during meiosis. This rate satisfies 5.00  r . 
Recombination can therefore contribute to a decay of LD over time, given by 
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)1(' rDrDDD  . Since 'D  is directly proportional to r , SNPs or markers 
which have a low recombination rate stay in linkage through generations within a 
population and are therefore said to be in LD. 
Cases of LD are now also measured by using 2R . This is an output obtained from 
logistic regression which measures how well one SNP can act as a proxy for another 
(The International HapMap Consortium, 2005). Values for 2R  can lie anywhere 
within the boundaries of 0 and 1, with a score of 1 indicating perfect LD between 
SNPs (undisrupted by recombination). 
These instances are cases of interest for GWAS because without this property, 
association studies would have to independently analyse each SNP. That is, co-
inheritance of SNPs on a population scale provides us with a cost-effective way of 
performing GWAS, as continuous stretches of DNA containing particular SNPs are 
shared among a vast group of people. 
There are two main classifications of phenotypes in GWAS: categorical and 
quantitative. The categorical class is often case versus control, and arguably seems 
an oversimplified method, given the complex nature of many disorders. The most 
common method of statistical analysis for categorical data is a contingency table 
method – using either the chi-square test or Fisher’s exact test (a variant of chi-
square). The null hypothesis would be that there is no association between the 
phenotype and genotype classes, and a low p-value would indicate the chance of 
seeing no association is small. Genome-wide significance is set at 8105 p  due to 
allowances being made for multiple testing –  610  comparisons are needed, resulting 
in a Bonferroni correction of 86 1051005.0 p . The quantitative class is often 
analysed using Analysis of Variance (ANOVA), with the null hypothesis being that 
there is no difference between the trait means of any genotype group. Despite a 
preference for quantitative measures, both classifications are used in GWAS and 
both yield successful results, although one should be wary of factors which may 
influence a particular trait, such as gender and age. These factors cause an increase 
in degrees of freedom and therefore a loss of statistical robustness. 
99 
 
6.2. Materials 
6.2.1. Dataset of Schizophrenia Genes 
We obtained a list of 347 genes that are known to have an association with 
schizophrenia. These SNP-containing genes were identified on a sample of 21,856 
individuals of European ancestry and replicated on a sample of 29,839 independent 
subjects (table A6.1; Ripke et al., 2011). The genomic positions of each gene were 
lifted over to the hg19 reference genome assembly using the Lift Genome 
Annotation program available at https://genome.ucsc.edu/cgi-bin/hgLiftOver (Kent 
et al., 2002). The purpose of lifting over to the hg19 reference genome is to align  
gene positions with both in situ Hi-C and Capture Hi-C data. 
6.2.2. Dataset of SNPs 
A total of 1,252,901 SNPs spanning 22 chromosomes have been catalogued and 
scored according to their association with schizophrenia via p-values (Ripke et al., 
2011). These scores lie within the range 998.0103.4 11   p , with only 136 SNPs 
reaching the genome-wide significance threshold of 8105 p . Each SNP in this 
dataset is labelled with an exact genomic location relative to the hg19 reference 
genome, in order to align with in situ/Capture Hi-C data. 
6.2.3. Database of Gene Expression Regulators 
We utilised data from the Functional Annotation of the Mammalian Genome project 
(FANTOM5; The FANTOM Consortium, 2014) in order to locate transcription start 
sites (TSSs), and therefore promoters, from the Cap Analysis of Gene Expression 
(CAGE) method (Kanamori-Katayama et al., 2011). The CAGE method reads short 
nucleotide sequences (known as tags) and identifies the origin of the tag using a 
reference genome. CAGE peaks are genomic regions that show a high concentration 
or clustering of tags, which are quantified by normalised tags per million (TPM) 
values. Typically, CAGE peaks with a high TPM count correlate with high expression 
changes. 
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Although the FANTOM5 project investigates expression across 975 human and 399 
mouse samples, we are interested specifically in human brain tissues. The database 
called Semantic catalogue of Samples, Transcription initiation And Regulators (SSTAR; 
Abugessaisa et al., 2016) provided us with the data for the brain tissue samples from 
three sources: an adult sample from both genders with ages 77, 79 and 81 years, 
another adult sample from a male aged 18 years, and finally a fetal sample (both 
genders) of age 20-33 weeks. We used SSTAR to search for transcription factors (TFs) 
with enriched expression in these tissue samples. The data itself contains the CAGE 
peak names (labelled with the corresponding TF and in descending order of tag 
support, i.e. p1 is the promoter with the highest tag support, followed by p2, etc.), 
TPM values and normalised expression values. For each sample, we have access to 
the top 1000 TFs in terms of their expression enrichment. 
6.2.4. Gene Expression in Brain Regions 
In order to identify SNPs which are significantly associated with the change in 
expression of known genes, we use expression quantitative trait loci (eQTL) analysis 
(reviewed in Shabalin, 2012). Specifically, we use an exon-specific database which 
describes expression in ten different brain regions: cerebellar cortex (CRBL), frontal 
cortex (FCTX), hippocampus (HIPP), inferior olivary nucleus (sub-dissected from the 
medulla; MEDU), occipital cortex (OCTX), putamen (PUTM), substantia nigra (SNIG), 
temporal cortex (TCTX), thalamus (THAL) and intralobular white matter (WHMT). 
This database is known as the Brain eQTL Almanac (Braineac; Ramasamy et al., 2014). 
Ramasamy et al. (2014) reported that trans-eQTL signals had a high false positive 
rate, therefore only cis-eQTL signals (up to 1 Mb in distance from a given marker, 
hence intra-chromosomal) were used for our analysis. 
By using the Braineac web tool available at www.braineac.org, we are able to input 
SNPs (by their genomic location or reference SNP cluster ID (rsID)) and obtain an 
expression profile of the most affected genes in all ten brain regions, including an 
expression average across all regions (aveALL). The relative expressions are 
calculated by modelling the effect of genotype using a least squares or ANOVA 
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(analysis of variance) model and resulting p-values correlate with the strength of 
expression change of the affected gene. 
6.2.5. Gene Functional Classification 
The Database for Annotation, Visualisation and Integrated Discovery (DAVID) is a 
web tool that is able to classify groups of genes with similar function (Huang et al., 
2009). There are two motivations behind utilising this web tool; firstly, we wish to 
save ourselves from investigating biological functions on a gene-by-gene basis for 
large lists and secondly, we want to be able to understand the function of a gene (or 
group of genes) in order to make conclusions about possible links to schizophrenia 
development. 
Our first motivation is achieved by using the Gene Functional Classification tool. The 
user inputs a list of gene names as well as a choice of classification stringency 
(default is medium), which decides the threshold for strength of functional 
association between genes within a group. Genes are consequently clustered into 
groups if they meet the association criteria and the overall similarity strength 
between grouped genes is described via an enrichment score. The higher the 
enrichment score, the tighter the biological relationship between genes. This score is 
logarithmically correlated with the calculation of an EASE (Expression Analysis 
Systematic Explorer) score, which is a one-tailed modification of Fisher’s exact test 
used to measure gene enrichment in annotation terms (Huang et al., 2009). An 
enrichment score greater than 1.3 corresponds to an EASE score of 05.0p , 
therefore scores exceeding 1.3 are interesting cases. 
The Gene Name Batch Viewer tool is used to ascertain the biological function of 
genes on a one-by-one basis. Once a functional group of genes is found, we can 
explore the properties of each gene. As well as the biological function, we are able to 
find other related features, such as tissue specificity, known disease associations and 
also extra information via links to publications that cite the gene in their studies. 
 
 
102 
 
6.3. Methods 
In general, our approach for schizophrenia was two-fold. Firstly, we constructed 3D 
interaction networks from Hi-C data and performed unbiased analysis in what we 
called our top-down (or global) approach. This approach consisted of identifying the 
most important nodes by: (1) creating sub-networks containing only the highest Hi-C 
interaction frequencies, (2) calculating various network measures from raw and 
normalised Hi-C networks and (3) identifying connected components at given 
interaction frequency thresholds. The aim of this approach was to indiscriminately 
find nodes corresponding to genomic regions that could be associated with 
schizophrenia. Once we had found such regions, we termed them candidate regions. 
We then introduced our bottom-up (or targeted) approach, in which we investigated 
our candidate regions more closely. This was achieved by going through a checklist 
of features that could be signposts for schizophrenia association, such as an 
overrepresentation of SNPs, functionally relevant genes and enrichment of gene 
expression in brain tissues. Some methods from our global approach were also 
utilised in our targeted approach, such as examining the centrality measures of 
particular nodes and comparing their scores relative to the rest of the network. 
Candidate regions exhibiting many or all of these features were therefore identified 
as being the most likely contributors to schizophrenia development. 
6.3.1. Extended Gene Regions 
Using Capture Hi-C data (for a chosen cell line – see justification for the choice of cell 
line in section 6.3.5) which identifies significant interactions between promoters and 
genes/enhancers, we were able to pair each gene associated with schizophrenia to 
its corresponding promoter by concatenating regions recorded as baits, thus forming 
continuous gene-promoter regions. From here, we employed Capture Hi-C data from 
the same cell line which identifies promoter-other interactions (‘other’ consisting of 
regulatory elements such as enhancers) in order to find associated enhancers both 
upstream and downstream of any given gene-promoter region. Once we had found 
these, we included the genomic locations of the enhancers to our existing gene-
promoter regions to form a larger amalgamated, continuous region which we term 
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as an extended gene region (EGR; figure 6.1). In most cases, these EGRs were 
labelled with the name of the corresponding gene. However, there are also two 
special cases to consider. In instances where one or more of the original 347 EGRs 
were wholly contained within another EGR, we would amalgamate these into a 
single EGR. For example, if G1 had G2 within its genomic boundaries, we would label 
the new EGR as G1{G2}. Our second special case involves EGRs which are not wholly 
contained, but slightly overlap, i.e. there is some shared genomic space between two 
or more EGRs. Assuming G3 and G4 overlapped, this would be labelled G3-G4. The 
resulting EGR list for our analysis is reported in table A6.2. 
 
Figure 6.1 Schematic representation of the creation of extended gene regions (EGRs). Genes (green 
circles), promoters (red triangles) and enhancers (blue squares) are depicted here in 1D space. An EGR 
is the concatenation of regulatory elements associated with a gene. Boundaries of EGRs are represented 
by the brackets in this figure. Promoters and enhancers are identified by the presence of baits and 
fragments interacting with these baits from the Capture Hi-C procedure. These fragments are shown as 
coloured rectangles upon closer inspection of a regulatory element. These typically overlap, and so the 
length of our regulatory elements are decided by the length of the amalgamated baits. 
6.3.2. Network Analysis 
Sub-networks of Regions Connected with High Interaction Frequencies 
For the first part of our global approach, our initial set of all nodes, V , was 
partitioned to create two new, distinct subsets, U  and V , where VWU  . This 
resulted in a bipartite network representation between subset  ,, 21 uuU  , 
containing all unique EGRs, and subset  ,, 21 wwW  , containing genomic regions 
which interact with one or more element in U  with a suitably high interaction 
frequency (IF) from inter-chromosomal in situ Hi-C data. Nodes in U  and W  were 
connected by an edge if the IF between the regions described by each node 
exceeded a threshold which we defined. The threshold was chosen such that our 
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networks described <1% of all interaction frequencies: only the very highest 
remained. Typically, resulting networks contained between 100 and 1,000 nodes, 
where nodes in U  could only be connected to nodes in W  and vice versa (i.e. the 
bipartite property, described above). 
We were therefore left with a network describing the regions of the human genome 
that interacted most frequently with our EGRs. The network was described by using 
a weighted adjacency matrix, in which the weights represent the IF between regions. 
This was used in order to identify the most important connections and to be able to 
distinguish those particular edges from the rest of the network. The edges were 
assigned weights according to the number of connections between nodes iu  and jw , 
which was derived from the relevant in situ Hi-C dataset (figure 6.2). 
 
Figure 6.2 Example bipartite 3D interaction network between binned EGRs (regions from U ; green 
nodes) and binned regions found to have a Hi-C interaction frequency above our chosen threshold 
(regions from W ; black nodes). 
Multiple regions from W  were merged into a single node if and only if  ,, 1jj ww  
formed a continuous region and were all connected to a distinct EGR, iv . We made 
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this alteration because consecutive genomic fragments that interact with the same 
regions are effectively a single longer fragment with one cumulative connection. The 
network consequently reduces in complexity without any loss of information. Also, if 
an interacting region from the network (in set W ) was found to share some common 
genomic space with a node in set U , we would change the label of node jw   to the 
corresponding node in U , thus introducing the possibility of connections within set 
U . This second alteration was performed in order to avoid distinct nodes in our 
network describing identical stretches of DNA. Our final network would therefore no 
longer necessarily have bipartite properties, although nodes in W  would still not 
share connections. 
 
Figure 6.3 Pruned 3D interaction network. Weighted connections of less than 25 have been removed. 
Remaining black nodes are potential candidates for schizophrenia association. 
After constructing networks for both raw and seven other normalised in situ Hi-C 
datasets (described in Chapter 2), we pruned them such that only the edges with the 
highest weights remained (figure 6.3). This thresholding was chosen because of the 
population-based nature of Hi-C data: there is no one fixed moment during the cell 
cycle or a single cell/specific tissue where proximities are being captured. Therefore, 
since the genome is not static within the cell nucleus during its lifetime, it is possible 
for proximities to be captured in passing. We assumed these passing cases were 
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described by low interaction frequencies and were therefore considered not to be 
representative of sustained contacts between two fragments. Hence, passing cases 
were removed through the pruning procedure. This typically left us with a network 
of approximately 10 nodes from W , as well as a number of EGRs. The regions from 
W  were listed and ranked according to the edge with the highest weight that was 
incident to jw . Since we performed these steps with eight raw/normalised variants 
of in situ Hi-C data (described in chapter 2), we could also investigate the prevalence 
of nodes from W  across all eight lists (i.e. how often a particular node appears in the 
pruned networks). Hence, we constructed a master list, which sorted all remaining 
regions via two criteria: individual list rank and list prevalence. For list ranking, the 
node with the largest single edge weight was assigned rank 1, and subsequent nodes 
were ranked with increasing numbers. Nodes with equal edge weights were ranked 
identically, with the next node being given rank 1n , where n  is the number of 
nodes which have already been assigned a rank. List prevalence was assigned to 
nodes according to the number of lists a given node would appear in. This left us 
with our desired output – the nodes that were sorted to the top of our master list 
would represent the regions of the genome which hypothetically had the most 
profound influence on schizophrenia via long-range interactions. Figure 6.4 
summarises these steps algorithmically. 
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N1. 
[Filter Hi-C matrix.] Set entries of the Hi-C interaction matrix to zero 
if they do not meet our chosen threshold, t . If a pair of nodes, 
 
ji vv , , are connected by an edge and neither iv  or jv  are an EGR, 
remove the edge connecting them. That is, M  is a submatrix 
containing indices only applicable to EGRs and 0)( ,  tM ji vv . 
N2. 
[Construct node subsets.] Partition the node set  ,, 21 vvV   into 
subsets U  and W , where nodes from U  are EGRs and nodes from 
W  are all interacting regions. Any nodes which overlap in position 
are amalgamated into single nodes. 
N3. 
[Create network.] Construct a weighted adjacency matrix, A , which 
describes the connections between nodes in U  and W . Edges are 
weighted according to the number of connections fragments in iu  
have with fragments in jw . 
N4. 
[Prune network.] If entries of A  do not meet our edge weight 
threshold, set them to zero. 
N5. 
[Identify remaining jw  nodes.] Any remaining nodes from W  are 
listed and sorted in descending order of incident edge weights. 
N6. 
[Compile master list.] Steps N1-N5 are repeated for each normalised 
in situ Hi-C data. Then, from all 8 independent lists, we compile a 
master list of all remaining nodes and sort them according to the rank 
within their individual list and their list prevalence (i.e. the number of 
lists they appear in). Nodes do not have to appear in all lists to 
become an entry of our master list, but those which appear in most 
are likely to be ranked higher (a highly ranked candidate would 
typically appear in 4  lists). Nodes at the top of this list are 
therefore identified as possible schizophrenia-related candidate 
regions. 
Figure 6.4 Algorithm N: pseudocode identifying the regions of the genome which interact most 
frequently with schizophrenia EGRs according to in situ Hi-C data. 
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Node Centrality Measures 
Given that the overarching aim of this chapter is to identify genomic regions which 
have an association with schizophrenia through analysis of 3D interaction networks, 
intuition tells us that this can be achieved by identifying the most important nodes. 
Centrality is a de facto way of finding nodes of influence. Since the relative influence 
of any node can be explicitly measured, it follows that nodes can be easily compared 
and contrasted, i.e. node i  is seen as more important than node j  simply because 
of its higher centrality score. 
For global 3D interaction networks, we used four centrality measures: betweenness, 
degree, eigenvector and PageRank (descriptions and motivations for use are given in 
chapter 3) to identify important nodes which consequently correspond to candidate 
regions. Intra- and inter-chromosomal in situ Hi-C data was used at 100 kb resolution 
to construct these networks, which were converted from weighted to unweighted by 
setting an interaction frequency threshold. Our first inter-chromosomal threshold 
was set so that any entry exceeding the median of non-zero entries from the Hi-C 
adjacency matrix was considered as an interaction and our second inter-
chromosomal threshold was set as the third quartile of non-zero entries of the Hi-C 
matrix. We set these thresholds because the distribution of IFs in Hi-C data is heavily 
left-skewed. That is, there is a large number of low IFs, therefore we set the 
thresholds to ignore these counts in favour of genomic fragments that are more 
frequently crosslinked (hence removing potential false positive cases). For intra-
chromosomal data, we set the threshold at 0F . That is, any non-zero entry of the 
adjacency matrix was considered an interaction. The motivation for our intra-
chromosomal threshold was that setting anything higher than zero would increase 
the chance of removing remote (3D) interactions in favour of interacting regions that 
were one-dimensionally close. We chose more than one threshold for inter-
chromosomal data in order to examine the behaviour of nodes at varying 
stringencies, i.e. answering the question, “Would the most central nodes change or 
be preserved at different thresholds?” 
109 
 
From our binary Hi-C networks, we sorted the centrality scores in descending order, 
identifying those at the top as being our candidates ready for targeted analysis. We 
put additional emphasis on nodes that appeared near the top of more than one 
ranked centrality list and also nodes that were present between different threshold 
choices, as these are regions that communicate extremely well with other nodes in 
the network. We also recognised that some centrality measures are highly correlated 
compared to others (an example being eigenvector and PageRank centrality). We 
therefore emphasised the importance of nodes that rank highly in lists of 
uncorrelated measures (such as betweenness centrality) more so than those ranking 
highly between similar measures. 
Local Clustering Coefficients 
We were able to identify communities of nodes that preferentially interacted with 
one another (i.e. clustered) via the local clustering coefficient. That is, clustering is 
not a measure that identifies a node’s importance relative to the whole network, 
rather it acts as a means of finding small areas of close communication – in our case, 
this means finding genomic regions that consistently share a 3D neighbourhood. 
Our Hi-C networks were constructed exactly as seen above (identical to those used 
for centrality measures) and we identified nodes with the highest local clustering 
coefficients as regions of interest that consistently participated in 3D interactions 
with other distinct regions. Clusters of most interest were those that contained 
genes that have an association with schizophrenia. Subsequent targeted approaches 
would also reveal the potential functional relevance of the novel regions found 
within particular clusters – perhaps clusters indicate regions of functional similarity, 
for example. 
Connected Component Analysis 
Our final top-down (global) approach aimed to identify candidate regions by 
examining the components of our 3D interaction networks. Initially, we had our raw 
and normalised inter-chromosomal, weighted adjacency matrices, describing the 3D 
proximities between pairs of genomic regions between chromosomes. We treated 
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this data by first setting an interaction frequency threshold, which allowed us to 
distinguish between genomic pairs that were sufficiently close in a 3D setting and 
those that were not 3D neighbours. Hence, our Hi-C adjacency matrices had binary 
properties and were therefore unweighted. After choosing a suitable interaction 
frequency threshold for raw Hi-C data, we ensured that an equivalence of thresholds 
was struck between raw and normalised matrices by examining the percentile of the 
raw threshold choice, and consequently mimicking that percentile with other data. 
For example, let 50F  be our chosen interaction frequency threshold for raw, in 
situ Hi-C data. Suppose we found 50F  to be the 81st percentile of interaction 
frequencies in the raw data, we would then seek the 81st percentile within a 
normalised matrix and set the threshold accordingly (e.g. if the 81st percentile for the 
Knight & Ruiz normalised Hi-C matrix was 32F , then our threshold for the KR 
matrix would be 32). Note that for cases where an irrational F  was found, F  was 
rounded to the nearest integer. In short, we threshold so that the same percentage 
of interactions are present amongst different Hi-C datasets. 
After completion of the thresholding procedure, we were able to easily identify 
connected components by finding sub-networks which satisfied the condition that 
any pair of nodes were connected by at least one path, but did not connect to any 
node from elsewhere in the network (figure 6.5). 
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Figure 6.5 A network with three connected components. Nodes of identical colour are contained within 
the same component. 
Our next step of the search for candidate regions led us to look for families of nodes 
which consistently interacted within the same component – particularly if the 
component had a large presence of genes that have known associations with 
schizophrenia. Nodes of most interest were those that (1) connected with many 
nodes locally (i.e. within the component) and globally (i.e. within the whole network, 
given that the interaction frequency threshold was relaxed to allow for components 
to be more connected), or (2) did not necessarily have a high degree, but did connect 
important components. In other words, we used our centrality measures as a tool to 
identify and verify important nodes within components. 
Crucially, our analysis only focused on influential nodes that share 
connections/components with schizophrenia-associated genes. Otherwise, our 
findings would be non-specific and we would therefore fail to identify candidate 
regions for schizophrenia association. In addition, we implemented our targeted 
approach within our component analysis by identifying the most influential genes 
from our pool of existing schizophrenia associated genes. We identified important 
genes by their presence in components of all raw/normalised data. Since raw, inter-
chromosomal vanilla coverage (INTERVC) and inter-chromosomal Knight & Ruiz 
(INTERKR) thresholded networks were used, if a schizophrenia-associated gene 
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appeared as a member of a connected component (with other genes/regions) in all 
three Hi-C networks, we identified that gene as having the most overlaps and 
perhaps therefore being more influential. 
6.3.3. SNP Analysis 
After locating schizophrenia candidate regions through various indiscriminate 
network approaches, we wished to investigate these genomic regions in more detail. 
In particular, the occurrence of SNPs is perhaps one of the most important features 
to assist in identifying important regions. Features of SNPs across a bounded region 
that we were interested in included the SNP frequency, the spread or distribution of 
said SNPs, and the strength of association with schizophrenia (obtained by p-values 
from GWAS). 
Since candidates forming the set W  can vary in size (from 100 kb to several Mb), the 
raw frequency of SNPs may introduce a bias towards the larger regions. Hence, we 
formulated a SNP density score, which calculates the average number of SNPs per 
100 kb fragment. This, together with observing the range of SNP p-values each 
region contains, will give us an insight as to which regions from W  in particular may 
have the most influence on schizophrenia. 
6.3.4. Analysis of Expression Regulators 
Using FANTOM5 brain tissue data, we explored the association between gene-
containing candidate regions for schizophrenia and the presence of TSS enrichment, 
which indicates a promoter region. Both the raw count of CAGE peaks and the 
relative expression values were used as a measure to confirm/deny whether the 
regions we found from our network analysis were likely to play a role in 
schizophrenia development. 
We also used age as a variable due to its difference in our three brain tissue samples. 
Similarities/differences in the frequency of CAGE peaks between all three samples 
were explored, as well as the strength of expressions and TPM counts. This analysis 
in particular could further explain properties of the regions our network algorithm 
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finds, hypothetically indicating at what stage in life a functional element could 
contribute to schizophrenia formation, and not just where. 
6.3.5. Choice of Hi-C Cell Line to Emulate 3D Interactions in Brain Tissues 
We sought to validate the use of in situ Hi-C, which was obtained from various non-
brain cell lines, for the study of interactions in brain tissues. Our first conundrum was 
to choose the most suitable data from the available in situ cell lines: GM12878 
(lymphoblastoid cell line), HMEC (mammary epithelial) or IMR90 (lung fibroblast). A 
cell line with the highest percentage of brain-related eQTL pairs residing within intra-
chromosomally interacting regions was considered suitable for further identification 
of SNPs and their target genes. The eQTL pairs used were the average of all (aveALL) 
brain regions from Braineac data (Ramasamy et al., 2014). We first created three 
groups of cis-eQTL pairs based on their relative one-dimensional locations. Pairs 
separated by >10 kb, >100 kb or >1 Mb were placed into respective groups and any 
remaining pairs that were within these distance thresholds were deleted. That is, if 
the SNP and TSS positions of an eQTL pair were within the same binned region, the 
eQTL pair was not considered. We also only used one SNP for any given bin – this 
was selected by using the SNP causing the most expression change per TSS. For 
example, consider three SNPs: S1, S2 and S3, that are all located on the same binned 
genomic fragment. SNPs S1 and S2 both pair with TSS T1, and S3 pairs with T2 (note 
that T1 and T2 are located on a different genomic fragment to the SNPs). The 
expression change p-values corresponding to S1, S2 and S3 are 0.03, 0.004 and 0.007, 
respectively (figure 6.6). In this scenario, we would use only the pair corresponding 
to S2 for our analysis (i.e. S2-T1), as it is responsible for the most gene expression 
change from the available options. The cell line exhibiting the most overlap between 
eQTL pairs and interactions in Hi-C data would then be chosen as the preferred 
library to emulate 3D interactions in brain tissues. 
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Figure 6.6 Example of three SNP and TSS (eQTL) pairs located on the same bins. The pair with the 
most expression change (hence smallest p-value; bold line) remains, whereas other cases are deleted 
(dotted lines). 
6.3.6. Brain eQTL Analysis 
We then used eQTL data to further test at a more stringent level for an association 
between the presence of cis-eQTL pairs and their corresponding 3D proximity from 
our chosen in situ Hi-C cell line. This was achieved by constructing a 2-by-2 
contingency table of true/false counts corresponding to the presence of cis-eQTL 
pairs and 3D proximity of SNP and gene regions (figure 6.7). Fisher’s exact test was 
then employed to consider association between these variables across data for all 
ten brain regions, as well as for the average of all regions (aveALL). Note that p-
values correlate with a strong dependency amongst SNP-TSS pairs of 3D proximity 
and expression change. 
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Figure 6.7 Network interpretation of the construction of contingency tables for Hi-C and eQTL 
association. There are four scenarios to consider: (1) if a SNP (orange node) and gene (green node) 
have a high interaction frequency in Hi-C data, they are connected by a dashed edge (first connection, 
from left to right); (2) if a SNP and gene form a cis-eQTL pair, they are connected by a dotted edge 
(second connection); (3) if both conditions (1 & 2) are met, nodes are connected by a solid edge (third 
and fourth connection); (4) if neither of the first two conditions are met, there is no connection between 
nodes (furthest right green node). Frequencies of each type of connection are counted and subsequently 
implemented into a 2-by-2 contingency table (table 6.1). 
 
Table 6.1 Example 2-by-2 contingency table corresponding to information from figure 6.7. 
 Cis-eQTL pair No cis-eQTL pair 
Hi-C interaction 2 1 
No Hi-C interaction 1 1 
 
A SNP and corresponding gene are said to be neighbouring in 3D space according to 
the IF threshold we set for them. Since we employed this method for three 
resolutions of in situ Hi-C data (5 kb, 10 kb and 25 kb), our choice of IF threshold 
needed to reflect the chosen bin size appropriately. Therefore, we said that a pair of 
genomic regions are sufficiently close in 3D space if the IF was greater than the 
median of non-zero counts in our intra-chromosomal Hi-C matrices. With respect to 
our contingency tables, anything that exceeded this threshold would be counted as 
true (condition 1, and in some cases condition 3; figure 6.7). 
The strength of gene expression change that a SNP had on a gene was measured by 
its p-value from cis-eQTL analysis. Small p-values indicated a significant change of 
expression in the affected gene, therefore we also set a threshold to decipher pairs 
that did not experience an expression change to those that did. Our threshold was 
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set such that entries of our contingency table were counted as true for the presence 
of cis-eQTL pairs if 05.0p  (conditions 2 and 3; figure 6.7). 
Assuming there was a link between eQTL pairs and their proximity in 3D space for 
our chosen cell line, candidate regions (from W ) found from our network analysis 
were consequently investigated in our targeted approach. All SNPs occurring within 
any genomic region from W  were entered into the Braineac web tool, which 
subsequently returned a comprehensive list of all affected genes with corresponding 
expression p-values across all brain regions. 
Our aim with this data was two-fold – firstly, we wished to examine the expression 
profile of regions that we had found to be schizophrenia candidates on a macro scale. 
That is, given a region of the genome spanning one or more 100 kb bins, we wished 
to find the brain region(s) which exhibited the most expression change according to 
Braineac data. Secondly, from our highly expressed, large genomic regions we sought 
to identify clusters of SNPs spanning smaller genomic regions which had the most 
profound impact on gene expression. Both of these objectives were best visualised 
by producing heat maps of expression in genomic regions across our ten distinct 
brain regions. We converted our p-values from Braineac data into expression scores 
by taking a 10log  transform. Areas of high expression and SNP clusters were 
therefore easily identifiable from the resulting heat maps. On a macro scale, we took 
the mean expression score per genomic fragment, and on a more refined scale, we 
were able to take mean expression score for each SNP by averaging the best ten 
markers. We focused on the best ten markers because averaging all markers per SNP 
results in homogeneity due to the vast number of markers with low expression 
scores. 
6.4. Results and Discussion 
6.4.1. Justification of Using GM12878 Hi-C Data for Emulating the Brain 
Using in situ Hi-C data at corresponding resolutions (10 kb, 100 kb and 1 Mb), we set 
the interaction frequency threshold at 80 as a means of defining that a pair of intra-
chromosomal regions were reasonably nearby in 3D. We then sought the binned 
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locations of each cis-eQTL pair with p-value, corresponding to the expression change, 
being less than 10-6 and determined whether cis-eQTL harbouring fragments had an 
interaction frequency greater than our threshold, hence constituting a significant 
interaction. Almost all (95%) cis-eQTL pairs were found on interacting fragments in 
all cell lines used (GM12878, HMEC, IMR90) across all bin sizes combined.  However, 
the proportion of cis-eQTL pairs residing within strongly (with frequency of 
interactions ≥80) interacting fragments was the highest in the GM12878 cell line 
(73%). These proportions were much lower for IMR90 (23.8%) and HMEC (6.6%) cell 
lines. Using Fisher’s exact test to compare the proportions of strongly interacting 
fragments harbouring cis-eQTL pair in different cell lines, we found that GM12878 
had a significantly higher proportion as compared to IMR90 or HMEC ( 39810p ). 
With only 27% of cis-eQTL pairs not forming a strong looping interaction in GM12878 
data, we concluded that this cell line was the most suitable for emulating the 3D 
architecture of the human genome in brain tissues. Henceforth, all mention of Hi-C 
data corresponds to in situ Hi-C for the GM12878 cell line, unless otherwise stated. 
Using our preferred cell line from in situ Hi-C data (blood; GM12878), we have shown 
that the presence of eQTL pairs in ten brain regions and corresponding proximities in 
3D space are not independent (Fisher’s exact test; table 6.2). Entries in table 6.2 
have been corrected for multiple testing by multiplying p-values by ten, which is the 
total number of brain regions in this study. There is some variability in association 
strength between brain regions and resolution choice, and perhaps what is most 
striking is the consistently small p-values found with smaller bin sizes (particularly 5 
kb resolution). This is encouraging, since we can conclude that as region specificity 
improves, so does the association between gene expression and 3D proximity. This 
gives further validity to our use of in situ Hi-C data from the blood cell line in 
studying brain interactions. 
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Table 6.2 Results from Fisher’s exact tests between cis-eQTL pairs and 3D proximity according to 
Braineac and in situ Hi-C data respectively (see section 6.3.6 for method). 
 5 kb resolution 10 kb resolution 25 kb resolution 
aveALL 2.54 × 10-37 2.44 × 10-20 3.31 × 10-2 
CRBL 5.73 × 10-25 4.75 × 10-12 2.20 × 10-8 
FCTX 5.79 × 10-15 5.94 × 10-10 1.07 × 10-8 
HIPP 1.31 × 10-34 1.03 × 10-14 1.13 × 10-5 
MEDU 1.10 × 10-21 2.59 × 10-12 1.90 × 10-5 
OCTX 8.31 × 10-19 1.53 × 10-8 1.77 × 10-4 
PUTM 6.42 × 10-15 6.64 × 10-9 1 
SNIG 6.16 × 10-23 0.101 0.311 
TCTX 1.70 × 10-27 5.85 × 10-11 5.51 × 10-4 
THAL 1.28 × 10-28 2.36 × 10-19 0.192 
WHMT 1.38 × 10-10 1.27 × 10-14 1 
 
6.4.2. Global Approach: Identifying Candidate Regions 
3D Interaction Sub-networks 
We found a number of high ranking regions from W  that contained genes which are 
known to have an association with schizophrenia (table 6.3). From a total of 54 
nodes (covering 35 unique continuous regions) in W across all raw and normalised in 
situ Hi-C data, 28 of these were found to contain at least one gene not present in our 
original dataset. There were four particular nodes of interest which harbour genes 
with a known association with schizophrenia, reported by various authors. 
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Table 6.3 Novel nodes identified by our network analysis that contain schizophrenia-associated genes. 
Node (hg19 
position) 
Dataset used 
Schizophrenia-
associated genes 
Reference(s) 
chr6:200,000-
400,000 
RAW, SQRTVC IRF4 
Moskvina et al., 
2010 
chr6:26,000,000-
26,500,000 
RAW, INTERKR 
HIST1H2BC, 
HIST1H2BD, 
HIST1H2BG, 
HIST1H2BH 
Sanders et al., 2013 
chr6:26,000,000-
26,500,000 
RAW, INTERKR HIST1H1E Föcking et al., 2014 
chr6:26,000,000-
26,500,000 
RAW, INTERKR BTN3A3 Chen et al., 2014 
chr11:100,000-
800,000 
RAW 
IFITM1, IFITM2, 
IFITM3 
Hwang et al., 2013; 
Saetre et al., 2007; 
Arion et al., 2007 
chr11:100,000-
800,000 
RAW HRAS 
Goriely & Wilkie, 
2012; Comings et al., 
1996 
chr11:100,000-
800,000 
RAW IRF7 Lukasz et al., 2013 
chr11:100,000-
800,000 
RAW DRD4 Cheng et al., 2014 
chr19:300,000-
1,400,000 
RAW FGF22 Terauchi et al., 2010 
chr19:300,000-
1,400,000 
RAW GRIN3B Lin et al., 2014 
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Figure 6.8 Glossary for in situ Hi-C data types. 
Of the raw and seven normalised sets of in situ Hi-C data used in this study (figure 
6.8 serves as a reference for identifying the type of in situ Hi-C data from their 
respective acronyms/abbreviations), we found that regions from W  containing 
genes associated with schizophrenia were all found in the raw data (15 out of 15 
associated genes). A region on chromosome 6 between positions 26,000,000-
26,500,000 (hg19 assembly) containing genes HIST1H2BC, HIST1H2BD, HIST1H2BG, 
HIST1H2BH, HIST1H1E and BTN3A3, was additionally found from the INTERKR data. 
Five of these genes belong to the histone gene family, which are responsible for the 
compaction of chromatin into higher order structures and therefore play a role in the 
3D organisation of the human genome. Furthermore, a region on chromosome 6, 
positions 200,000-400,000, found from raw data and containing gene IRF4, was also 
found from the normalised, SQRTVC data. From genes listed in table 6.3, we found 
FGF22 to have a particularly high comparative expression in brain tissues (second 
highest of 27 tested human tissues; Fagerberg et al., 2014). This gene belongs to the 
fibroblast growth factor family of genes and plays a role in many processes, such as 
embryonic development, tissue repair and cell growth. 
Results obtained from this indiscriminate, global network analysis confirm the initial 
hypothesis that genes and genomic regions associated with schizophrenia are in 
close physical contact with each other, since we have found fragments that do not 
RAW:   Raw interaction counts. 
KR:   Knight & Ruiz matrix balancing. 
INTERKR:  Inter-chromosomal Knight & Ruiz matrix balancing. 
GWKR:  Genome-wide Knight & Ruiz matrix balancing. 
VC:   Vanilla coverage normalisation. 
INTERVC:  Inter-chromosomal vanilla coverage normalisation. 
GWVC:  Genome-wide vanilla coverage normalisation. 
SQRTVC:  Square-rooted vanilla coverage normalisation. 
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appear in our original dataset but are reported to have an association to 
schizophrenia in other publications. The raw in situ Hi-C data is perhaps the best 
predictor for finding regions which have significant disease associations, but we 
should not discard results from various normalised data as they could act as a 
validation technique in some cases, particularly since normalisation procedures serve 
to remove experimental bias from data. 
Amongst entries of table 6.3, we have found gene-rich regions occurring on 11 
different chromosomes which had no previous implication in schizophrenia at the 
time of analysis; the highest ranked from our sorted master list are shown in table 
6.4. We identify these regions and the genes contained within them as having a 
potential influence on this disease according to our hypothesis, and therefore may 
warrant further inspection in future schizophrenia research. 
Table 6.4 Genomic regions from network analysis that contain genes with no previous schizophrenia 
association. These are sorted according to step N6 of algorithm N (figure 6.4, section 6.3.2). 
Node (hg19 position) Dataset used Genes in region 
chr9:137,400,000-
138,900,000 
RAW 32 
chr21:15,000,000-
15,200,000 
INTERVC, GWVC 
POTED, DQ590589, 
DQ591735 
chr9:39,800,000-40,300,000 INTERVC SPATA31A2, FAM74A1 
chr1:143,400,000-
143,600,000 
VC, SQRTVC, KR 
DQ587539, DQ590126, 
DQ596206, BC070106 
chr6:171,000,000-
171,100,000 
INTERVC, GWVC BC036251 
chr22:16,000,000-
16,200,000 
VC, INTERKR 
AK022914, LINC00516, 
BC017398, AK056135 
chr11:100,000-200,000 RAW, SQRTVC, KR, GWKR 
AL137655, LOC100133161, 
SCGB1C1, ODF3 
chr10:48,000,000-
48,200,000 
INTERVC CTSL1P2, BMS1P6, AGAP9 
chr16:100,000-900,000 RAW 57 
 
For all gene-containing fragments in table 6.4, we used the DAVID Gene Functional 
Classification and Gene Name Batch Viewer web tools available at 
https://david.ncifcrf.gov/home.jsp (Huang et al., 2009) in order to find common gene 
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functions. From a total of 110 genes tested, two groups of genes were found to 
cluster with enrichment scores greater than 1.3 (implying 05.0p  for functional 
similarity). The first group contained four genes that were found to be functionally 
similar: PAEP, LCN9, LCN1 and OBP2A (an enrichment score of 1.36). These genes are 
predominantly expressed in the lachrymal/salivary glands as well as the nasal cavity 
(OBP2A), the lungs (OBP2A) and the endometrium (uterus lining; PAEP). They are all 
part of the lypocalin family, which are proteins that transport hydrophobic molecules. 
From the same clustering procedure, we found a group of five genes which shared 
strong functional similarities: HBM, HBA2, HBZ, HBA1, and HBQ1 (an enrichment 
score of 4.45). All of these genes are part of the haemoglobin family and their 
function is to transport oxygen throughout the body via red blood cells. A possible 
link to schizophrenia here could be the efficacy of this group of genes in regulating 
oxygen transportation to the brain. This observation is supported by findings that 
signs of asphyxia at birth are associated with an increased risk of schizophrenia in 
adults (Dalman et al., 2001). 
Table 6.4 contains regions with different properties compared to those in table 6.3. 
The main difference is which data these nodes have been identified from. Just three 
of nine from this list have been discovered from the raw in situ Hi-C data (with other 
regions being identified from other normalised Hi-C datasets), whereas all four 
regions in table 6.3 were identified using raw in situ Hi-C. There is also a wide range 
of region lengths in table 6.4, with the smallest and largest lengths being 100 kb and 
1.5 Mb, respectively. 
There are numerous ways we could interpret these results. Our algorithm has 
identified schizophrenia-associated regions almost entirely from raw in situ Hi-C data 
(table 6.3), so one could assume that regions found only in raw data are worth 
interrogating. This would leave us with three candidates: chr9:137,400,000-
138,900,000, chr11:100,000-200,000 and chr16:100,000-900,000. Perhaps the most 
interesting case is the region on chromosome 11, as it is found not only in raw data, 
but is also discovered in SQRTVC, KR and GWKR data. Since we see a distinct 
difference between the outputs from investigations of raw and normalised data, it is 
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reasonable to suggest that further lab-based functional ascertainment of candidate 
regions is required. 
Centrality/Clustering Measures 
For our inter-chromosomal Hi-C data thresholded at the median and third quartile 
(excluding zero entries), we created unweighted networks containing 30,367 nodes 
and 108,390,265 and 65,685,996 edges, respectively. From these 3D interaction 
networks, we found a number of regions that appeared more than once as one of 
the top five most central nodes (i.e. regions which dominate in the communication 
of a network; figures 6.9 and 6.10). 
 
Figure 6.9 Overlap frequency of regions identified as one of the five most central nodes from the inter-
chromosomal in situ Hi-C network thresholded at the median of non-zero interaction frequencies. 
From our network thresholded at the median of non-zero interaction frequencies, 
we found six distinct regions that had a high centrality score for more than one type 
of measure (figure 6.9). Two of the six regions had a top five centrality score for all 
types of measure. Both were gene-poor regions: the first on chromosome 1, 
positions 121,400,001-121,500,000 and the second on chromosome 6, positions 
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58,700,001-58,800,000. Despite the lack of known functional genes in these regions, 
it is possible that either (1) there is additional information yet to be found from 
these regions, or (2) adjacent genomic fragments that may contain genes/SNPs could 
be the hidden drivers. 
Since betweenness centrality is calculated in a different manner to all other 
measures (and is thus the least correlated), we were interested by the single region 
found in the top five for betweenness score and not found from other measures. 
This was a region on chromosome 6, positions 57,400,001-57,500,000, containing 
only one gene, PRIM2, that encodes for an enzyme that plays a key role in DNA 
replication. 
 
Figure 6.10 Overlap frequency of regions identified as one of the five most central nodes from the 
inter-chromosomal in situ Hi-C network thresholded at the third quartile of non-zero interaction 
frequencies. 
Of the nine unique regions identified in our median thresholded network as being 
the most central, seven were identical for our network thresholded at the third 
quartile. Six regions appeared in more than one top five list (figure 6.10), and two 
regions appeared in all lists – one of which was the same region on chromosome 1 
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found in the preceding analysis. The other prevalent region was on chromosome 1, 
positions 145,000,001-145,100,000, which contained five genes. In order for 
consistent inter-chromosomal contacts to be made, one may conclude that genomic 
regions must spend most of their time on the periphery of the folded globule. With 
our centrality measures in mind, we hypothesise that regions found to be central for 
inter-chromosomal networks must have this property. We also identify these regions 
as candidates for our subsequent targeted analysis. 
From our intra-chromosomal Hi-C network, thresholded at 0F , we found very few 
overlaps of central nodes. Despite this, we did find an interesting property from our 
degree and eigenvector centrality top five lists: all of the most central nodes were 
located on chromosome 2, between positions 85,000,000 and 110,100,000. A similar 
property was also found from our PageRank list, but for a slightly longer region 
(chromosome 9, positions 38,000,000-81,100,000). In contrast to central nodes from 
inter-chromosomal networks, this suggests that intra-chromosomally central nodes 
are also literally central within the folded globule, i.e. they are found at the interior, 
where relatively long stretches of DNA are knotted in the centre. 
The local clustering coefficient was used to determine the connectedness of 
immediately neighbouring nodes, with scores ranging from zero (completely sparse) 
to one (completely connected), in an effort to identify small groups of 
communicating genomic regions. Results from our intra-chromosomal network were 
fairly trivial, since the network was small-world (93.75% of nodes had a local 
clustering coefficient of at least 0.92). Hence, there were no areas of the network 
that were relatively more connected than anywhere else. For our inter-chromosomal 
networks, we found that 0.079% and 0.125% of nodes had a local clustering 
coefficient of at least 0.9 for the median and third quartile thresholds, respectively. 
Regions with a perfect local clustering coefficient ( 1C ), corresponding to 
neighbouring nodes being completely connected, are listed in table 6.5. 
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Table 6.5 Regions which have the maximum possible local clustering coefficient, from unweighted in 
situ Hi-C networks at both median and third quartile thresholds. 
Regions (chromosome:100kb bin) 
1:1210 3:758 7:632 10:480 16:187 23:586 
1:1483 5:465 7:1023 10:816 16:331 23:887 
2:51 6:619 8:469 11:512 17:348 23:890 
2:874 7:572 9:664 14:193 17:446 23:900 
2:894 7:617 9:692 14:196 18:155 23:909 
2:1071 7:628 9:700 14:201 19:206 23:923 
2:1309 7:631 9:1412 16:164 22:207 
 
 
Since regions in table 6.5 are each part of a cluster of inter-chromosomal contacts, 
we can infer a couple of things: (1) in order to form inter-chromosomal 3D 
interaction clusters, these regions are very likely to lie on the surface of their 
respective folded chromosomes because this is where they would be most accessible; 
(2) at the periphery of two (or more) colliding chromosomes, regions participating in 
clusters are likely to be tangled at these locations for at least a small amount of time. 
Even brief communications between one-dimensionally remote regions can alter the 
expression of genes, therefore the clusters we identified are perhaps the focal point 
of expression variation. 
Component Analysis 
Using a raw threshold of 80, an INTERKR threshold of 42 and an INTERVC threshold 
of 41, we investigated the components of the resulting binary networks (figures 6.11, 
6.12 and 6.13, respectively) to find a similarity of network architecture (table 6.6). 
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Figure 6.11 Harel-Koren (HK) fast multi-scale layout (Harel & Koren, 2000) of 3D interaction 
network using raw Hi-C data with interaction frequency threshold F≥80. 
 
Figure 6.12 HK fast multi-scale layout of 3D interaction network using normalised (INTERKR) Hi-C 
data with interaction frequency threshold F≥42. 
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Figure 6.13 HK fast multi-scale layout of 3D interaction network using normalised (INTERVC) Hi-C 
data with interaction frequency threshold F≥41. 
 
Table 6.6 Overview of  binary in situ Hi-C networks (all with 30,367 total nodes). 
 RAW INTERKR INTERVC 
Number of edges 4459 4316 4305 
Size of largest 
component 
2189 2799 3219 
Largest 
component % of 
global network 
7.21 9.22 10.6 
Next three largest 
component sizes 
22, 7, 7 18, 14, 13 24, 15, 12 
Number of isolated 
nodes 
28074 27198 26799 
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All three networks contained a single, predominant component, followed by a string 
of much smaller components. Since our pool of schizophrenia-associated genes were 
mostly either isolated nodes or contained within our largest components, we 
decided to further investigate these components, to see if there was a common 
subset of genes which interacted in most/all largest components. 
From a total of 347 schizophrenia-associated genes, three were found in the largest 
components of all Hi-C networks (figure 6.14). These were: (1) HCN1 – a gene known 
to contribute to spontaneous rhythmic activity in both the heart and brain (Pan et al., 
2015), (2) the family of PCDHA genes – which are predominantly expressed in the 
developing nervous system (Sano et al., 1993), and (3) ZSWIM6 – a mutant allele of 
which is linked to brain malformation (Smith et al., 2014). Interestingly, all three of 
these genes are on chromosome 5 (HCN1: positions 45,255,052-45,696,220; ZSWIM6: 
positions 60,628,100-60,841,999; PCDHA: positions 140,144,410-140,391,929), 
which could be a signpost that particular locations on this chromosome could have 
the most profound influence. 
 
Figure 6.14 The number of schizophrenia-associated genes found in the largest component of our 
inter-chromosomal binary Hi-C networks. 
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There was also a large overlap between both normalised networks, with 34 out of 39 
genes being located in the largest component (a list of these genes can be found in 
supplementary table A6.3). Perhaps this is due to similarities between the KR and VC 
procedures (described in chapter 2). Since there is also very little overlap between 
processed and unprocessed Hi-C networks, one should be wary of the effect of 
normalisation procedures and the possibility that genuine interactions are diluted 
and therefore missed. However, it is also possible that unprocessed Hi-C data 
contains particular biases that overwrite genuine interactions. We hence preserve 
genes found from all largest components to avoid the risk of discarding important 
regions. 
After closer inspection of our raw in situ Hi-C network, we noticed one node in 
particular that overwhelmingly acted as the main hub in the largest component, 
connecting to 1,670 (or 76.33% of) other nodes within the component. This node 
corresponds to a fragment on chromosome 1, positions 121,400,001-121,500,000, 
which is a gene-poor region. Further investigation revealed that this fragment was 
added to the hg19 assembly and was not present in previous reference genomes. 
We therefore concluded that either (1) this region is poorly understood and is in fact 
an important candidate region that requires more investigation, or (2) this region is 
an anomaly, or a false positive, in Hi-C data. We included this region in the pool of 
candidate regions for our targeted approach, in case (1) was true, but we also 
decided to remove this region from our raw network and run the component 
analysis once more, which accounted for the possibility that (2) was true. 
With our interaction frequency threshold still set at 80, we found that the largest 
connected component had significantly reduced in size when the potential anomaly 
was removed (from 2,189 nodes to 699 nodes; figure 6.15). The number of 
schizophrenia-associated genes found in the largest component reduced from 26 to 
12, none of which overlapped with either largest component from normalised 
networks, although all 12 were found from our initial raw Hi-C network analysis. 
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Figure 6.15 Comparison of 3D interaction networks using (A) raw Hi-C data with interaction 
frequency threshold F≥80 and (B) identical conditions, except a potentially anomalous node 
corresponding to chromosome 1, bin 1,215 has been removed. 
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6.4.3. SNP Distributions 
From the master list constructed by our algorithm, the candidate nodes from set W  
were shown to have a highly variable number of SNPs (table 6.7). Of the 35 novel 
regions found, 22 harboured schizophrenia-associated SNPs within their genomic 
boundaries. Only one of these 22 regions contained SNPs with genome-wide 
significance (p-values below the threshold of 8105  ): the fragment on chromosome 
6 between positions 26,000,000-26,500,000. This is the same fragment which 
contains a number of schizophrenia-associated genes: HIST1H2BC, HIST1H2BD, 
HIST1H2BG, HIST1H2BH (Sanders et al., 2013), HIST1H1E (Föcking et al., 2014) and 
BTN3A3 (Chen et al., 2014). 
Table 6.7 Genomic regions from network analysis which are ranked in ascending order of minimum p-
value (corresponding to the SNP with the lowest p-value found in this region; a small p-value indicates 
a strong disease association). Regions which contain known schizophrenia-associated genes are 
highlighted in bold. 
Node (hg19 
position) 
Observed number of 
SNPs 
SNP density (SNPs 
per 100 kb) 
Minimum p-value 
chr6:26,000,000-
26,500,000 
391 78.2 1.46 × 10-9 
chr19:300,000-
1,400,000 
514 46.73 2.98 × 10-5 
chr16:89,600,000-
90,100,000 
251 50.2 1.11 × 10-4 
chr16:100,000-
900,000 
386 48.25 3.31 × 10-4 
chr9:137,400,000-
138,900,000 
922 61.47 1.09 × 10-3 
chr21:15,000,000-
15,200,000 
26 13 0.013502 
chr11:100,000-
800,000 
324 46.29 0.0137088 
 
Entries in table 6.7 which have a considerably higher SNP density compared to the 
chromosomal average (table 6.8) are perhaps the most interesting cases. Despite 
only one node containing SNPs within the genome-wide significance threshold, the 
sheer number of SNPs could be an indicator for schizophrenia association. One could 
argue that a high concentration of SNPs which lie just outside of the required 
significance threshold could have a larger combined effect on disease formation than 
an individual, significant SNP does, which also ties into the possibility that such SNPs 
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could be in linkage disequilibrium. This conjecture is perhaps supported by the 
fragment on chromosome 19 between positions 300,000-1,400,000. It has a higher 
than expected SNP density (46.73, compared to the expected density of 39.37 from 
table 6.8), there are no individual SNPs which satisfy genome-wide significance (all 
SNPs satisfy 51098.2 p ) and yet it contains two genes not found in our original 
dataset that are known to have an association with schizophrenia: FGF22 (Terauchi 
et al., 2010) and GRIN3B (Lin et al., 2014). 
Table 6.8 SNP density across 22 chromosomes. 
Chromosome 
Chromosome length 
(in 100 kb) 
Observed number of 
SNPs 
Expected SNP 
density 
1 2493 103559 41.56 
2 2432 104572 43.00 
3 1980 87436 44.16 
4 1911 77631 40.62 
5 1810 79438 43.89 
6 1711 83730 48.94 
7 1592 68689 43.15 
8 1464 68130 46.54 
9 1412 57968 41.05 
10 1356 67121 49.50 
11 1350 63688 47.18 
12 1339 61944 46.26 
13 1152 47170 40.95 
14 1073 41313 38.50 
15 1026 37926 36.96 
16 903 39549 43.80 
17 812 34161 42.07 
18 781 36805 47.13 
19 592 23306 39.37 
20 630 32764 52.01 
21 482 17735 36.79 
22 513 18226 35.53 
 
6.4.4. Gene Expression in Brain Tissues 
After probing our master list obtained from network analysis of 327 genes, a total of 
four promoters corresponding to three genes were identified via high tags per 
million (TPM) counts in brain tissues (table 6.9). Three of these promoters – 
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p4@ZNF276, p3@ZNF276 and p3@TCF25 – correspond to two genes (ZNF276 and 
TCF25) that are neighbours in a single genomic region identified by our network 
analysis (chromosome 16, positions 89,600,000-90,100,000). TCF25 is part of a family 
of transcription factors that are important for embryonic development (Steen & 
Lindholm, 2008) and is highly expressed in brain tissues (third highest of 27 human 
tissues tested; Fagerberg et al., 2014). ZNF276 belongs to the family of zinc finger 
genes that are responsible for a number of protein functions. Furthermore, a 
member of the zinc finger family, ZNF323, has previously been identified as a risk 
gene for schizophrenia via brain eQTL and GWAS analysis (Luo et al., 2015). The 
region containing TCF25 and ZNF276 was found to have an incident edge of high 
weighting in our network analysis (RAW data) and contains a total of 26 genes. There 
are no genes in this region which have any previous implications in schizophrenia. 
Identifying a cluster of promoters corresponding to two genes that are in close linear 
proximity (within 200 kb) could lead us to hypothesise that there is evidence of 
digenic activity between ZNF276 and TCF25 that contributes to schizophrenia 
development. This is especially likely, considering that this region contains 251 SNPs, 
which is higher than the expected SNP density for chromosome 16 (an observed 
density of 50.2, versus an expected density of 43.8; table 6.7). 
Table 6.9 Relative expression (normalised TPM) values across all brain tissue samples (FANTOM5 
data) for promoters identified from expression analysis of master list regions. 
TSS region TPM (fetal) TPM (adult, 18) 
TPM (adult, 
77/79/81) 
p4@ZNF276 0.58 0.87 - 
p3@ZNF276 - 0.5 - 
p3@TCF25 - 0.43 - 
p1@DEAF1 0.94 0.6 0.57 
 
The final TSS identified was p1@DEAF1, a promoter corresponding to the gene 
DEAF1 with the highest tag support. DEAF1 regulates transcription through a protein 
that contains a zinc finger structure, which perhaps implies an association with the 
ZNF gene family. The encoded protein is also important in the regulation of 
embryonic development and is very highly expressed in brain tissues (significantly 
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higher expression than 26 other human tissues; Fagerberg et al., 2014). Interestingly, 
p1@DEAF1 is the only TSS found within our master list regions which has high TPM 
counts across all three brain tissue samples. The DEAF1 gene, located in a region on 
chromosome 11, was found in four in situ Hi-C lists from network analysis (RAW, 
SQRTVC, KR, GWKR; positions 100,000-800,000) which contains a total of 47 genes 
and 324 SNPs. Perhaps even more interestingly, this region contains six genes with 
previous schizophrenia implication (IFITM1, IFITM2, IFITM3, HRAS, IRF7, DRD4) – 
HRAS in particular has a high expression in brain tissue (second highest of 27 human 
tissues; Fagerberg et al., 2014). These findings either (1) solidify the assumption that 
DEAF1 may contribute to the development of schizophrenia through a small 
neighbourhood of interactions, or (2) are a misinterpretation of the involvement of 
DEAF1 in schizophrenia; other neighbouring/overlapping genes may be responsible. 
Indeed, both interpretations are plausible, but further functional ascertainment is 
required in order to confidently resolve the issue. 
The collection of promoters found within this analysis is perhaps too small to make 
any feasible conclusions about the differences in age between the three brain tissue 
samples used. Although from the promoters we did find, all four had a high TPM 
count in the male, 18 year-old sample (and two for the fetal sample), suggesting that 
the foundations for schizophrenia development are laid at a young adult age, or even 
as soon as the post-embryonic stage of pregnancy. Recent publications of Hi-C data 
for the developing brain confirm this (Won et al., 2016). 
6.4.5. Enrichment of cis-eQTL Pairs in Distinct Brain Regions 
Using our global approach (see section 6.4.2), we identified a total of 35 genomic 
regions which were deemed as potential candidates for schizophrenia association. As 
part of our subsequent targeted approach (see section 6.4.3 for other results), we 
found 22 candidate regions that contained a minimum of one SNP from our dataset 
of schizophrenia-associated SNPs described in section 6.2.2 (Ripke et al., 2011). We 
continued our targeted approach by using the Braineac web tool – we interrogated 
all SNPs within our candidate regions with the aim of discovering the presence of cis-
eQTL pairs. That is, after entering a SNP (or group of SNPs) into Braineac, we hoped 
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to receive an output of affected genes with corresponding p-values which would 
describe the magnitude of the SNP’s influence on gene expression in particular brain 
regions. The lower the p-value, the greater the SNP’s effect on the expression of a 
target gene. After interrogation of SNPs within these 22 genomic regions, we found 
that cis-eQTL pairs existed within eight distinct regions.  
The relative strength of these pairs in terms of gene expression change is visualised 
in figure 6.16. This shows a heat map of the average expression scores for each 
genomic region. Vertical blocks of red indicate expression change in particular brain 
regions, whereas horizontal blocks indicate a particular genomic region that has a 
high influence on gene expression. Whilst most of the heat map seems fairly 
homogenous, there are areas which display a relatively high expression score. For 
example, particular genomic regions seem to have more of an impact on gene 
expression in the whole brain (such as 6:261-265, 11:2-8 and 16:2-9) than others 
(such as 6:3-4 and 9:1375-1389). These hot zones also tend to exhibit variable 
expression levels between distinct brain regions (CRBL having consistently high 
expression in comparison to other brain regions, for example). 
 
Figure 6.16 Heat map of genomic regions (described in chr:bin form on the y-axis at 100 kb resolution) 
potentially harbouring cis-acting elements influencing expression in ten brain regions (x-axis). 
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The macro scale of expression scores gives us an indication of where to look in more 
detail. Therefore, we have identified three areas which exhibit high expression to 
investigate in greater detail – 6:261-265, 16:2-9 and 11:2-8. 
Figure 6.17 is a heat map of expression resulting from individual SNPs on 
chromosome 6, positions 26,000,001-26,500,000. The aim with such micro scale heat 
maps is to identify clusters of cis-acting SNPs leading to high expression. This is in 
order to find smaller fragments of the genomic region which affect expression 
change in corresponding genes, or to identify one or more distinct brain regions 
where expression change is commonplace. We have identified both of these traits 
within figure 6.17 by identifying clusters which have expression scores of higher than 
5 at each endpoint (and consistently high expression in between). Firstly, we see a 
block of high expression scores in a number of brain regions, but most pronounced in 
WHMT and HIPP. The genomic region this spans is positions 26,184,041-26,251,601, 
therefore we suggest that SNPs found within this boundary are warrant a closer 
inspection – particularly with regard to their association with schizophrenia 
development and importantly, whether this region is in linkage disequilibrium (LD). 
Outside of this cluster, our most expressed region is CRBL at positions 26,351,597-
26,405,990. Hence, for this genomic region alone, we suggest that schizophrenia 
development is most associated with the CRBL region of the brain. But, looking at 
the bigger picture, a sensible conclusion would be that this region on chromosome 6 
is most expressed in WHMT, HIPP and CRBL. 
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Figure 6.17 Expression heat map from SNPs on chromosome 6, positions 26,000,001-26,500,000. 
Areas of relatively high expression (satisfying 5)(log10  p  for boundary endpoints) are enclosed 
by blue rectangles. 
Our second area of interest lies on chromosome 16, positions 100,001-900,000 
(figure 6.18). The clusters here are somewhat less pronounced, therefore our 
threshold of endpoint expression scores was reduced from five to four 
(corresponding to a p-value of 4101  ). We found the highest expression scores in 
small clusters of brain regions TCTX, THAL, WHMT and HIPP and genomic regions 
covering positions 105,444-176,743 (HIPP and TCTX), 449,162-536,686 (THAL), 
709,001-719,933 (WHMT) and 811,433-852,137 (TCTX). We identify SNPs contained 
within these fragments as being potentially influential in schizophrenia development, 
but we must first take a closer look and determine whether SNPs are individually 
associated, and secondly we must find whether this region is in LD. 
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Figure 6.18 Expression heat map from SNPs on chromosome 16, positions 100,001-900,000. Areas of 
relatively high expression (satisfying 4)(log10  p  for boundary endpoints) are enclosed by blue 
rectangles. 
Our final area of interest spans positions 100,001-800,000 on chromosome 11. The 
behaviour of clusters in our heat map for this area (figure 6.19) is slightly different to 
the preceding heat maps, since they have discontinuous sections of high expression 
within a small genomic boundary. Although not in solid blocks of red, we identify 
brain regions CRBL, OCTX and TCTX and genomic positions 641,563-694,257 (CRBL) 
and 721,570-791,462 (OCTX and TCTX) to be candidates of cis-eQTL-containing 
regions responsible for high expression in schizophrenia. 
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Figure 6.19 Expression heat map from SNPs on chromosome 11, positions 100,001-800,000. Areas of 
relatively high expression (satisfying 4)(log10  p  for boundary endpoints) are enclosed by blue 
rectangles. 
After finding SNP-containing fragments within our schizophrenia candidate regions 
and investigating their effect on expression levels, we wished to determine whether 
these SNPs had an individual association with schizophrenia, and whether the 
fragments we found exhibited LD. We therefore used the three regions analysed 
above (on chromosomes 6, 16 and 11 respectively) as an input into LDlink – a web 
tool that visualises LD by producing heat maps of 2R  values (Machiela & Chanock, 
2015). From our outputs, we were able to hone in on particular regions which had 
strong LD blocks and subsequently investigate the SNPs lying within these blocks. We 
hypothesised that SNP-containing fragments which highly influenced gene 
expression in brain tissues were in LD. We also suggested that within these LD blocks 
were SNPs with a relatively high individual association with schizophrenia. 
Blocks enclosed by blue in figures A6.1, A6.2 and A6.3 contain one or more 
fragments which are in LD and also SNPs which influence gene expression in the 
brain. Table 6.10 gives a full description of these regions, including the number of 
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SNPs found and whether any have a relatively small individual schizophrenia 
association. 
Table 6.10 Genomic fragments in linkage disequilibrium containing SNPs that highly affect gene 
expression in brain tissues. P-values indicate the strength of association with schizophrenia for an 
individual SNP. 
Fragment (hg19) 
Observed number 
of SNPs 
Number of SNPs 
satisfying p<0.05 
Minimum p-value 
chr6:26,180,000-26,235,000 39 1 0.0029 
chr6:26,352,000-26,410,000 70 13 4.756 × 10-7 
chr16:80,000-200,000 69 2 0.0141 
chr16:475,000-575,000 44 1 0.0139 
chr16:610,000-785,000 87 0 0.1554 
chr16:790,000-880,000 36 9 3.309 × 10-4 
chr11:625,000-725,000 53 0 0.0559 
chr11:735,000-810,000 32 0 0.0921 
 
The fragments on chromosome 6, positions 26,352,000-26,410,000 and 
chromosome 16, positions 790,000-880,000 seem the most interesting, since they 
have a substantial group of SNPs that have a relatively strong individual association 
with schizophrenia ( 05.0p ; 13 and 9 SNPs respectively). Figure 6.20 shows the 
distribution of p-values (hence schizophrenia association) for all SNPs contained 
within our regions containing LD blocks. 
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Figure 6.20 Box plots of schizophrenia association levels of SNPs lying within regions of linkage 
disequilibrium (LD). The web tool LDlink was used to find LD blocks (Machiela & Chanock, 2015) 
with the CEU population (Utah residents from north and west Europe ancestry). The blue line indicates 
a p-value threshold of 05.0p  . Entries above this line are SNPs which have an association with 
schizophrenia to a minimum of 95% confidence. 
Although there are no SNPs which meet a genome-wide significance threshold of 
8105 p , we conclude that a network of interactions between SNPs found in 
these LD regions might play a role in schizophrenia development – particularly those 
which already have a mild association with the disease (such SNPs are identified in 
supplementary table A6.4). 
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Chapter VII 
Conclusions 
 
7. Conclusions 
In this thesis we employed a mix of mathematical, computational and statistical 
approaches in order to test the general hypothesis that linearly remote genomic 
fragments come into close proximity when folded in the cell nucleus, which 
consequently affects function (e.g. through regulation of gene expression) and 
therefore phenotype. Data describing the 3D architecture of the human genome was 
used to analyse such long-range interactions, in order to reveal whether they 
regulate various diseases and genetic phenomena. 
The many components of the genome, including genes, promoters, enhancers and 
silencers are well studied, whereas their communication is the area much less well-
understood. For this reason, we often represented the 3D genome as a network, 
where our units were genomic fragments of equal length and interactions were 
added if pairs were neighbours in 3D space. Thus, fragments potentially containing 
biological units of expression or regulation (sometimes mutated) acted as nodes and 
the extent of proximity was modelled by weighted edges. That is, larger weights 
corresponded to smaller distances between nodes. In some cases, we preprocessed 
our 3D interaction data in an effort to remove bias from experimental procedures 
(described in chapter 2). 
In this chapter we summarise our results, discuss their implications and finish by 
suggesting directions for future work. 
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7.1. Summary 
7.1.1. Reduced Penetrance 
The challenge of accurately measuring penetrance by detecting variants that 
genuinely reduce occurrences of expected phenotype is still rife, despite attempts 
being made in family- and population-based studies. Although the literature 
acknowledges polygenic activity in complex diseases and cites this as a contributor to 
the difficulties of identifying penetrance-associated variants (reviewed by Cooper et 
al., 2013), there is a lack of methods that account for this when analysing data. 
Typically, variants are investigated independently and are given individual appraisals 
with regards to their disease associations, whereas in this dissertation we placed the 
spotlight firmly on polygenic activity by using 3D interaction (Hi-C) data to show that 
linearly remote regions do cooperate and ultimately alter gene expression. 
Our first hypothesis was that gene partners that are known to influence penetrance 
via digenic activity are non-randomly chosen, based on them sharing a 
neighbourhood in 3D. We tested for a difference in proportions of Hi-C interaction 
enrichment between fragments containing genes associated with reduced 
penetrance and non-associated control regions. No differences were found, 
suggesting that either the 3D structure of the human genome plays a diluted role in 
affecting penetrance, or additional regulatory regions are responsible for connecting 
putative penetrance genes. 
As a result of the above findings, we considered that there could be an added layer 
of complexity regarding the 3D interactions between partner genes. This led us to 
introduce third-party fragments, suggesting that these unknown fragments could 
have acted as a connecting bridge between our remote gene pairs. We first 
hypothesised that our collection of gene pairs associated with reduced penetrance 
were managed by common third-party regulators. After testing for the presence of 
fragments consistently having enriched interactions with known penetrance regions, 
we found a handful of regions satisfying this criteria. However, many of these 
regions were also found to have enriched interactions for controls. Therefore, one 
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must be wary of the possibility that these fragments ubiquitously interact, rather 
than interacting specifically with regions associated with reduced penetrance. 
Consequently, we then hypothesised that instead of all digenic pairs sharing the 
same third-party regulators, perhaps each pair was regulated by its own unique 
third-party fragment. From a dataset of gene partners responsible for influencing 
disease penetrance, we sought the fragments of most interaction with each gene 
and looked for any commonality (or intersect) between the lists of highly interacting 
fragments. There was no significant difference of intersect frequency found between 
cases and controls, suggesting a lack of evidence for the presence of third-party 
penetrance regulators. 
Whilst our analysis seems inconclusive, it is important to note a couple of 
methodological shortcomings that may have inhibited our ability to obtain results. 
Firstly, our intersect analysis focused on the number of intersects, rather than which 
regions were intersecting. A qualitative method, focused on identifying the locations 
of intersecting regions is perhaps suitable here as a follow-up approach – this would 
bring the added benefit of being able to recognise and deal with false positives. 
Secondly, the database of genes known to affect penetrance is perhaps too small. 
Repeating our quantitative analysis with a larger and more reliable set of genes 
(when it becomes available) could give way to a better understanding of the role of 
the 3D genome structure in penetrance. 
7.1.2. Gene Fusion Events 
Next generation sequencing (NGS) methods provide an effective means of detecting 
fusion events in hindsight. That is, signatures of translocations, deletions or 
inversions are identified from sequence data of diseased patients and variants 
common in these individuals are suggested to be the catalyst for fusion events. 
Whilst this method does partially address what causes gene fusion events (although 
the underlying mechanisms are not yet fully understood), it does not address why. 
We were therefore motivated in chapter 5 to investigate why fusions occur by 
observing the 3D behaviour of known fusion gene partners in healthy cell lines (i.e. a 
foresight method). 
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Our general hypothesis was that the occurrence of gene fusion events is governed by 
the 3D proximity of fusion partners. Moreover, we suggested that a required 
condition for genes to fuse after a translocation/deletion/inversion is the 3D 
neighbouring of breakpoint sites. Hence, our first specific hypothesis was that 
genomic fragments that harboured a known fusion gene were enriched in 
interactions from Hi-C data. We tested this using dilution and in situ Hi-C data at 1 
Mb and 100 kb resolutions and found that in most cases, there was a significant 
enrichment of Hi-C interactions in cases versus controls. Furthermore, the difference 
in cases and controls was huge for inter-chromosomal data. This was perhaps 
because intra-chromosomal data suffers from a one-dimensional proximity bias that 
leads to a higher mean and lower variance for intra-chromosomal interaction 
frequencies, thus resulting in smaller differences. 
We then hypothesised that the choice of fusion partner was non-random; a head 
gene would fuse to a tail gene as a result of the two partners sharing the same 
spatial domain. We tested each fusion pair by determining whether they were 
relatively local or remote, which we defined by setting an interaction frequency rank 
threshold. At various threshold choices, we found that the number of fusion pairs 
deemed local was significantly more than the number of local controls. These 
findings support our hypothesis of finding evidence for 3D neighbourhoods of fusion 
genes in healthy cell lines. Hence, the 3D structure of the human genome is either a 
catalyst for fusion events, or provides the ideal conditions for fusions to occur. 
7.1.3. Schizophrenia 
Initial attempts to individually identify single nucleotide polymorphisms (SNPs) 
associated with schizophrenia via genome-wide association studies (GWAS) have 
yielded relative success (Ripke et al., 2011, 2013), and subsequent studies have 
acknowledged the complex nature of schizophrenia by calculating the polygenic risk 
score (PRS) of SNPs (Euesden et al., 2014). Pathway- and set-based analyses are 
methods that also account for polygenic activity – they are categorise SNPs and 
transcription start sites (TSSs) into distinct biological processes or functions, 
therefore grouping units of perceived similarity (de Leeuw et al., 2015). These 
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methods for detecting influential SNPs assume, however, that SNPs primarily affect 
the expression of the nearest downstream gene. Moreover, SNPs are combined if 
they are within a certain distance from the gene (such as <100 kb or <1 Mb), despite 
some regulatory elements (such as enhancers) occurring at a distance beyond 1 Mb. 
These initial assumptions are not always correct, and have resulted in the incorrect 
SNP-to-gene pairings of approximately 86% of all cases (Mumbach et al., 2017). In 
chapter 6, we therefore proposed an alternative method that resolves this issue by 
incorporating Hi-C data to identify the true, longer-range target genes and therefore 
more accurately predict schizophrenia associated genomic fragments. 
At the time of study, we had access to a limited number of Hi-C cell lines – this did 
not include any form of brain tissue. Since schizophrenia is a disorder of the brain, 
we first wished to select Hi-C data that best emulated cell behaviour in the brain. We 
achieved this by finding overlaps between eQTL pairs (SNPs which affect the 
expression of corresponding genes in brain tissues; Ramasamy et al., 2014) and 3D 
interactions in our available Hi-C data (Rao et al., 2014). From three available Hi-C 
cell lines: GM12878 (lymphoblastoid), HMEC (mammary epithelial) and IMR90 (lung 
fibroblast), we found that the blood cell line (GM12878) was the best emulator of 
brain tissues, with 73% overlap between eQTL pairs and Hi-C interactions, compared 
to 23.8% and 6.6% for IMR90 and HMEC, respectively. 
After choosing the most suitable Hi-C data to emulate brain cells, we started work on 
our aim to identify novel genomic regions that influence schizophrenia via long-
range interactions. Generally speaking, our analysis consisted of two parts. The first 
part was termed the global approach – we constructed networks of Hi-C interactions 
and sought out nodes of highest importance through various network measures 
(described in chapter 3). Nodes from our Hi-C networks that exhibited significantly 
higher interaction frequencies with our extended gene regions (EGRs), as well as 
nodes that had high centrality scores were classified as schizophrenia candidate 
regions. We were able to construct a database of candidate regions corresponding to 
important nodes from these networks – the majority of which were gene-rich 
fragments (positions listed in table 6.4). Furthermore, our approach found four 
candidate regions containing a total of 15 genes independent from the original 
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dataset. Interestingly, these genes were found to be associated with schizophrenia 
through a subsequent literature search (positions listed in table 6.3). Our 
methodology was therefore validated, since we were not only finding unique 
candidate regions independently, but we had also found gene-containing regions 
already associated with schizophrenia. 
We also investigated the connected components of raw and normalised Hi-C 
networks and found common regions contained within each of the largest 
components that shared connections with schizophrenia genes from our original 
dataset. These were added to our dataset of candidate regions. Thus, our global 
approach indiscriminately identified novel schizophrenia candidate regions (some of 
which were found via independent literature to be associated with schizophrenia), 
ready for further analysis. 
Once we had collected our database of candidate regions, we implemented the 
second part of our analysis: the targeted approach. In essence, we wished to solidify 
claims that our candidate regions were indeed associated with schizophrenia by 
running each region through a series of checks. Those that satisfied most, or all, of 
the checks were consequently deemed the strongest candidates for schizophrenia 
association. We found that of all candidate regions analysed, most satisfied at least 
one check and many satisfied numerous checks. Our first check showed that 22 
candidate regions contained at least one schizophrenia associated SNP within its 
boundaries, with most containing more SNPs than expected, assuming SNPs were 
uniformly distributed throughout each chromosome. Secondly, we found groups of 
genes from novel candidate regions that had functional similarities. Perhaps the 
most interesting group was a haemoglobin gene family that is responsible for 
transporting oxygen to the brain. It is clear that any change in the expression of 
these genes could easily affect the health of the brain and therefore possibly induce 
schizophrenia. Thirdly, four promoters affecting the expression of three genes in 
brain tissue samples of different ages were found using FANTOM5 data. All four 
promoters resided on one of two particular candidate regions. We also found that 
the four promoters all affected expression in the young adult brain tissue sample, 
confirming that schizophrenia is a disorder of the developing brain. Our final check 
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was to utilise eQTL data once more to investigate the expression of target genes in 
specific brain regions. eQTL pairs in eight of our candidate regions were found, with 
many exhibiting a large variation in expression between brain regions. On a micro-
scale, we discovered that some linear sequences of SNPs were in clusters displaying 
high expression change. Further analysis using LDlink revealed that some of these 
SNP clusters were in linkage disequilibrium, whilst some SNPs were shown via GWAS 
to have a high individual association with schizophrenia. 
Each of the above targeted approaches revealed a number of candidate regions that 
exhibited the expected characteristics for schizophrenia association. We have 
explicitly stated these regions throughout chapter 6, and we consequently suggest 
that the most mentioned novel candidate regions (corresponding to the most checks 
satisfied) are the most likely to influence schizophrenia, although further functional 
ascertainment is required. 
7.2. Outlook 
Historically, approaches have tended to isolate one factor attributed to a disease or 
genetic phenomenon and independently test the strength of its association. More 
recently, however, studies have acknowledged that aberrant traits can occur as a 
result of the cooperation of many genetic components, often at seemingly remote 
distances from one another. The term polygenic best describes the nature of 
complex disorders, although the underlying causes of many polygenic diseases are 
yet to be elucidated. 
This thesis has continued the recent trend of inclusive analysis by incorporating prior 
knowledge and datasets to the relatively new concept of functional change induced 
by the 3D genome architecture. We have effectively added a layer to existing 
knowledge by transforming what were once studies of the one-dimensional genome 
into contextually relevant, three-dimensional methods. In particular, we have 
investigated the extent to which long-range interactions of genomic elements 
influence genetic phenomena, and have even predicted novel genomic regions that 
are likely to affect the complex brain disorder, schizophrenia. 
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One key limitation of our studies was the lack of cell diversity from available Hi-C 
libraries. Therefore, a direction for future work would certainly include the use of 
cell-specific 3D interaction data, such as brain Hi-C data for schizophrenia studies 
which became available recently (Won et al., 2016). Since this thesis centres on the 
application of an overarching method to different case studies, it follows that a 
plethora of routes for future work in cell-specific disorders will emerge with Hi-C 
availability of corresponding cell lines. For example, future prediction and 
identification techniques for schizophrenia would be conceivably much more 
accurate and reliable with brain Hi-C as opposed to blood Hi-C data, despite the high 
overlap shown in our analysis. As for the use of new data, the methodological 
foundations have been laid in this thesis: the designed algorithms require little 
editing to be effective with new Hi-C libraries and are only limited by cell line 
availability of such data. Experimental Hi-C methodologies and the subsequent 
removal of biases via normalisation techniques is also a fast-moving area, therefore 
future Hi-C libraries are likely to be more comprehensive, have better fragment 
resolutions and be more reliable. It is expected that the methods seen in this thesis 
will branch out into a broader range of case studies, given the right data. Revisions or 
improvements of bioinformatics tools used in our subsequent targeted analysis also 
promise to benefit the prediction/identification methodology. 
We also envisage future work continuing to aggregate methods and results 
published from various literatures, in an attempt to include as much knowledge as 
possible to validate assertions about genetic variants and disease. In particular, the 
inclusion of network theory in various analyses of cell biology has changed the way 
we think about genetic components – especially their communications. We propose 
that Hi-C networks could form part of a greater multi-layered network (including 
protein-protein interaction networks, regulatory networks and disease gene 
networks), where connections can describe more than one type of communication. 
Although seemingly complex, a holistic multi-layered network such as this could be 
key to revealing previously overlooked properties. 
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Appendix A 
Table A4.1 Putative primary and modifier gene pairs which exhibit epistatic properties, hence 
modulating penetrance levels (Cooper et al., 2013). 
Disease 
Primary 
gene 
Modifier 
gene 
Reference 
X-linked retinitis pigmentosa RPGR IQCB1 Fahim et al., 2011 
X-linked retinitis pigmentosa RPGR RPGRIP1L Fahim et al., 2011 
Retinoblastoma RB1 MDM2 Castéra et al., 2010 
Familial hypercholesterolaemia LDLR PCSK9 Abifadel et al., 2009 
Familial hypercholesterolaemia LDLR APOB 
Benlian et al., 
1996/Taylor et al., 2010 
Familial hypercholesterolaemia LDLR CFH Koeijvoets et al., 2009 
Familial hypercholesterolaemia LDLR APOH Takada et al., 2003a 
Familial hypercholesterolaemia LDLR GHR Takada et al., 2003b 
Familial hypercholesterolaemia LDLR EPHX2 Sato et al., 2004 
Breast cancer BRCA2 RAD51 Antoniou et al., 2007 
Ovarian cancer BRCA1 IRS1 Ding et al., 2012 
Ovarian cancer BRCA2 IRS1 Ding et al., 2012 
Lynch syndrome MSH2 RNASEL Krüger et al., 2007 
Lynch syndrome MLH1 RNASEL Krüger et al., 2007 
Lynch syndrome MSH2 TP53 Krüger et al., 2007 
Lynch syndrome MLH1 TP53 Krüger et al., 2007 
Cystic fibrosis CFTR TGFB1 Drumm et al., 2005 
Familial pulmonary arterial 
hypertension 
BMPR2 TGFB1 Phillips et al., 2008 
Paget’s disease SQSTM1 TNFRSF11A Gianfrancesco et al., 2012 
X-linked variable immunodeficiency XIAP CD40LG Rigaud et al., 2011 
Haemochromatosis HFE CYBRD1 Constantine et al., 2009 
Parkinson’s disease GBA MTX1 Gan-Or et al., 2011 
Recessive dystrophic epidermolysis 
bullosa 
COL7A1 MMP1 Titeux et al., 2008 
Amyotrophic lateral sclerosis SOD1 CHGB Gros-Louis et al., 2009 
Huntingdon disease HTT HAP1 Metzger et al., 2008 
170 
 
Fatal kernicterus G6PD UGT1A1 Zangen et al., 2009 
Atypical haemolytic uraemic 
syndrome 
CFH C4BPA Blom et al., 2008 
Spinal muscular atrophy SMN1 SMN2 Prior et al., 2009 
Long QT syndrome KCNQ1 KCNH2 Cordeiro et al., 2010 
Long QT syndrome KCNQ1 ADRB1 Paavonen et al., 2007 
Long QT syndrome KCNQ1 NOS1AP Crotti et al., 2009 
Familial venous thrombosis PROC F5 
Koeleman et al., 
1994/Gandrille et al., 
1995/Cafolla et al., 2012 
Familial venous thrombosis PROS1 F5 Koeleman et al., 1995 
Familial venous thrombosis SERPINC1 F5 Van Boven et al., 1996 
Hypertrophic cardiomyopathy MYBPC3 CALM3 Friedrich et al., 2009 
Hypertrophic cardiomyopathy MYH7 CALM3 Friedrich et al., 2009 
Familial Mediterranean fever MEFV SAA1 Migita et al., 2013 
 
Table A4.2 Putative examples of digenic mutations causing inherited disease (Cooper et al., 2013). 
Disease Gene 1 Gene 2 Reference 
Waardenburg syndrome type 2 MITF 
PAX3/OCA3/
TYR/GJB2 
Morell et al., 1997; 
Chiang et al., 2009; Yan 
et al., 2011/Yang et al., 
2013 
Retinitis pigmentosa PRPH2 
ROM1/RHO/
PDE6B 
Kajiwara et al., 1994; 
Loewen et al., 2001; 
Sullivan et al., 2006/Jin 
et al., 2008 
Retinitis pigmentosa RHO PRPF31 Lim et al., 2009 
Retinitis pigmentosa PDE6B GPR98 Hmani-Aifa et al., 2009 
Progressive cone dystrophy CNGA3 CNGB3 Thiadens et al., 2010 
Frontotemporal dementia PSEN1 PRNP Bernardi et al., 2011 
Leber congenital amaurosis RPE65 GUCY2D Silva et al., 2004 
Idiopathic hypogonadotropic 
hypogonadism 
FGFR1 GNRHR/NELF Pitteloud et al., 2007 
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Bilateral cystic renal dysplasia DACH1 BMP4 Schild et al., 2013 
Glaucoma, early onset MYOC 
CYP1B1/LTBP
2 
Vincent et al., 
2002/Geyer et al., 
2011/Azmanov et al., 
2011 
Severe insulin resistance PPARG PPP1R3A Savage et al., 2002 
Usher syndrome type 2 PDZD7 GPR98 Ebermann et al., 2010 
Usher syndrome type 1-
associated deafness 
CDH23 PCDH15 Zheng et al., 2005 
Hidrotic ectodermal dysplasia GJB2 GJA1 Kellermayer et al., 2005 
Non-syndromic deafness GJB2 GJB3 Liu et al., 2009 
Hearing loss GJB2 SLC26A4 Sagong et al., 2013 
Non-syndromic hearing loss 
associated with an enlarged 
vestibular aqueduct/Pendred 
syndrome 
KCNJ10 SLC26A4 Yang et al., 2009 
Porphyria CPOX PPOX 
van Tuyll van 
Serooskerken et al., 
2011 
Atypical haemolytic uremic 
syndrome 
CFI 
CD46/C3/CF
B/CFHR1 
Esparza-Gordillo et al., 
2006/Westra et al., 
2010/Bresin et al., 2013 
Atypical haemolytic uraemic 
syndrome 
CFH 
CD46/CFI/C3
/THBD 
Sullivan et al., 
2011/Bresin et al., 
2013/Fan et al., 2013 
Epidermolysis bullosa simplex KRT14 KRT5 
Padalon-Brauch et al., 
2012 
Junctional epidermolysis bullosa COL17A1 LAMB3 
Floeth/Bruckner-
Tuderman, 1999 
Long QT syndrome KCNQ1 
KCNH2/KCNE
1/SCN5A 
Schwartz et al., 
2003/Westenskow et al., 
2004/Tester et al., 
2005/Itoh et al., 2010 
Long QT syndrome KCNH2 SCN5A/KCNE Schwartz et al., 
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1 2003/Westenskow et al., 
2004/Tester et al., 2005 
Long QT syndrome SCN5A 
SNTA1/KCNE
1 
Westenskow et al., 
2004/Hu et al., 2013 
Haemochromatosis HFE HAMP/TFR2 
Merryweather-Clarke et 
al., 2003/Jacolot et al., 
2004/Island et al., 
2009/Altès et al., 
2009/Del-Castillo-Rueda 
et al., 2012 
Kallmann syndrome PROK2 PROKR2 
Cole et al., 2008/Sarfati 
et al., 2010/Shaw et al., 
2011 
Kallmann syndrome NELF KAL1/TACR3 
Xu et al., 2011/Quaynor 
et al., 2011 
Kallmann syndrome PROKR2 KAL1 
Dodé et al., 2006/Canto 
et al., 2009/Shaw et al., 
2011 
Kallmann syndrome KAL1 
TACR3/WDR
11/CHD7 
Quaynor et al., 
2011/Shaw et al., 2011 
Normosmic idiopathic 
hypogonadotrophic 
hypogonadism 
GNRH KAL1 Quaynor et al., 2011 
Normosmic idiopathic 
hypogonadotrophic 
hypogonadism 
WDR11 GNRHR Quaynor et al., 2011 
Normosmic idiopathic 
hypogonadotrophic 
hypogonadism 
FGFR1 
GNRHR/PRO
KR2/FGF8/K
AL1/GPR54 
Raivio et al., 
2009/Sykiotis et al., 
2010/Shaw et al., 2011 
Systemic amyloid A amyloidosis TNFRSF1A MEFV 
Cigni et al., 
2006/Mereuta et al., 
2013 
Familial hypercholesterolaemia LDLR PCSK9 
Pisciotta et al., 
2006/Noguchi et al., 
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2010/Bertolini et al., 
2013 
Familial hypercholesterolaemia LDLR APOB Bertolini et al., 2013 
Familial hypercholesterolaemia LDLR LDLRAP1 Tada et al., 2011 
Severe congenital neutropenia ELANE G6PC3/HAX1 
Germeshausen et al., 
2010 
McArdle’s disease PYGM CPT2 Vockley et al., 2000 
Parkinson’s disease, early onset PINK1 
PARK2/PARK
7 
Tang et al., 
2006/Funayama et al., 
2008 
Parkinson’s disease LRRK2 PRKN Dächsel et al., 2006 
Emery–Dreifuss muscular 
dystrophy 
LMNA DES Muntoni et al., 2006 
Joubert syndrome and 
nephronophthisis 
NPHP1 NPHP6 Tory et al., 2007 
Axenfeld–Rieger syndrome FOXC1 PITX2 Kelberman et al., 2011 
Cortisone reductase deficiency HSD11B1 H6PD 
Draper et al., 2003/San 
Millán et al., 2005 
Hypertrophic cardiomyopathy MYBPC3 
TNNT2/TNNI
3/MYH7/TP
M1 
Richard et al., 2003/Van 
Driest et al., 2004 Ingles 
et al., 2005/Millat et al., 
2010/Kubo et al., 
2011/Zou et al., 2013 
Hypertrophic cardiomyopathy MYH7 
TNNT2/MYL2
/TNNI3/ACTC
1 
Millat et al., 2010/Zou et 
al., 2013 
Restrictive cardiomyopathy MYL2 MYL3 Caleshu et al., 2011 
Rasopathy phenotype with 
severe hypertrophic 
cardiomyopathy 
PTPN11 SOS1 Fahrner et al., 2012 
Arrhythmogenic right ventricular 
cardiomyopathy 
DES PKP2 Lorenzon et al., 2013 
Arrhythmogenic right ventricular 
cardiomyopathy 
DES DSG2 Rasmussen et al., 2013 
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Arrhythmogenic right ventricular 
cardiomyopathy 
PKP2 
DSP/DSG2/P
KP4/DSC2 
Xu et al., 2010 
Arrhythmogenic right ventricular 
dysplasia/cardiomyopathy 
DSG2 DSC/PKP2 
Bhuiyan et al., 
2009/Nakajima et al., 
2012 
Familial dilated cardiomyopathy LMNA TTN Roncarati et al., 2013 
Dent’s disease CLCN5 OCRL Addis et al., 2013 
Amyotrophic lateral sclerosis SOD1 CNTF Giess et al., 2002 
Amyotrophic lateral sclerosis VAPB C9orf72 
van Blitterswijk et al., 
2012b 
Dravet syndrome PCDH19 TSPYL4 Kwong et al., 2012 
Dravet syndrome SCN9A SCN1A Singh et al., 2009 
Dravet syndrome CACNA1A SCN1A Ohmori et al., 2013 
Severe myoclonic epilepsy CACNB4 SCN1A Ohmori et al., 2008 
Severe myoclonic epilepsy POLG SCN1A Bolszak et al., 2009 
Progressive external 
ophthalmoplegia 
POLG SLC25A4 Galassi et al., 2008 
Bartter syndrome CLCNKA CLCNKB Nozu et al., 2008 
Chronic pancreatitis SPINK1 
CASR/CFTR/C
TRC/PRSS1 
Felderbauer et al., 
2003/Masson et al., 
2007/Tzetis et al., 
2007/Schneider et al., 
2011/LaRusch et al., 
2012/Rosendahl et al., 
2013 
Oculocutaneous albinsim OCA2 
TYRP1/SLC45
A2/TYR 
Chiang et al., 2008/Wei 
et al., 2013 
Oculocutaneous albinsim TYR SLC45A2 Wei et al., 2013 
Cystinuria SLC3A1 SLC7A9 Font-Llitjós et al., 2005 
Transposition of the great 
arteries 
ZIC3 
FOXH1/NKX2
-5 
De Luca et al., 2010 
Congenital heart disease MYH6 
NKX2-
5/GATA4 
Granados-Riveron et al., 
2012 
Charcot–Marie–Tooth disease PMP22 ABCD1/LITAF Meggouh et al., 
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2005/Hodapp et al., 
2006 
Charcot–Marie–Tooth disease GJB1 EGR2 Chung et al., 2005 
Charcot–Marie–Tooth disease GDAP1 MFN2 Vital et al., 2012 
Refractory auto-inflammatory 
syndrome 
TNFRSF1A CIAS1 Touitou et al., 2006 
Short-rib polydactyly syndrome 
type 2 
NEK1 DYNC2H1 Thiel et al., 2011 
Maturity-onset diabetes of the 
young 
HNF1A HNF1B Karges et al., 2007 
Maturity-onset diabetes of the 
young 
HNF1A HNF4A 
Forlani et al., 
2010/Shankar et al., 
2013 
Polycystic kidney disease PKD1 PKD2 
Pei et al., 
2001/Dedoussis et al., 
2008 
Hyperimmunoglobulinaemia D 
and periodic fever syndrome 
MVK TNFRSF1A Hoffmann et al., 2005 
Obesity, hyperinsulinaemia and 
insulin resistance 
TCF1 NROB2 Tonooka et al., 2002 
Progressive external 
ophthalmoplegia 
POLG C10orf2 
Van Goethem et al., 
2003 
Neuronal ceroid lipofuscinosis POLG CLN5 Staropoli et al., 2012 
Chronic lung disease SFTPC ABCA3 Bullard/Nogee, 2007 
Lafora disease EPM2B PPP1R3C Guerrero et al., 2011 
Congenital erythropoietic 
porphyria 
UROS ALAS2 To-Figueras et al., 2011 
Familial venous thrombosis PROC PROS1 
Formstone et al., 
1996/Brenner et al., 
1996/Boinot et al., 
2003/Knoll et al., 
2001/Hayashida et al., 
2003 
Familial venous thrombosis PROC SERPIND1 Bernardi et al., 1996 
176 
 
Breast cancer BRCA1 BRCA2 
Leegte et al., 2005/Lavie 
et al., 2011/Heidemann 
et al., 2012 
Breast cancer BRCA1 PALB2 Pern et al., 2012 
Multiple tumours of different 
types 
BRCA1 MLH1 Pedroni et al., 2013 
Familial pulmonary arterial 
hypertension 
BMPR2 THBS1 Maloney et al., 2012 
Hereditary nonpolyposis 
colorectal cancer 
MUTYH MSH6 
Van Puijenbroek et al., 
2007/Giráldez et al., 
2009 
Colorectal cancer EPCAM MSH2 Li-Chang et al., 2013 
Colorectal cancer, juvenile onset APC MSH2 
Uhrhammer/Bignon, 
2008 
Autoimmune 
lymphoproliferative syndrome 
FAS CASP10 Cerutti et al., 2007 
Autoimmune 
lymphoproliferative syndrome 
FAS PRF1 Clementi et al., 2004 
Steroid-resistant focal 
segmental glomerulosclerosis 
NPHS2 
NPHS1/CD2A
P 
Löwik et al., 2008 
Severe infantile liver disease AKR1D1 SKIV2L Morgan et al., 2013 
Ataxia, dementia and 
hypogonadotropism 
RNF216 OTUD4 Margolin et al., 2013 
Paediatric inflammatory bowel 
disease 
NOD2 
GSDMB/ZNF
365/ERAP2/S
EC16A/GMP
BB 
Christodoulou et al., 
2013 
Paediatric inflammatory bowel 
disease 
BACH2 IL10 
Christodoulou et al., 
2013 
Hutchinson-Gilford progeria 
syndrome 
ZMPSTE24 LMNA Denecke et al., 2006 
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Figure A6.1 Linkage disequilibrium (LD) heat map of chromosome 6, positions 26,100,000-
26,410,000 (via LDlink; Machiela & Chanock, 2015). Blocks of red indicate high 
2R  values, 
corresponding to genomic regions in LD. Blocks enclosed by blue squares are regions which have been 
found to harbour SNPs that affect gene expression change in the brain. 
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Figure A6.2 Linkage disequilibrium (LD) heat map of chromosome 16, positions 100,000-890,000 (via 
LDlink; Machiela & Chanock, 2015). Blocks of red indicate high 
2R  values, corresponding to 
genomic regions in LD. Blocks enclosed by blue squares are regions which have been found to harbour 
SNPs that affect gene expression change in the brain. 
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Figure A6.3 Linkage disequilibrium (LD) heat map of chromosome 11, positions 100,000-800,000 (via 
LDlink; Machiela & Chanock, 2015). Blocks of red indicate high 
2R  values, corresponding to 
genomic regions in LD. Blocks enclosed by blue squares are regions which have been found to harbour 
SNPs that affect gene expression change in the brain. 
 
Table A6.1 List of 347 schizophrenia genes, which were identified by GWAS (Ripke et al., 2013). 
Gene IDs 
ABCB9 CNKSR2 HIRIP3 PAK6 SLC39A8 
AC005477.1 CNNM2 HSPA9 PARD6A SLC45A1 
AC005609.1 CNOT1 HSPD1 PBRM1 SLC4A10 
AC027228.1 CNTN4 HSPE1 PBX4 SLC7A6 
AC073043.2 COQ10B IGSF9B PCCB SLC7A6OS 
ACD CR1L IK PCDHA1 SMDT1 
ACTR5 CREB3L1 IMMP2L PCDHA10 SMG6 
ADAMTSL3 CSMD1 INA PCDHA2 SMIM4 
AGPHD1 CTNNA1 INO80E PCDHA3 SNAP91 
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AKT3 CTNND1 IREB2 PCDHA4 SNX19 
AL049840.1 CTRL ITIH1 PCDHA5 SPCS1 
ALDOA CUL3 ITIH3 PCDHA6 SREBF1 
AMBRA1 CYP17A1 ITIH4 PCDHA7 SREBF2 
ANKRD44 CYP26B1 KCNB1 PCDHA8 SRPK2 
ANKRD63 CYP2D6 KCNJ13 PCDHA9 SRR 
ANP32E DDX28 KCNV1 PCGEM1 STAB1 
APH1A DFNA5 KCTD13 PCGF6 STAC3 
APOPT1 DGKI KDM3B PDCD11 STAG1 
ARHGAP1 DGKZ KDM4A PITPNM2 STAT6 
ARL3 DNAJC19 KLC1 PJA1 SUGP1 
ARL6IP4 DND1 L3MBTL2 PLA2G15 TAC3 
AS3MT DOC2A LCAT PLCB2 TAF5 
ASPHD1 DPEP2 LRP1 PLCH2 TAOK2 
ATG13 DPEP3 LRRC48 PLCL1 TBC1D5 
ATP2A2 DPP4 LRRIQ3 PLEKHO1 TBX6 
ATPAF2 DPYD LUZP2 PODXL TCF20 
ATXN7 DRD2 MAD1L1 PPP1R13B TCF4 
BAG5 DRG2 MAN2A1 PPP1R16B THAP11 
BCL11B DUS2L MAN2A2 PPP2R3A THOC7 
BOLL EDC4 MAPK3 PPP4C TLE1 
BTBD18 EFHD1 MARS2 PRKD1 TLE3 
C10orf32 EGR1 MAU2 PRR12 TM6SF2 
C11orf31 ENKD1 MDK PRRG2 TMCO6 
C11orf87 EP300 MED19 PSKH1 TMEM110-MUSTN1 
C12orf42 EPC2 MEF2C PSMA4 TMEM194A 
C12orf65 EPHX2 MIR137 PSMB10 TMEM219 
C12orf79 ERCC4 MIR548AJ2 PSMD6 TMTC1 
C16orf86 ESAM MLL5 PTGIS TMX2 
C16orf92 ESRP2 MMP16 PTN TNFRSF13C 
C1orf132 ETF1 MPHOSPH9 PTPRF TOM1L2 
C1orf51 F2 MPP6 PUS7 TRANK1 
C1orf54 FAM109B MSANTD2 R3HDM2 TRIM8 
C2orf47 FAM53C MSL2 RAI1 TRMT61A 
C2orf69 FAM57B MUSTN1 RANBP10 TSNARE1 
C2orf82 FAM5B MYO15A RANGAP1 TSNAXIP1 
C3orf49 FANCL MYO1A RCN3 TSR1 
C4orf27 FES NAB2 REEP2 TSSK6 
CA14 FURIN NAGA RERE TYW5 
CA8 FUT9 NCAN RFTN2 USMG5 
CACNA1C FXR1 NCK1 RGS6 VPS14C 
CACNA1I GALNT10 NDUFA13 RILPL2 VPS45 
CACNB2 GATAD2A NDUFA2 RIMS1 VRK2 
CCDC39 GDPD3 NDUFA4L2 RRAS VSIG2 
CD14 GFOD2 NDUFA6 SATB2 WBP1L 
CD46 GFRA3 NEK1 SBNO1 WBP2NL 
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CDC25C GID4 NEK4 SCAF1 WDR55 
CDK2AP1 GIGYF2 NFATC3 SDCCAG8 XRCC3 
CENPM GLT8D1 NGEF Sep-03 YPEL3 
CENPT GNL3 NISCH SERPING1 YPEL4 
CHADL GOLGA6L4 NLGN4X SETD8 ZDHHC5 
CHRM4 GPM6A NOSIP SEZ6L2 ZFYVE21 
CHRNA3 GRAMD1B NRGN SF3B1 ZMAT2 
CHRNA5 GRIA1 NRN1L SFXN2 ZNF408 
CHRNB4 GRIN2A NT5C2 SGSM2 ZNF536 
CILP2 GRM3 NT5DC2 SHISA8 ZNF804A 
CKAP5 HAPLN4 NUTF2 SHMT2 ZSCAN2 
CKB HARBI1 NXPH4 SLC12A4 ZSWIM6 
CLCN3 HARS OGFOD2 SLC32A1  
CLP1 HARS2 OSBPL3 SLC35G2  
CLU HCN1 OTUD7B SLC38A7  
 
Table A6.2 List of 97 extended gene regions (EGRs) and corresponding genomic positions. 
EGR ID hg19 position (Chr, Start, End) 
PLCH2 1 2407754 2436964 
SLC45A1{RERE} 1 7136076 9502487 
PTPRF{KDM4A} 1 43166725 44779619 
LRRIQ3 1 74309811 74794591 
DPYD-MIR137 1 96758959 99100978 
VPS45{APH1A OTUD7B}-PLEKHO1{ANP32E APH1A 
OTUD7B}-C1orf51{ANP32E APH1A C1orf54 CA14 
OTUD7B} 
1 149815778 151245170 
FAM5B 1 176238088 178364194 
C1orf132{CD46 CR1L} 1 207005216 209798531 
SDCCAG8-AKT3 1 243419307 244282764 
VRK2-FANCL 2 57655500 60917597 
CYP26B1 2 71908225 72807021 
EPC2 2 148355764 150085782 
SLC4A10 2 162480845 162841786 
DPP4 2 162848755 162931052 
ZNF804A 2 184137898 186082304 
PCGEM1 2 193614571 193641625 
SF3B1{AC073043.2 ANKRD44 BOLL COQ10B 
HSPD1 HSPE1 MARS2 PLCL1 RFTN2 SATB2 TYW5}-
C2orf47{AC073043.2 C2orf69 TYW5} 
2 196972133 201568864 
CUL3 2 224775116 225814198 
GIGYF2{C2orf82 EFHD1 KCNJ13}-NGEF{C2orf82 
EFHD1 KCNJ13} 
2 232630330 234661428 
CNTN4 3 1103727 3458808 
TBC1D5 3 17198654 19068576 
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TRANK1 3 36704648 37283621 
GNL3{GLT8D1 ITIH1 ITIH4 NEK4 NISCH NT5DC2 
PBRM1 SMIM4 SPCS1 STAB1}-MUSTN1{GLT8D1 
ITIH1 ITIH3 ITIH4 NEK4 NISCH NT5DC2 PBRM1 
SMIM4 SPCS1 TMEM110-MUSTN1} 
3 51523089 53938766 
C3orf49-THOC7{ATXN7 PSMD6} 3 63327080 64504050 
PCCB{MSL2 NCK1 PPP2R3A SLC35G2}-
STAG1{MSL2 NCK1 PPP2R3A SLC35G2} 
3 134764021 138361288 
CCDC39{FXR1}-DNAJC19{FXR1} 3 179424471 181029187 
MIR548AJ2 4 23464696 23464726 
SLC39A8 4 103182821 103266655 
NEK1{C4orf27 CLCN3} 4 169960467 170720959 
GPM6A 4 175672336 178256786 
HCN1 5 45255052 46147700 
ZSWIM6 5 60347967 60841999 
MEF2C 5 88014058 88199922 
MAN2A1 5 107783599 110444200 
GFRA3{CDC25C EGR1 ETF1 FAM53C KDM3B 
REEP2}-HSPA9{CDC25C EGR1 ETF1 FAM53C 
KDM3B REEP2} 
5 136974195 139092464 
NDUFA2{AC005609.1 CD14 DND1 HARS HARS2 IK 
PCDHA1 PCDHA10 PCDHA2 PCDHA3 PCDHA4 
PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 
TMCO6 WDR55 ZMAT2} 
5 139346411 141030658 
GRIA1-GALNT10 5 151894201 154222766 
RIMS1 6 71769468 73112845 
SNAP91 6 83409589 85562549 
FUT9 6 96463845 96663488 
MAD1L1 7 1142906 2690329 
DFNA5{MPP6 OSBPL3} 7 23393355 25261123 
GRM3 7 85207255 87309798 
PUS7{SRPK2} 7 104536115 105796193 
PODXL 7 130644170 131943940 
PTN-DGKI 7 136384831 138163595 
CSMD1 8 2792875 4916754 
CLU{EPHX2} 8 26433842 28250633 
CA8 8 59643721 62485987 
MMP16 8 87936967 90632845 
KCNV1 8 110809503 111262738 
TSNARE1 8 142508513 144110524 
TLE1 9 83123419 85560764 
CACNB2 10 18223287 18830688 
ARL3{AS3MT C10orf32 NT5C2 PDCD11 SFXN2 
TRIM8 USMG5 WBP1L}-CYP17A1{AS3MT 
C10orf32 NT5C2 PDCD11 SFXN2 TAF5 TRIM8 
USMG5 WBP1L}-CNNM2{AS3MT NT5C2 PDCD11 
SFXN2 TAF5 USMG5 WBP1L}-INA{AS3MT NT5C2 
PDCD11 TAF5 USMG5 WBP1L}-PCGF6{AS3MT 
10 103581302 105408987 
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NT5C2 PDCD11 TAF5 USMG5} 
LUZP2 11 23723074 25104186 
HARBI1{AMBRA1 ATG13 CHRM4 CKAP5 CREB3L1 
DGKZ MDK ZNF408}-F2{AMBRA1 ARHGAP1 
ATG13 CKAP5 CREB3L1 ZNF408} 
11 45850311 47765368 
SERPING1{BTBD18 C11orf31 MED19 TMX2 
YPEL4}-CTNND1{BTBD18 C11orf31 CLP1 MED19 
TMX2 YPEL4 ZDHHC5} 
11 56887198 59411566 
C11orf87 11 109203086 109339543 
DRD2 11 112171763 114011104 
GRAMD1B-NRGN{ESAM MSANTD2 VSIG2} 11 122727700 126065367 
SNX19 11 129734531 131543436 
IGSF9B 11 132848137 134271219 
CACNA1C 12 1243304 3279035 
TMTC1 12 29213919 30967424 
TMEM194A{NAB2 R3HDM2 SHMT2 TAC3}-
LRP1{MYO1A NAB2 NDUFA4L2 NXPH4 R3HDM2 
SHMT2 STAC3 STAT6 TAC3} 
12 56677347 58245642 
C12orf79 12 92378752 92536447 
C12orf42 12 103128804 104278072 
ATP2A2 12 110719032 110788897 
OGFOD2{ABCB9 ARL6IP4 CDK2AP1 MPHOSPH9 
PITPNM2 RILPL2 SBNO1 SETD8}-C12orf65{ABCB9 
ARL6IP4 CDK2AP1 MPHOSPH9 PITPNM2 RILPL2 
SBNO1 SETD8} 
12 121722819 124308277 
PRKD1 14 29224481 30931651 
RGS6{AC005477.1} 14 72399156 73033238 
BCL11B 14 99635625 99737822 
TRMT61A{APOPT1 BAG5 CKB KLC1 XRCC3 
ZFYVE21}-AL049840.1{APOPT1 BAG5 CKB KLC1 
PPP1R13B XRCC3 ZFYVE21} 
14 103489114 105289120 
ANKRD63{PAK6} 15 39906215 40937199 
TLE3 15 69724037 71047194 
IREB2{AC027228.1 AGPHD1 CHRNA3 CHRNA5 
CHRNB4 PSMA4} 
15 76785048 80148768 
ADAMTSL3 15 83975968 84722793 
GOLGA6L4 15 84904525 84914120 
ZSCAN2 15 85096833 85681159 
MAN2A2{FES FURIN} 15 90682138 92618436 
GRIN2A 16 8982345 10981350 
ERCC4 16 12704748 14769348 
DOC2A{ALDOA ASPHD1 C16orf92 FAM57B GDPD3 
HIRIP3 INO80E KCTD13 MAPK3 SEZ6L2 TAOK2 
TBX6 TMEM219 YPEL3}-PPP4C{ALDOA ASPHD1 
FAM57B GDPD3 HIRIP3 KCTD13 MAPK3 SEZ6L2 
TBX6 YPEL3} 
16 28839158 30771265 
CNOT1{SLC38A7} 16 58134256 58833839 
ACD{C16orf86 CENPT CTRL DDX28 DPEP2 DPEP3 
DUS2L EDC4 ENKD1 ESRP2 GFOD2 LCAT NRN1L 
16 66861562 69771395 
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NUTF2 PARD6A PLA2G15 PSKH1 PSMB10 
RANBP10 SLC12A4 THAP11 TSNAXIP1}-
SLC7A6{C16orf86 CTRL DDX28 DPEP2 DPEP3 
ENKD1 ESRP2 GFOD2 NRN1L NUTF2 PARD6A 
PLA2G15 PSKH1 PSMB10 SLC12A4 THAP11 
TSNAXIP1}-NFATC3{C16orf86 CTRL DDX28 DPEP2 
DPEP3 ENKD1 ESRP2 GFOD2 NRN1L NUTF2 
PARD6A PLA2G15 PSKH1 PSMB10 SLC12A4 
THAP11 TSNAXIP1}-SLC7A6OS{C16orf86 CTRL 
DDX28 DPEP2 ENKD1 ESRP2 NUTF2 PARD6A 
PLA2G15 PSMB10 SLC12A4 TSNAXIP1} 
TSR1{SGSM2 SMG6 SRR} 17 1024099 2933986 
RAI1{ATPAF2 DRG2 GID4 LRRC48 MYO15A 
SREBF1 TOM1L2} 
17 16112939 19671395 
HAPLN4{CILP2 GATAD2A MAU2 NCAN NDUFA13 
PBX4 SUGP1 TM6SF2 TSSK6} 
19 18316601 20008019 
ZNF536 19 29557055 32850323 
RCN3{NOSIP PRR12 PRRG2 RRAS}-SCAF1{NOSIP 
PRR12 PRRG2 RRAS} 
19 49404637 50661517 
PPP1R16B{ACTR5 SLC32A1} 20 37291161 37678722 
KCNB1-PTGIS 20 47638985 48768940 
CACNA1I-L3MBTL2{CHADL RANGAP1}-
EP300{CHADL RANGAP1}-CENPM{CYP2D6 
FAM109B NAGA SEPT3 SHISA8 SMDT1 SREBF2 
TNFRSF13C WBP2NL}-NDUFA6{CYP2D6 FAM109B 
NAGA SEPT3 SHISA8 SMDT1 SREBF2 TCF20 
TNFRSF13C WBP2NL} 
22 39291157 43480828 
NLGN4X 23 5808083 6666551 
CNKSR2 23 20595156 21693982 
PJA1 23 67636502 69240034 
 
Table A6.3 Genes found to overlap in the largest components of INTERKR and INTERVC binary Hi-
C networks. 
Genes 
AC073043.2 ESAM MSANTD2 TCF4 
ATXN7 ETF1 NLGN4X TLE1 
C2orf69 FAM5B NRGN TMTC1 
CNTN4 GALNT10 PCDHA TYW5-C2orf47 
CSMD1 GPM6A PDCD11 VSIG2 
CTNNA1 HCN1 PLCL1 ZNF804A 
CYP26B1 HSPA9 PRKD1 ZSWIM6 
DYPD IMMP2L PSMD6 
 
EGR1 MMP16 RIMS1 
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Table A6.4 SNPs within linkage disequilibrium blocks which satisfy schizophrenia association  
05.0p  (figure 6.20). 
rsID Chromosome Position (hg19) P-value 
rs1978 6 26377573 4.76 × 10-7 
rs9393714 6 26373740 6.93 × 10-7 
rs1977 6 26377546 7.54 × 10-7 
rs12176317 6 26372786 7.80 × 10-7 
rs9358932 6 26362705 9.17 × 10-7 
rs2073529 6 26375159 9.76 × 10-7 
rs9379855 6 26364930 1.06 × 10-6 
rs9393713 6 26373678 1.15 × 10-6 
rs9393708 6 26362643 1.19 × 10-6 
rs9393710 6 26367833 1.21 × 10-6 
rs9379851 6 26354780 1.31 × 10-6 
rs9379858 6 26367689 1.35 × 10-6 
rs9393705 6 26361011 1.52 × 10-6 
rs9366653 6 26354247 1.60 × 10-6 
rs9379859 6 26369549 1.60 × 10-6 
rs9379856 6 26366836 1.66 × 10-6 
rs13218591 6 26376832 6.64 × 10-6 
rs3734536 6 26365346 8.81 × 10-6 
rs12199613 6 26367218 9.59 × 10-6 
rs1985732 6 26376161 9.60 × 10-6 
rs9393709 6 26365147 1.07 × 10-5 
rs6933583 6 26355283 1.38 × 10-5 
rs4712980 6 26355758 1.46 × 10-5 
rs3799378 6 26404374 1.87 × 10-5 
rs4712981 6 26361430 2.15 × 10-5 
rs9379870 6 26374410 2.67 × 10-5 
rs4712984 6 26379537 0.00011 
rs2076029 6 26390830 0.000154 
rs2073526 6 26374658 0.000161 
rs1796518 6 26388672 0.000183 
rs12214031 6 26376628 0.00026 
rs10456045 6 26404958 0.000437 
rs1614887 6 26393021 0.000589 
rs10946808 6 26233387 0.002906 
rs2858944 16 193586 0.014088 
rs6600233 16 143503 0.035136 
rs12596306 16 572882 0.013867 
rs742285 16 872531 0.000331 
rs12445974 16 866053 0.003636 
rs3765263 16 840378 0.019352 
186 
 
rs4984931 16 852137 0.021463 
rs742319 16 841966 0.030402 
rs3765264 16 840409 0.031203 
rs3765266 16 840769 0.033247 
rs2294451 16 847743 0.035097 
rs1078903 16 854689 0.040022 
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Appendix B 
PROGRAM Penetrance regulators: 
 S = (Size of reduced penetrance gene dataset); 
 FOR 1 to S 
  Find top ten interacting fragments; 
  Store fragments in list; 
  Find top ten interacting fragments for controls; 
  Store fragments in list for controls; 
 END FOR; 
 Concatenate case list into one large list; 
 Concatenate control list into one large list; 
 FOR (Each unique region in case list) 
  Construct 2-by-2 table; 
  Count frequency of region in case list; 
  Store frequency in index (1, 1) of table; 
  Subtract frequency from S; 
  Store result in index (1, 2) of table; 
  Count frequency of region in control list; 
  Store frequency in index (2, 1) of table; 
  Subtract frequency from S; 
  Store result in index (2, 2) of table; 
  Perform Fisher’s exact test on table; 
  Store region, table and result in new table; 
 END FOR; 
 Sort new table in descending order of table(1, 1) magnitude; 
 Print sorted new table; 
END. 
Figure B4.1 Pseudocode for analysis described in section 4.3.2. 
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PROGRAM Third-party regulators: 
 Define interaction frequency rank threshold, h; 
 S = (Size of reduced penetrance pairs dataset); 
 Construct 2-by-2 table; 
 FOR 1 to S 
  Find top h interacting fragments for gene 1 of pair; 
  Store fragments in list 1; 
  Find top h interacting fragments for gene 2 of pair; 
  Store fragments in list 2; 
  Find top h interacting fragments for gene 1 of control pair; 
  Store fragments in control list 1; 
  Find top h interacting fragments for gene 2 of control pair; 
  Store fragments in control list 2; 
  Count frequency of identical regions appearing in both list 1 and list 2; 
  IF (Frequency > 0) 
   THEN Add one to index (1, 1) of table; 
   ELSE Add one to index (1, 2) of table; 
  END IF; 
  Count frequency of identical regions appearing in both control list 1 
  and control list 2; 
  IF (Frequency > 0) 
   THEN Add one to index (2, 1) of table; 
   ELSE Add one to index (2, 2) of table; 
  END IF; 
 END FOR; 
 Perform Fisher’s exact test on table; 
 Print result; 
END. 
Figure B4.2 Pseudocode for analysis described in section 4.3.3. 
 
PROGRAM Fusion interactions: 
 S = (Size of gene fusions dataset); 
 FOR 1 to S 
  Find mean (excluding zeroes) of all interactions with fusion gene  
  region; 
  Store mean in case list; 
  Find mean (excluding zeroes) of all interactions with control region; 
  Store mean in control list; 
 END FOR; 
 Perform two-sample t-test on case list versus control list; 
 Print result; 
END. 
Figure B5.1 Pseudocode for analysis described in section 5.3.2. 
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PROGRAM Fusion pair proximity: 
 Define interaction frequency rank threshold, h; 
 S = (Size of gene fusion pairs dataset); 
 Construct 2-by-2 table; 
 FOR 1 to S 
  IF (Interaction frequency rank of gene fusion pair <= h) 
   THEN Add one to index (1, 1) of table; 
   ELSE Add one to index (1, 2) of table; 
  END IF; 
  IF (Interaction frequency rank of control pair <= h) 
   THEN Add one to index (2, 1) of table; 
   ELSE Add one to index (2, 2) of table; 
  END IF; 
 END FOR; 
 Perform Fisher’s exact test on table; 
 Print result; 
END. 
Figure B5.2 Pseudocode for analysis described in section 5.3.3. 
 
PROGRAM Cell line choice: 
 Set interaction frequency threshold, h; 
 S = (Size of eQTL pairs dataset); 
 Create 3-by-2 table; 
 FOR 1 to S 
  IF (eQTL pair interaction frequency >= h for GM12878 Hi-C) 
   THEN Add one to index (1, 1) of table; 
   ELSE Add one to index (1, 2) of table; 
  ENDIF; 
  IF (eQTL pair interaction frequency >= h for HMEC Hi-C) 
   THEN Add one to index (2, 1) of table; 
   ELSE Add one to index (2, 2) of table; 
  ENDIF; 
  IF (eQTL pair interaction frequency >= h for IMR90 Hi-C) 
   THEN Add one to index (3, 1) of table; 
   ELSE Add one to index (3, 2) of table; 
  ENDIF; 
 ENDFOR; 
 Perform Fisher’s exact test between cell line groups of table; 
 Print result; 
END. 
Figure B6.1 Pseudocode for analysis described in section 6.3.5. 
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PROGRAM eQTL and Hi-C overlap: 
 Set interaction frequency threshold, h; 
 Set expression p-value threshold, x; 
 S = (Size of eQTL pairs dataset); 
 Create 2-by-2 table; 
 FOR 1 to S 
  IF (Interaction frequency of pair >= h AND expression p-value <= x) 
   THEN Add one to index (1, 1) of table; 
  ELSEIF (Interaction frequency of pair >= h AND expression p-value > x) 
   THEN Add one to index (1, 2) of table; 
  ELSEIF (Interaction frequency of pair < h AND expression p-value <= x) 
   THEN Add one to index (2, 1) of table; 
  ELSEIF (Interaction frequency of pair < h AND expression p-value > x) 
   THEN Add one to index (2, 2) of table; 
  ENDIF; 
 ENDFOR; 
 Perform Fisher’s exact test on table; 
 Print result; 
END. 
Figure B6.2 Pseudocode for analysis described in section 6.3.6. 
